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uncover diverse genes and repetitive elements silenced by each protein. We conducted RNA-seq
experiments both with and without the addition of hiHep reprogramming factors. We identified four
unique clusters of these proteins based on their common targets of repression, including differences in
H3K9me3 and H3K27me3 marks across genes derepressed by each cluster. In an additional study, I
investigated how KRAB domain-containing zinc finger proteins (KRAB-ZFPs) might silence hepatic genes
in alternate lineages. I identified six putative liver lineage antagonistic KRAB-ZFPs. A mostly unstudied
primate-specific KRAB-ZFP known as ZNF695 became the top candidate for allowing hundreds of genes,
including hepatic genes, to be derepressed following knockdown in the hiHep reprogramming model and
facilitated the widespread loss of H3K9me3. I mapped ZNF695 localization throughout the genome and
tied these patterns to the observed gene expression changes. Additionally, we were able to see that
depletion of ZNF695 in hiHeps transplanted in a diseased liver mouse model were able to produce higher
levels of human albumin that hiHeps without the knockdown. Together, these findings greatly expanded
our knowledge of H3K9me3-based repression in humans and provided a novel picture of ZNF695
regulatory capabilities.
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ABSTRACT
UNLOCKING COMPACTED HETEROCHROMATIN THROUGH MODULATION
OF ASSOCIATED PROTEINS
Kelsey Elizabeth Mercado Kaeding
Kenneth S. Zaret

The hundreds of cell types that compose human body tissues contain identical genomes
yet vary considerably in their gene activity and protein content. While the underlying
blueprints that define these diverse cell types exist in all cells, a given cell’s specific
transcriptomic and proteomic landscape is controlled by an incredibly complex system of
gene regulatory complexes and epigenetic marks which promote activation of cell-type
specific gene expression profiles and silence alternative cell fate genes. However, the
mechanism by which specific genomic loci are silenced in different cell types is still not
well understood. Here I strove to understand the vital contribution of tightly compacted
heterochromatin on cell identity at specific loci. I studied how 97 unique heterochromatinassociated human proteins play a role in heterochromatin-based gene and repetitive
element silencing. As H3K9me3 can block cellular reprogramming, we used a humaninduced fibroblast to hepatocyte (hiHep) reprogramming model to uncover diverse genes
and repetitive elements silenced by each protein. We conducted RNA-seq experiments
both with and without the addition of hiHep reprogramming factors. We identified four
unique clusters of these proteins based on their common targets of repression, including
differences in H3K9me3 and H3K27me3 marks across genes derepressed by each
cluster.
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In an additional study, I investigated how KRAB domain-containing zinc finger
proteins (KRAB-ZFPs) might silence hepatic genes in alternate lineages. I identified six
putative liver lineage antagonistic KRAB-ZFPs. A mostly unstudied primate specific
KRAB-ZFP known as ZNF695 became the top candidate for allowing hundreds of genes,
including hepatic genes, to be derepressed following knockdown in the hiHep
reprogramming model and facilitated the widespread loss of H3K9me3. I mapped ZNF695
localization throughout the genome and tied these patterns to the observed gene
expression changes. Additionally, we were able to see that depletion of ZNF695 in hiHeps
transplanted in a diseased liver mouse model were able to produce higher levels of human
albumin that hiHeps without the knockdown. Together, these findings greatly expanded
our knowledge of H3K9me3-based repression in humans and provided a novel picture of
ZNF695 regulatory capabilities.
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CHAPTER 1: INTRODUCTION
1.1 The role of heterochromatin in the establishment and maintenance of
cell identity
The tissues of the human body are made up of hundreds of cell types, and yet they contain
identical genomes. Therefore, while the underlying blueprints that define these diverse
cell types exist in all cells, the actual transcriptomic and proteomic landscape of a cell is
controlled by an incredibly complex system of gene regulatory complexes and epigenetic
marks. The physical structure of chromatin plays an important role in regulating the overall
transcriptional landscape of a cell. Physical compaction of chromatin creates either a
permissive or exclusionary structure for transcriptional machinery, thereby contributing
substantially to the overall cell type specification process. Through the normal course of
development, physically compacted chromatin known as heterochromatin is drastically
rearranged from a very low level in human embryonic stem cells (ESCs) to significantly
higher levels in somatic cells and is also accompanied by rearrangements to nuclear
structure (Hawkins et al., 2010b; Underwood et al., 2017). However, little is known about
how cell-type inappropriate genes are silenced in any given cell type (Becker et al., 2016;
Fisher and Merkenschlager, 2002; Hemberger et al., 2009; Meister et al., 2011). This
thesis will explore how genes and repetitive elements throughout the genome are targeted
for silencing.
The other main type of chromatin, euchromatin, represents the more open
chromatin structure and appears lighter on electron micrographs. Open euchromatic
chromatin fibers correlate with highest gene density, and is where the majority of
transcription occurs; however, interestingly an open chromatin state does not lead to a
1

direct correlation with gene expression as there can be diverse gene activity levels in
different chromatin states (Gilbert et al., 2004). It should also be noted that there are
regions of the genome that are not marked by any known histone mark and can be referred
to as “naïve” or “low signal” chromatin. Therefore, the main types of chromatin can be
described as open, transcriptionally active euchromatin, unmarked “naïve” chromatin, and
condensed heterochromatin (Figure 1A).
Heterochromatin was first discovered cytologically as having a dense, dark
appearance with electron microscopy due to a high uptake of DNA dyes, remains
condensed during interphase, and tends to be made up of large amounts of repetitive DNA
sequences and transposable elements (Beisel and Paro, 2011; Hawkins et al., 2010b;
Peters et al., 2001). Classically, heterochromatin was thought to contain few genes
(Allshire and Madhani, 2018; Brown, 1966; Heitz, 1928). The physically compact nature
of heterochromatin makes it refractory to binding by transcriptional machinery as the DNA
template is inaccessible, as demonstrated by resistance to nucleases (Wallrath and Elgin,
1995) and compaction in biophysical assays (Frenster et al., 1963; Gilbert and Allan,
2001). Heterochromatin also plays a key role in protecting the genome by preventing
aberrant recombination at repetitive sequences in the genome (Fanti et al., 1998; Peters
et al., 2001) and helps to ensure proper chromosome segregation. Compacted
heterochromatin is also essential for the silencing of transcription and transposons
(Allshire and Madhani, 2018). Heterochromatin has the ability to spread beyond nucleation
sites, with the classic example in Drosophila being position effect variegation phenotypes
that are propagated through altered chromatin packaging (Wallrath and Elgin, 1995)
allowing for distribution over regions up to megabases in size.
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The classic view of heterochromatin divides it into “facultative” versus “constitutive”
heterochromatin. Constitutive heterochromatin is described as repeat-rich, virtually
identical across different cell types and developmental lineages, stable throughout the cell
cycle (Saksouk et al., 2015). This constitutive heterochromatin is marked by the repressive
histone post translational modifications histone 3 lysine 9 di- and trimethylation (H3K9me2
and H3K9me3) (Nakayama et al., 2001; Rea et al., 2000). H3K9me3-marked
heterochromatin in mammals is deposited by the methyltransferases SUV39H1,
SUV39H2, and SETDB1 (O'Carroll et al., 2000; Rea et al., 2000; Schultz et al., 2002),
while the H3K9me1 and H3K9me2 methyltransferases are G9a and GLP (Tachibana et
al., 2001; Tachibana et al., 2002; Tachibana et al., 2005). H3K9me2 and H3K9me3marked regions are also compacted by heterochromatin binding protein (HP1), which in
turn can recruit histone modifiers including histone deacetylases (HDACs) and DNA
methyltransferases, helping heterochromatin to spread across domains (Al-Sady et al.,
2013; Bannister et al., 2001; James and Elgin, 1986; Lachner et al., 2001). HP1 has the
ability to self-oligomerize, allowing it to create tightly compacted chromatin regions
(Canzio et al., 2011). These histone methyltransferases also play a role in DNA
methylation at CpG dinucleotides and low-level histone acetylation (Epsztejn-Litman et
al., 2008; Lehnertz et al., 2003).
Facultative heterochromatin, on the other hand, is described as dynamic
throughout development, able to silence cell-type specific genes and enhancers, and
variable throughout the cell cycle (Trojer and Reinberg, 2007). This type of
heterochromatin is typically marked by histone 3 lysine 27 trimethylation (H3K27me3) and
is deposited by the Polycomb repressive complex 2 (PRC2) (Boyer et al., 2006; Ezhkova
et al., 2009; Lee et al., 2006; Xu et al., 2014). PRC2 marks and silences many lineage3

specific genes, such as the homeobox family of transcription factors (Beisel and Paro,
2011; Margueron and Reinberg, 2011). The methyl groups deposited by PRC2 are able
to block transcriptional initiation which helps to explain the gene silencing capabilities
(Dellino et al., 2004).
Ultimately, this view of constitutive versus facultative heterochromatin is far too
simplistic. There is strong evidence to support the notion that H3K9me2/3 is also able to
form in a cell type specific manner, rejecting the idea that it is purely constitutive and
identical across cell types. Instead H3K9me2/3 is in fact dynamically regulated throughout
development across thousands of genes (Becker et al., 2017; Becker et al., 2016; Hawkins
et al., 2010a; Nicetto et al., 2019; Pace et al., 2018; Soufi et al., 2012; Wang et al., 2018).
H3K9me3-marked heterochromatin has clearly been shown to silence cell-type
inappropriate protein coding genes in other lineages (Biferali et al., 2021; Nicetto et al.,
2019). In an effort to uncover the most tightly compacted heterochromatin in the genome,
our lab developed a method known as Gradient-seq that relies upon sonication of
formaldehyde crosslinked chromatin to separate tightly compacted sonication-resistant
heterochromatin from loosely compacted sonication-sensitive euchromatin that is then
separated by size on a sucrose gradient (Becker et al., 2017). The tightly compacted
heterochromatin was termed sonication-resistant heterochromatin (srHC) (Becker et al.,
2017). 60.8% of srHC domains are also called as H3K9me3 domains, 32.8% are
H3K27me3 domains and 7.0% of domains have both marks (Becker et al., 2017) as seen
elsewhere (Chandra et al., 2012; Hawkins et al., 2010a) (Figure 1A, B).
There are also regions of the genome marked by H3K9me3 that are dependent
upon the human silencing hub (HUSH) complex and SETDB1 that are classified as
euchromatic and are more permissive to gene expression (Becker et al., 2017;
4

Tchasovnikarova et al., 2015). Additionally, while H3K27me3-marked promoters are
correlated with gene repression, these promoters are also accessible to transcription
factor binding, indicating that gene regulation at these loci is likely more complex (Breiling
et al., 2001). There are several other known marks associated with heterochromatin
including H4K20me3 (Schotta et al., 2004), H4K20me1 (Schotta et al., 2008), H3K64me3
(Lange et al., 2013), and H3K56me3 (Jack et al., 2013) though these types of
heterochromatin are even less well understood. The findings of this thesis will further
highlight the blurring between classical facultative and constitutive heterochromatin.

1.2 Cellular reprogramming and how heterochromatin impedes
reprogramming
Establishing and maintaining cell identity through selective gene expression and
repression is an essential cellular function. As there are shortages of fully mature native
cells of many different cell types, there is a desire to induce cellular reprogramming to
create differentiated cells that could be used for transplantation into diseased human
tissue or for disease modelling. One such method is reprogramming of a human fibroblast
to an induced pluripotent stem cell (iPSC) reprogramming through the ectopic expression
OCT4, SOX2, KLF4, and cMYC (Takahashi and Yamanaka, 2006). Reprogrammed iPSCs
impressively recapitulate true ESCs with very similar transcriptomes, functions, and
epigenetic landscapes (Cahan et al., 2014; Maherali et al., 2007; Wernig et al., 2007).
However, the classic iPSC reprogramming methods were highly inefficient with less than
1% of cells successfully reprogramming (Papp and Plath, 2013; Vierbuchen and Wernig,
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2012). Inefficiencies in reprogramming led to the hypothesis that there is a “barrier” to
reprogramming.
In mouse iPSCs, H3K9me3-marked heterochromatin is compacted in partial
iPSCs but then reorganizes and disperses as full reprogramming occurs (Fussner et al.,
2011). Our lab uncovered that large megabase scale domains of the genome enriched for
H3K9me3 are refractory to binding of the iPSC reprogramming transcription factors during
the first 48 hours of reprogramming (Soufi et al., 2012; Soufi and Zaret, 2013) (Figure 2A).
In part, this barrier to reprogramming is conferred by the tightly compacted
heterochromatin marked by H3K9me3 and can be overcome by depletion of key
methyltransferases (Chen et al., 2013; Onder et al., 2012; Soufi et al., 2012; Sridharan et
al., 2013). Compared to H3K9me3, H3K27me3 is much more accessible to transcription
factor binding and paused polymerase (Becker et al., 2017; Soufi et al., 2012) and does
not pose the same hurdle to reprogramming technologies.
There also exist many direct reprogramming or transdifferentiation methods that
rely upon the overexpression of key transcription factors for a particular lineage starting
from fibroblasts. There are protocols for the myoblast lineage (Davis et al., 1987),
cardiomyocytes (Ieda et al., 2010), macrophages (Feng et al., 2008), and hepatocytes
(Huang et al., 2011; Sekiya and Suzuki, 2011) among others. While these methods are
more efficient on a per cell basis than iPSC reprogramming, the successfully
reprogrammed cells do not fully recapitulate the desired phenotype of the primary cell
starting at the transcriptomic level, and none have been shown to be fully functional in cell
transplantation models. Transcriptome analysis of various direct reprogramming models
have shown significant differences between transdifferentiated and primary cells (Cahan
et al., 2014; Morris et al., 2014). Again, our lab was able to determine that genes marked
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by H3K9me3 in the starting fibroblasts failed to be activated during fibroblast to hiHep
direct reprogramming and H3K27me3 did not have as strong of a repressive effect (Becker
et al., 2017) (Figure 2B). In Caenorhabditis elegans (C. elegans) it has been seen that
H3K9me can play a direct role in restricting transcription factor access in terminally
differentiated cells (Methot et al., 2021) which aligns well with our findings.
Our lab has a long-standing interest in the liver lineage, so we used a transcription
factor-based protocol to transdifferentiate human BJ fibroblasts to hiHeps through the
ectopic expression of the liver lineage transcription factors HNF1a, HNF4a, and FOXA3
(Huang et al., 2014) as our reprogramming model. The ability to study human liver
development, physiology and drug metabolism continues to be limited by a lack of
sufficient models. Hepatocytes make up 70-80% of the human liver by mass and are
responsible for most key liver functions including bile production, albumin secretion,
carbohydrate and fatty acid metabolism, and detoxification of xenobiotics. The role of
hepatocytes in drug metabolism makes them an extremely important model for drug
discovery and development. Currently, primary human hepatocytes (PHH) are considered
the “gold standard” model on which to study metabolism and toxicity of new drugs;
however, there is a shortage in their availability, they are difficult to culture, they undergo
physiological changes in vitro, and they are susceptible to high donor-to-donor variability.
Therefore, there continues to be a need for improvements to hepatic culture conditions,
iPSC derived hepatic systems, and direct reprogramming systems, such as human
fibroblasts to hiHeps. Protocols to create hepatocytes either from iPSCs or from fibroblasts
result in cells where fetal genes can be activated but the cells fail to mature, cytochrome
P450 enzymes fail to activate, fetal genes such as AFP fail to be repressed, and all of the
genes expressed in the starting cell fail to be silenced (Chen et al., 2012; Duan et al.,
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2010; Roelandt et al., 2013; Si-Tayeb et al., 2010; Song et al., 2009). Advanced
techniques for promoting the complete reprogramming of iPSC-derived hepatocytes have
improved the process with varying degrees of success including generation of liver
organoids (Takebe et al., 2013), 3D printed livers (Faulkner-Jones et al., 2015), and the
use of decellularized scaffolds (Park et al., 2016).
A further challenge to reprogrammed cells is to test their function in vivo. One way
to test hiHeps is to reprogram them and then transplant them into mice with a genetically
perturbed liver that promotes regeneration. The cells can then be evaluated for function
including albumin secretion, metabolite processing, or other function. One useful model
for functional tests is the immune deficient NSG-PiZ mouse model (Borel et al., 2017). PiZ
is a mutant allele of α-1 antitrypsin (AAT), in which a glutamate to lysine substitution has
occurred (Glu342Lys) (Brantly et al., 1988). This is the characteristic mutation of the
human disease AAT deﬁciency. Accumulation of misfolded PiZ mutant AAT protein
triggers hepatocyte injury by aggregating in the endoplasmic reticulum, ultimately leading
to inﬂammation and cirrhosis (Lomas et al., 1992). The NSG-PiZ mouse liver readily
accepts high levels of engraftment of human xenotransplants and was used for hiHep
engraftment experiments presented in Chapter 3 of this thesis. Ultimately, it could one day
be possible to take a patient’s readily accessible skin fibroblasts, transdifferentiate them
to hepatocytes, and reimplant them into a diseased liver to avoid a transplant; however,
direct reprogramming systems still require considerable improvement.

1.3 Repetitive elements and their role in mammalian gene regulation
There is still a limited understanding of how specific repeat elements are silenced
specifically throughout the genome. Silencing of repeat elements is critical during
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embryonic development and prevents aberrant chromosomal recombination. Improper
repeat element silencing has been implicated in human diseases such as cancer. As
heterochromatin plays a key role in silencing repetitive regions of the genome, it is
reasonable to imagine disrupting heterochromatin during cellular reprogramming could
have effects on the expression, activity, or compaction of these regions. There is also a
growing body of evidence to support the conclusion that repetitive sequences can act as
cis-regulatory elements, and even act on protein evolution which could in turn impact gene
expression (Frank and Feschotte, 2017).
In humans, at least 50% of human genome content is derived from transposable
element (TE) DNA and much of this DNA is compacted by heterochromatin. TEs were
originally discovered in maize and referred to as “controlling elements” as their movement
throughout the genome resulted in phenotypic changes (Britten and Davidson, 1971;
McClintock, 1956) which indicates the importance of understanding the silencing of TEs
in relation to development and gene regulation. The classification of TEs contains two
major categories: Class I known as retrotransposons, and Class II known as DNA
transposons (Finnegan, 1989; Wells and Feschotte, 2020). Class I elements replicate
through the genome with an RNA intermediate, are reverse transcribed into DNA, and
then integrate into the genome. The majority of Class II elements replicate through direct
excision from the genome and then physically move to a new genomic location.
Class

I

can

further

be

split

into

autonomous

and

non-autonomous

retrotransposons. Autonomous retrotransposons are named because they encode all the
required proteins for their retrotransposition and include endogenous retroviruses (ERVs)
that have two long terminal repeats (LTRs) flanking the open reading frame that encodes
viral proteins. Another type of autonomous retrotransposon are long interspersed nuclear
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elements (LINEs) which contain two open reading frames for retrotransposition proteins
and are flanked by untranslated regions and a 3’ adenine tail. Non-autonomous
retrotransposons co-opt the retrotransposition machinery of another element and include
short interspersed nuclear elements (SINEs) (Kramerov and Vassetzky, 2011). DNA
transposons encode a transposase allowing for their excision and insertion, and the
transposase open reading frame is flanked by two inverted terminal repeats (Fueyo et al.,
2022).
In the human genome only about one in ten thousand TEs remain active, and these
sequences were formerly frequently referred to as “junk DNA”. We now know there is a
strong correlation between TE expansion and major phenotypic changes in evolution, that
occurred, for example, during the emergence of the primate lineage (Chalopin et al., 2015;
Cordaux and Batzer, 2009). These discoveries have led to increasing interest in
understanding how TEs act to shape evolution, but also how TEs continue to function as
cis-regulatory elements. In human ESCs, ~19% of pluripotency transcription factor binding
sites are derived from TE insertions (Kunarso et al., 2010). In a broader study of even
more factors, 2-40% of transcription factor binding sites were found to be derived from
TEs (Sundaram et al., 2014) indicating that TE insertions throughout evolution have been
a source of novel transcription factor binding sites. TEs also play a critical role during
embryonic development, where pluripotency fluctuates with endogenous retrovirus activity
(Macfarlan et al., 2012) and naïve-like stem cells are associated with elevated primatespecific HERVH endogenous retrovirus activity (Wang et al., 2014). ERV LTRs are known
to act as important transcriptional regulatory elements in mammals (Thompson et al.,
2016) and so can other types of TEs (Fueyo et al., 2022). ERV co-option has specifically
impacted development and host immunity (Frank and Feschotte, 2017) indicating the
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overall importance of these elements. During development, ERVs are dynamically
regulated and provide a signature for different embryonic stages. LINE-1 element insertion
can lead to human cancers and autoimmune diseases (Hancks and Kazazian, 2016). Up
to 50% human tumors contain retrotransposition of LINE-1 elements (Helman et al., 2014;
Lee et al., 2012; Solyom et al., 2012; Tubio et al., 2014) and aberrant LINE-1
retrotransposition can lead to amplification of oncogenes and deletion of tumor suppressor
genes (Rodriguez-Martin et al., 2020). Changes in repetitive element expression with be
discussed in both Chapters 2 and 3 of this thesis.

1.4 Heterochromatin is regulated by diverse associated proteins with
unique target loci
The actual mechanisms through which H3K9me3 is directed to specific loci remains poorly
understood (Ninova et al., 2019). One known mechanism of heterochromatin direction is
mediated by a class of transcription factors known as Krüppel-associated box domain
containing zinc finger proteins (KRAB-ZFPs), with members in the hundreds in humans
capable of binding DNA directly at unique motifs. This class of transcription factor has
frequently been implicated in silencing and regulation of endogenous retroviruses (ERVs)
and other transposable elements (TEs) both during embryonic development and
throughout evolution. In fact, new families of ERVs throughout evolution can predict the
appearance of new KRAB-ZFP genes through duplication and divergence (Thomas and
Schneider, 2011). The silencing of TEs by KRAB-ZFPs is thought to be mediated through
the KRAB domain interacting with the co-repressor KRAB-associated protein-1 (KAP1),
which is also known as both tripartite motif-containing 28 and transcriptional intermediary
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factor 1beta (TRIM28/TIF1b)(Bruno et al., 2019; Jacobs et al., 2014; Najafabadi et al.,
2015; Turelli et al., 2014; Wolf and Goff, 2009; Wolf et al., 2015). KRAB-ZFPs and KAP1
then interact with the methyltransferase SETDB1, enabling deposition of repressive
H3K9me3 across kilobase scale domains (Schultz et al., 2002) (Figure 3A). KRAB-ZFPs
are a major focus of the research study presented in Chapter 3 of this thesis.
There are a few other known mechanisms of heterochromatin machinery direction.
Other proteins known to direct H3K9me3 heterochromatin machinery to mammalian
genes include the retinoblastoma protein Rb, which interacts with SUV39H1 and a protein
known as MAX that interacts with SETDB1 (Maeda et al., 2013; Nielsen et al., 2001;
Tatsumi et al., 2018). A few transcription factors in mice are required for the maintenance
of H3K9me3 heterochromatin compacted regions at pericentric satellites, but their
mechanisms of recruiting methyltransferases are unknown (Bulut-Karslioglu et al., 2012;
Vassen et al., 2006; Yamashita et al., 2007). Another known mechanism of H3K9me3
targeting is through RNA interference (RNAi) in which small RNAs including microRNA,
piRNAs, and miRNAs are able to be loaded into Argonaute family proteins which then can
be guided to nascent RNAs with complementary sequences and induce co-transcriptional
repression and heterochromatin formation (Holoch and Moazed, 2015a; b).
Recent studies have uncovered additional roles for H3K9me3. One study found
that SETDB1 dependent H3K9me3 may play a role in restricting CTCF binding within
SINE B2 repeats (Gualdrini et al., 2022). Another study in mice found that dual-marked
H3K9me3 and H3K36me3 domains conceal a subset of enhancers that can become
activated following Setdb1 loss, indicating additional ways in which H3K9me3 silences cisregulatory elements (Barral et al., 2022). Another found that the HUSH complex surveys
the genome for long endogenous intronless genes generated through retrotransposition
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of mRNAs, then binds and represses them allowing for immediate protection against new
TEs (Seczynska et al., 2021). A developmental study found that H3K9me3
heterochromatin reprogramming in the paternal pronucleus post-fertilization is catalyzed
by SUV39H2 and bookmarks promoters for compaction without being initially repressive
(Burton et al., 2020). Many recent studies have examined the role of heterochromatin in
promoting liquid-liquid phase separation within the nucleus. Initial studies found that HP1α
is able to form phase separated droplets (Larson et al., 2017). Another report argued that
the formation of H3K9me3 heterochromatin itself was mediated by phase-separation
(Strom et al., 2017). Further studies found that multivalent H3K9me3-chromodomain
engagement can promote formation of chromatin compartments through liquid-liquid
phase separation (Wang et al., 2019). Phase separation and heterochromatin interplay
continues to be an active area of investigation. Much more work is required to fully
understand the intricacies of mammalian heterochromatin.
In the fission yeast Schizosaccharomyces pombe (S. pombe) and in plants, H3K9
methylation is better understood (Allshire and Madhani, 2018). In S. pombe, Argonautebound small RNAs are required for H3K9me3 deposition at centromeric regions (Hall et
al., 2002; Volpe et al., 2002). There is only a single H3K9 methyltransferase known as
Clr4 in fission yeast (Zhang et al., 2008). Tethering Clr4 to chromatin is sufficient to drive
gene repression and, with ablation of H3K9 demethylases, this repression is stable
through multiple mitotic and meiotic generations even if the tethered Clr4 is removed
(Audergon et al., 2015; Ragunathan et al., 2015), demonstrating the ability of H3K9 to be
epigenetically inherited. In S. pombe a method of H3K9 dependent gene silencing is
established by RNA-dependent mechanisms where nascent transcripts are bound by the
Erh1-Mmi1 complex (EMC) (Sugiyama et al., 2016). In S. pombe, the primary function of
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the EMC is to suppress sporulation which is accomplished by targeting nascent transcripts
for degradation and recruiting Clr4 to induce H3K9me2-mediated silencing (Hazra et al.,
2020; Xie et al., 2019). In plants and S. pombe, silencing at repeats and centromeres is
induced by RNAi and an RNA-dependent RNA polymerase complex (Djupedal et al.,
2005; Kato et al., 2005; Onodera et al., 2005; Zofall et al., 2016) that is absent from
metazoans (Pinzón et al., 2019). The ability of enhancer of rudimentary homologue (ERH)
to target human genes and repeats for repression will be discussed in Chapter 2 of this
thesis.
Previous proteomics work from our lab and others has shown the vast array of
nuclear and heterochromatin-associated proteins that exist in human and other
mammalian cells (Alajem et al., 2015; Becker et al., 2017; Dutta et al., 2014; Federation
et al., 2020; Ji et al., 2015; Kulej et al., 2017; Kustatscher et al., 2014; Torrente et al.,
2011). However, the individual mechanisms through which many of these proteins act on
heterochromatin remains elusive. The specific genomic targets of many heterochromatinassociated proteins will be explored in Chapter 2 and Chapter 3 of this thesis.

1.5 REST as a model for lineage repression
The human BJ fibroblast heterochromatin-associated proteomics work conducted by our
lab through the use of Gradient-seq followed by mass spectrometry (Becker et al., 2017)
did not find many transcription factors associated with srHC. This is likely due to the low
abundance of these factors (Ghaemmaghami et al., 2003; Shiio et al., 2003; Washburn et
al., 2001). Therefore, knowing that transcription factors are indeed important for targeting
heterochromatin, we predicted there are many transcription factors associated with tightly
compacted heterochromatin that were not picked up by the proteomics assay.
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We were interested in the zinc finger protein complex RE-1 silencing transcription
factor/neuronal restricted silencing factor (REST/NRSF) that is able to silence neuronal
genes in non-neuronal cells and is ubiquitously expressed outside of the nervous system
(Chen et al., 1998b; Chong et al., 1995; Schoenherr and Anderson, 1995). REST/NRSF
can mediate cell-type specific neuronal gene silencing either through recruitment of the
corepressor (CoREST) or through the recruitment of HDACs (Ballas et al., 2001; Lunyak
et al., 2002). Interestingly, REST also functions as a negative regulator of exocrine cell
reprogramming to the endocrine lineage (Elhanani et al., 2020) and represses a subset of
the pancreatic endocrine differentiation program (Martin et al., 2015). This aligns with the
finding that while REST is expressed in most cell types of the pancreas and pancreatic
progenitors, it is excluded from islets (Martin et al., 2015). Using these findings from REST
as a model, we generated the hypothesis that some KRAB-ZFPs might have the ability to
act as silencers of specific lineages, such as the liver lineage, which is a focus of Chapter
3 of this thesis.

1.6 KRAB-ZFPs and their role in development and gene regulation
Krüppel-associated box domain containing zinc finger proteins (KRAB-ZFPs) represent a
hugely abundant class of tetrapod specific transcription factors defined by an N-terminal
KRAB domain and several C-terminal C2H2 tandem zinc fingers with over 350 proteins of
this class in humans (Bellefroid et al., 1991; Huntley et al., 2006; Imbeault et al., 2017)
(Figure 3A). Some KRAB-ZFPs contain both a KRAB A box and a KRAB B box domain
where the KRAB A domain possesses the majority of the transcriptional repressive
activities compared to KRAB B domain (Vissing et al., 1995; Witzgall et al., 1994). This
class of transcription factors has frequently been implicated in silencing and regulation of
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ERVs and other TEs both during embryonic development and throughout evolution by
interacting with the co-repressor KRAB-associated protein-1 (KAP1), which is also known
as both tripartite motif-containing 28 and transcriptional intermediary factor 1beta
(TRIM28/TIF1ß) (Bruno et al., 2019; Jacobs et al., 2014; Najafabadi et al., 2015; Turelli et
al., 2014; Wolf and Goff, 2009; Wolf et al., 2015) (Figure 3A). The KRAB domain directly
interacts with KAP1 without a need for post-translational modifications and this interaction
does not inhibit DNA binding (Peng et al., 2000). KRAB-ZFPs and KAP1 also interact with
the methyltransferase SETDB1, enabling deposition of repressive H3K9me3 across
kilobase scale domains (Schultz et al., 2002) (Figure 3A). KAP1 is also able to interact
with HP1 isoforms, HP1α/CBX5, HP1β/CBX1, and HP1γ/CBX3 in mammals, linking
KRAB-containing proteins to repressive chromatin structure and dynamics (Fodor et al.,
2010; Lechner et al., 2000; Peng et al., 2000). In mouse ESCs, SETDB1 and KAP1 are
required for H3K9me3 and silencing of endogenous and introduced retroviruses (Matsui
et al., 2010) indicating an essential role for KAP1 in development. KRAB-ZFPs exhibit cell
and developmental stage specific patterns of expression in the early embryonic period
which indicates the diversity of their action (Corsinotti et al., 2013). Interestingly, ancient
KRAB-ZFPs like PRDM9 do not interact with KAP1 (Helleboid et al., 2019) indicating they
act through alternative mechanisms. Another study found that the repressive activity of
the KRAB domain does not correlate with the ability to recruit KAP1, nor is this recruitment
sufficient to explain repressive activity (Murphy et al., 2016). Therefore, there is likely more
complexity to the KRAB-ZFP/KAP1 silencing mechanism than is currently appreciated.
It remains unknown whether ancient KRAB-ZFPs evolved to bind and repress TEs,
however many KRAB-ZFPs have been dated to about the same age as the targets they
repress (Senft and Macfarlan, 2021; Thomas and Schneider, 2011). KRAB- ZFPs use a
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C2H2-type zinc finger array to bind DNA, with about two-thirds of KRAB-ZFPs shown to
bind predominantly at TEs (Barazandeh et al., 2018; Imbeault et al., 2017; Yang et al.,
2017). Genetic ablation of many KRAB-ZFPs can lead to TE reactivation, indicating their
direct role in TE repression (Wolf and Goff, 2009; Wolf et al., 2020). KRAB-ZFP/KAP1
complexes can also help maintain heterochromatin at imprinting control regions and TEs
in naïve embryonic stem cells and protect loci from TET-mediated demethylation (Coluccio
et al., 2018). KRAB-ZFP ZFP57 is known to help maintain DNA methylation and
repressive histone marks at germline-derived imprinting control regions and is required for
maintenance of maternal and paternal methylation imprints at multiple domains (Li et al.,
2008; Shi et al., 2019). Members of the KRAB-ZFP family are rapidly and constantly
expanding throughout the genome, undergoing segmental duplications, evolving, and
gaining new functions (Emerson and Thomas, 2009; Nowick et al., 2010). The regulation
of genes and transcriptional networks by KRAB-ZFPs is under active investigation.
The ability to control some TEs gives KRAB-ZFPs a unique way to modulate gene
expression. As only about 2% of the human genome contains gene encoding information,
and humans share about 98% of their genes with chimpanzees, a huge amount of
evolutionary gene expression changes occur at non-coding regions of the genome, such
as through evolution and co-option of TEs (Chimpanzee and Analysis, 2005; Lander et
al., 2001; Wells and Feschotte, 2020). In fact, TEs often evolve into regulatory elements
controlling a huge variety of human physiology including in the placenta, during
pregnancy, and in the innate immune system, potentially representing the primary source
of novelty in primate gene regulation (Chuong et al., 2016; Chuong et al., 2013; Lynch et
al., 2011; Lynch et al., 2015; Trizzino et al., 2017). It has been shown that in some cases,
KRAB-ZFPs and KAP1 have co-opted TE regulation to establish transcriptional networks,
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demonstrating that their activity goes far beyond silencing of ERVs (Ecco et al., 2016;
Ecco et al., 2017a; Pontis et al., 2019). KRAB-ZFPs and KAP1 control TEs in adult tissues
in a species-specific manner, indicating that this regulatory interplay has played a role in
speciation (Ecco et al., 2016). There are instances where expression of KRAB-ZFPS and
the TEs that they regulate positively correlate, revealing that in this instance the KRABZFPs are not acting in a repressive manner (Helleboid et al., 2019; Ito et al., 2020; Wolf
et al., 2020). Other times, co-opted KRAB-ZFP regulated TEs act as tissue specific
enhancers (Pontis et al., 2019; Wolf et al., 2020). There is also direct evidence that KRAB
C2H2 zinc fingers bind to specific ERVs both in currently active and ancient families
(Najafabadi et al., 2015). The KRAB domain also plays a role in protein evolution. DNA
transposons can contribute to the evolution of new proteins through exon shuffling in a
process known as transposase capture. It was uncovered that the KRAB domain is
involved in about 30% of known host-transposase fusion proteins such as the bat specific
protein KRABINER (Cosby et al., 2021).
KRAB-ZFPs can modulate gene expression for as few as one gene (Gebelein and
Urrutia, 2001; Groner et al., 2010; Johansson et al., 2022). KRAB-ZFPs can direct HDACs
and the nucleosome remodeling and deacetylase (NuRD) complex to gene promoters
(Schultz et al., 2001) which provide mechanisms to their gene regulatory capabilities.
Many KRAB-ZFPs have also been shown to bind outside of TEs and often near
transcription start sites (Barazandeh et al., 2018; Imbeault et al., 2017; Yang et al., 2017).
It is thought that these differences in binding sites are associated with the age of KRABZFPs, where ancient KRAB-ZFPs do not bind recognizable TEs but are rather found at
promoters or over gene bodies and some are known to be able to activate or repress
genes (Frietze et al., 2010a; Frietze et al., 2010b; Imbeault et al., 2017; Liu et al., 2014).
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For example, KRAB-ZFP ZNF263 binds about 5000 sites and many are located within
transcribed regions of the gene (Frietze et al., 2010a). However since each of the many
C2H2 zinc fingers of a KRAB-ZFP are capable of interacting with 2-4 nucleotides, there
have been significant difficulties in predicting binding motifs for KRAB-ZFPs that continue
to persist (Persikov and Singh, 2014). Methyltransferase recruitment by the KRAB domain
can induce reversible heterochromatin, and binding to gene bodies does not induce stable
DNA methylation (Groner et al., 2012). Interestingly, ancient KRAB-ZFPs like PRDM9 do
not interact with KAP1 (Helleboid et al., 2019) indicating that many KRAB-ZFPs could act
through yet unknown mechanisms. Ultimately the functional repressive capabilities of
many individual members of the KRAB-ZFP family remain to be determined and
demonstrated in vivo.

1.7 Open questions of this thesis
The complexity behind heterochromatin silencing in the human genome requires further
exploration. To enhance our understanding of how genes and repetitive elements are
targeted for repression in the human genome, Chapter 2 of this thesis will focus on
uncovering functional genomic targets of a vast array of heterochromatin associated
proteins identified in human BJ fibroblasts. Genes and repetitive elements targeted for
repression by each individual protein were analyzed. These experiments were done both
during hiHep reprogramming and without the addition of hiHep reprogramming factors.
We also created a framework to predict new repressive complexes which is an open area
of investigation.
There is still considerable work to be done to understand the regulatory capabilities
of many members of the KRAB-ZFP family. I sought to further investigate if KRAB-ZFPs
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could play a role in specifically silencing liver genes in alternative lineages. Chapter 3 of
this thesis will explore six predicted liver lineage silencing KRAB-ZFPs and will explore
one, ZNF695, in depth. The repressive targets of each factor at genes and repetitive
elements are explored. ZNF695 depletion was shown to have profound effects on
H3K9me3, the expression of silenced genes, and even showed increased expression of
human albumin in ZNF695 depleted hiHeps following transplantation into a mouse model
of diseased liver.
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1.8 Figures

Figure 1 | Distribution of different types of chromatin in BJ fibroblasts.
A, Schematic of different types of chromatin in the human fibroblast cell nucleus including
open chromatin (euchromatin), unmarked chromatin that can also be called “low signal”
or “naïve”, and heterochromatin.
B, The distribution of heterochromatic srHC domains in human BJ fibroblasts and how
these regions overlap with the main histone marks for heterochromatin, H3K9me3 and
H3K27me3. Adapted from (Becker et al., 2017).
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Figure 2 | Large heterochromatic domains prevent transcription factor binding
during cellular reprogramming.
A, This figure shows ChIP-seq tracks over large megabase scale domains that are
refractory to iPSC reprogramming transcription factors Oct4, Sox2, Klf4, and cMyc binding
during the first 48 hours of iPSC reprogramming but are accessible in ESCs. These
regions are highly enriched for H3K9me3. They are referred to as differentially bound
regions (DBRs). Adapted from (Soufi et al., 2012).
B, These violin plots show gene expression as a percentage of normal liver based on the
histone mark over each gene in the starting fibroblasts. H3K9me3 is particularly repressive
and limits activation of genes, including key liver transcription factors, metabolic enzymes
and adhesion proteins. Adapted from (Becker et al., 2017).
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Figure 3 | KRAB-ZFPs can silence genes and transposable elements through
association with the co-repressor KAP1 and the methyltransferase SETDB1.
A, KRAB-ZFPs are comprised of an N-terminal KRAB domain and C-terminal tandem
C2H2 zinc fingers. Many KRAB-ZFPs can interact with the co-repressor KAP1 and recruit
the H3K9me3 methyltransferase SETDB1, which allows for H3K9me3 deposition over
regions up to 100kb away.
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CHAPTER 2: DIVERSE HETEROCHROMATIN-ASSOCIATED
PROTEINS REPRESS DISTINCT CLASSES OF GENES AND
REPETITIVE ELEMENTS
2.1 Preface
The manuscript presented in this chapter was originally published online on August 5th,
2021 in the journal Nature Cell Biology (McCarthy and Kaeding et al., 2021). It has been
reformatted here in accordance with University of Pennsylvania dissertation formatting
guidelines. RNA-seq, ChIP-seq, and srHC-seq data that support the findings of this study
have been deposited in the Gene Expression Omnibus (GEO) under accession code
GSE154233.
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2.2 Respective Contributions
The manuscript presented in this chapter was originally published in Nature Cell Biology
and published online on August 5th, 2021 (McCarthy and Kaeding et al., 2021). I am a cofirst author of this publication with Ryan L. McCarthy. The majority of the experiments,
analysis, and writing presented in this chapter were conducted by myself and Ryan
McCarthy with the guidance of my thesis advisor Kenneth S. Zaret. My contributions and
research interests in this manuscript were focused on the overall heterochromatinassociated protein screen where I conducted many of the sequencing experiments
including the screen-based RNA-seq and validation experiments, H3K9me3 and ERH
ChIP-seq, and srHC-seq. I focused more on performing analyses of the repeats and
transposable elements presented here than on the gene-based analyses, though I also
contributed ideas to those analyses. I spent considerable time validating all of the siRNAs
by RT-qPCR and some by Western Blot, on tissue culture, on categorization of cell
phenotypes, and on assay development. The specifics of ERH mechanisms were not a
major focus of my work, and instead were a focus of Ryan McCarthy. Samuel H. Keller,
Yong Hou, and Bomyi Lim performed confocal imaging, quantification and analysis. The
Beijing Genomics Institute provided support to allow for high throughput sequencing and
quality control conducted by Yu Zhong and Liqin Xu. Greg Donahue provided additional
support on bioinformatics analyses design. Antony Hsieh, Justin S. Becker, and Oscar
Alberto provided additional experimental support.
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2.3 Abstract
Heterochromatin, typically marked by histone H3 trimethylation at lysine 9 (H3K9me3) or
lysine 27 (H3K27me3), represses different protein-coding genes in different cells, as well
as repetitive elements. The basis for locus specificity is unclear. Previously, we identified
172 proteins that are embedded in sonication-resistant heterochromatin (srHC) harboring
H3K9me3. Here, we investigate in humans how 97 of the H3K9me3-srHC proteins repress
heterochromatic genes. We reveal four groups of srHC proteins that each repress many
common genes and repeat elements. Two groups repress H3K9me3-embedded genes
with different extents of flanking srHC, one group is specific for srHC genes with H3K9me3
and H3K27me3, and one group is specific for genes with srHC as the primary feature. We
find that the enhancer of rudimentary homologue (ERH) is conserved from
Schizosaccharomyces pombe in repressing meiotic genes and, in humans, now represses
other lineage-specific genes and repeat elements. The study greatly expands our
understanding of H3K9me3-based gene repression in vertebrates.
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2.4 Introduction
Heterochromatic repression of genes and repetitive elements maintains cell identity and
genome integrity (Becker et al., 2016). Heterochromatin consists of compacted arrays of
nucleosomes that can be mapped as sonication-resistant heterochromatin (srHC), which
is transcriptionally silent and contains histone domains enriched for H3K9me3,
H3K27me3, both marks, or neither (Becker et al., 2017; Becker et al., 2016; Margueron
and Reinberg, 2011). H3K9me3 has classically been associated with silencing of repeat
elements, including transposons and centromeric repeats (Bulut-Karslioglu et al., 2014),
while H3K27me3 has been demonstrated to repress developmentally regulated genes
(Margueron and Reinberg, 2011). Recent findings show that H3K9me3 orchestrates
repression of genes during development (Becker et al., 2016; Nicetto et al., 2019; Pace et
al., 2018; Wang et al., 2018) and impedes binding of transcription factors (Becker et al.,
2017; Soufi et al., 2012). The orchestration of these changes, maintaining repression at
certain genes, while others may lose repression, as well as repressing repetitive elements,
suggests that H3K9me3 heterochromatin may be controlled by diverse mechanisms.
H3K9me3 in humans is established by the three lysine methyltransferases (KMTs)
SUV39H1, SUV39H2, and SETDB1 (Rea et al., 2000; Schotta et al., 2004). Recruitment
of H3K9 KMTs can be facilitated by transcription factors, such as KRAB-ZNFs (Schultz et
al., 2002), or by RNA-dependent mechanisms (Johnson et al., 2017), but how H3K9me3
is established and maintained at different classes of protein coding genes, non-coding
genes, and repeat elements remains to be determined. In the fission yeast S. pombe,
where H3K9 methylation is catalyzed solely by the single histone methyltransferase (HMT)
Clr4 (Zhang et al., 2008), and in plants, the relevant mechanisms are more fully
understood (Allshire and Madhani, 2018). Facultative heterochromatin formation in S.
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pombe is established by an RNA-dependent mechanism where nascent transcripts,
especially from meiotic genes, are bound by the Erh1-Mmi1 complex (EMC) containing
Erh1 and Mmi1 (Sugiyama et al., 2016). The EMC complex targets a transcript for
degradation and recruits Clr4 to methylate H3K9 and enforce silencing to repress
sporulation (Hazra et al., 2020; Xie et al., 2019), the primary differentiation capability of
fission yeast. In S. pombe and plants, constitutive heterochromatin, at regions including
repeats and centromeres, occurs via the cooperation of RNA interference (RNAi) and an
RNA-dependent RNA polymerase complex (Djupedal et al., 2005; Kato et al., 2005;
Onodera et al., 2005) that is absent from metazoans, (Pinzón et al., 2019) leaving open
the question of how most repeat elements in humans are targeted for H3K9me3
repression.
Using the property of cross-linking and sonication resistance to separate
euchromatin and heterochromatin for sequencing and proteomic analysis, we previously
identified 172 H3K9me3 srHC-associated proteins, including known constituents of
heterochromatin, such as HP1α (Bannister et al., 2001), but also many proteins with no
known role in heterochromatin (Becker et al., 2017). By functionally assessing the srHC
proteins and identifying the genes that they repress, we sought to better understand how
heterochromatin is maintained and could be manipulated to enable selective gene
accessibility.
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2.5 Results
srHC proteins repress genes and repeats in heterochromatin
To assess the function of srHC associated proteins, we performed two successive cycles
of siRNA depletion of 94 srHC proteins, chosen from the 172 srHC proteins (Becker et al.,
2017), to include proteins with known and unknown roles in heterochromatin based upon
literature review, as well as of the three H3K9me3 KMTs, SUV39H1, SUV39H2, and
SETDB1, in human primary fibroblast cells (Fig. 1a). Knockdown of heterochromatin
proteins via the transient nature of siRNA would allow temporary target gene access, e.g.,
for a cell fate change, and then re-utilization of the proteins to establish new
heterochromatin states as needed. We chose the most robust of two independently
targeting siRNAs, in duplicate, for each srHC protein target, validating knockdown
efficiency by RT-qPCR and a limited number by Western blots, with 75 siRNAs exhibiting
greater than 70% mRNA depletion (Extended Data Fig. 1a, b). Global gene induction of
srHC genes, as previously annotated (Becker et al., 2017), was assessed by RNA-seq
relative to a non-targeting siControl, in order to identify srHC embedded genes and repeat
elements that were upregulated by depletion of srHC associated proteins. We separately
analyzed hepatic (Huang et al., 2014), neural (Liu et al., 2013), pluripotent (Cacchiarelli et
al., 2015), spermatogenic (Hermann et al., 2018), and oogenic (Zhang et al., 2018b) srHC
genes, defined as those transcriptionally silent in fibroblasts but with elevated expression
(p < 0.05, > 2-fold) in the indicated lineage (Fig. 1b). We found that 8 of the 97 depleted
srHC proteins significantly activated from 170 to 376 srHC genes, often in more than one
lineage category, with many of the activated srHC genes commonly co-repressed by ERH,
SUV39H1, RBMX, XRN2 and ZNF207 (Fig. 1b, c). RNA from additional cells treated with
a second siRNA was sequenced for siERH, siSUV39H1, siRBMX, siXRN2, and siZNF207
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and the results from both siRNAs in duplicate are reported for these targets (Fig. 1a).
Knockdown of srHC proteins, including GATAD2A and ERH, impaired cell proliferation
(Extended Data Fig. 1c).
Knockdown of ERH, a protein highly enriched in srHC (Becker et al., 2017)
(Extended Data Fig. 2a), and of SUV39H1 significantly activated the greatest total number
of srHC genes, 376 and 219 respectively, with 65 genes in common (Fig. 1c). To assess
whether ERH controls RNA processing (Xie et al., 2019) in this context, we measured preRNA induction for 3 srHC genes that were highly induced by ERH depletion and found
their pre-RNA levels to also be elevated relative to siControl (Extended Data Fig. 2b).
Thus, the primary role of ERH here is in transcriptional control. While srHC embedded
spermatogenic genes were most profoundly repressed by ERH and SUV39H1 (>5% srHC
gene activation), knockdown of 33 of the other 97 targeted srHC proteins, including UBE2I,
which represses iPS reprogramming (Cheloufi et al., 2015), also led to upregulation of at
least 3% of the srHC spermatogenic genes (Hermann et al., 2018) (Fig. 1b). Indeed, motifs
for spermatogenic transcription factors were enriched in the promoters of induced
spermatogenic genes (Extended Data Fig. 2c) and various spermatogenic transcription
factors are expressed in the starting fibroblast cells (Extended Data Fig. 2d), compared to
the lack of expression of transcription factors for the other lineages tested (Fig. 1d). Among
srHC genes that remained repressed in our screen, we observed enrichment of promoter
motifs for OCT4, SOX17, and HOXA9 that are not expressed in human fibroblasts, while
non-spermatogenic srHC genes exhibiting activation after ERH knockdown were enriched
for motifs bound by factors with high expression in fibroblasts, such as ETV5 and NFYB
(Fig. 1e); crucially the expression of these factors was itself not induced by ERH depletion
(Extended Data Fig. 2e). The correspondence of activated srHC genes to the presence of
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activating factors expressed in the starting human fibroblasts suggests that the
combination of de-repression of heterochromatin, assessed here through the proxy of
gene activation, and an activating transcription factor are required for expression.
We used SalmonTE (Jeong et al., 2018) to assess potential repeat element
activation following heterochromatin protein knockdown (Fig. 1b). ERH depletion led to
the induction of multiple ERV types and SINEs, while depletion of other factors allowed
for activation of other repeat classes, such as for POLDIP3 depletion, which allowed for
robust activation of LINE-1 and SINEs (Fig. 1b; Extended Data Fig. 2f, orange and purple
arrows). No single knockdown showed robust activation of all ERV, LINE and SINE
elements, indicating a diversity in mechanisms for silencing of repeat elements (Fig. 1b).

ERH maintains H3K9me3 heterochromatin in human cells
Orthologs with high sequence similarity to human ERH exist in S. pombe and plants such
as A. thaliana (Hazra et al., 2020), but ERH orthologs are notably absent from S.
cerevisiae, which lacks H3K9 methylation, and N. crassa, where the H3K9 KMT DIM-5 is
recruited through a different mechanism (Lewis et al., 2010). Depletion of ERH in human
fibroblasts

was

sufficient

to

globally

decrease

H3K9me3,

as

measured

by

immunofluorescence (Fig. 2a; Extended Data Fig. 3a), despite not decreasing the
expression of the H3K9me3-methyltransferase genes (Extended Data Fig. 3b). ERH
depletion in another cell line, HepG2, also decreased H3K9me3 by immunofluorescence
(Extended Data Fig. 3c). We investigated if the change in H3K9me3 may be due to
changes of HMT production and found that, upon ERH depletion, the total cellular levels
of SUV39H1, SUV39H2, and SetDB1 were unperturbed (Extended Data Fig 3d). Yet
strikingly, upon ERH depletion, SUV39H1 abundance decreased markedly within
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crosslinked and sonicated chromatin (Extended Data Fig. 3e), demonstrating that ERH
recruits and/or helps maintain the HMT in heterochromatin. The global role we observe
for ERH in humans is in contrast to S. pombe, where the RNA-dependent RNA polymerase
complex dominates by directing H3K9 methylated heterochromatin at repeats and ERH
directs H3K9me3-based repression primarily at meiotic genes (Sugiyama et al., 2016).
Indeed, the global decrease in H3K9me3 upon ERH knockdown in human cells, as well
as the induction of srHC-H3K9me3 genes, was greater than that observed for knockdowns
of SUV39H1 or SETDB1 (Extended Data Fig. 3f). ERH depletion decreased only
H3K9me3 and not H3K9me2 (Fig. 2a), as confirmed with multiple antibodies (Extended
Data Fig. 3g). In S. pombe the ERH complex interacts with MTREC (Sugiyama et al.,
2016) (PAXT in humans), several components of which we previously observed to be
enriched on H3K9me3 srHC (Becker et al., 2017), however depletion of the key PAXT
component SKIV2L2 in human fibroblasts did not phenocopy the loss of H3K9me3
(Extended Data Fig. 3h); thus the regulation of H3K9me3 by ERH may function
independent of PAXT. Taken together, the results indicate that ERH is integral to the
H3K9me3 methylation pathway and has evolved to become a dominant heterochromatin
effector in humans.
Knockdown of ERH in human fibroblasts significantly upregulated 36 of the 154
human orthologs of meiotic genes observed to be upregulated in an Erh-knockout S.
pombe (Xie et al., 2019) (Fig. 2b). By contrast, knockdowns of SUV39H1, RBMX, or XRN2
upregulated only 18, 14 and 9 meiotic homolog genes, respectively (Fig. 2b). ERH
depletion also upregulated more evolutionarily recent spermatogenic genes, including a
cluster of SPANX family genes (Extended Data Fig. 4a) that are unique to hominids
(Kouprina et al., 2007). We conclude that in addition to expanding its targets to repeat
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elements, human ERH has evolutionarily retained its role in repressing meiotic and
gametogenic genes, as seen in fission yeast.
ERH is localized to nascent RNAs in S. pombe via binding of Mmi1 to Determinant
of Selective Removal (DSR) motifs in RNA, which recruits ERH as part of the EMC
complex (Sugiyama et al., 2016). However, in contrast to the highly conserved ERH
protein (Xie et al., 2019) no conserved Mmi1 ortholog exists in humans and the closest
homologs, YTHDF1-3, show poor conservation of the ERH interacting domain (Extended
Data Fig. 4b). Human ERH has been independently detected in nascent RNA proteomics
(Bao et al., 2018), albeit at low levels, and upon examining the R-Deep mass spectrometry
database (Caudron-Herger et al., 2019), we found that ERH co-fractionates with histones
in an RNA-dependent manner (Extended Data Fig. 4c). More significantly, the protein
domain by which Mmi1 binds the DSR motif in S. pombe is absent from all Mmi1 human
orthologs (Wang et al., 2016). Thus, the recruitment mechanism for ERH has diverged
from that in S. pombe (Sugiyama et al., 2016).
Concordant with the cytological diminution of H3K9me3 after ERH knockdown,
H3K9me3 chromatin immunoprecipitation followed by sequencing (ChIP-seq) in ERHknockdown cells, with Drosophila chromatin as a spike-in control, revealed loss of
H3K9me3 at broad domains containing protein coding genes, non-coding genes, and
repeats (Fig. 2c). Notably, H3K9me3 was significantly decreased at 75% of the 15,154
H3K9me3 domains we previously mapped in human fibroblasts(Becker et al., 2017) (Fig.
2d). ERH knockdown elicited significant H3K9me3 loss for all categories of H3K9me3
domains, annotated based upon the presence of genes or repeat elements, with especially
strong H3K9me3 loss at pseudogenes, which are often silenced by H3K9me3 and can

34

encode non-coding RNAs involved in silencing(Scarola et al., 2015) and are often
misregulated in cancer (Kalyana-Sundaram et al., 2012).
In contrast to ERH function in S. pombe, which does not focus on constitutive
heterochromatin (Sugiyama et al., 2016), we observed that nearly all (59 of 60) H3K9me3
domains containing satellite repeats exhibited a strong loss of H3K9me3 in ERH
knockdowns (Fig. 2e), which may account for much of the global H3K9me3 changes
measured by immunofluorescence (Fig. 2a). Further categorization of ERH knockdowninduced satellite repeat changes using RepEnrich (Criscione et al., 2014) revealed a loss
of H3K9me3 at multiple classes of centromeric satellites, non-centromeric repeats, and
telomeric repeats that also exhibit an increase in RNA expression (Fig. 2f). Increased SVA,
Alu, and ERV, specifically ERVK, expression was observed in the ERH knockdown when
analyzed by RepEnrich (Extended Data Fig. 4d,e) and SalmonTE (Fig. 1b). Repeat
expression as measured by RNA-seq correlated with decreased H3K9me3; correlation
was especially high for Alu and ERVK elements while tRNAs exhibited much H3K9me3
loss but did not display elevated expression (Extended Data Fig. 4d). Most other classes
of repeats, including rDNA, which are under control of H3K9me2 and not H3K9me3 (Zhu
et al., 2010), were unchanged (Extended Data Fig. 4e). We observed an increase in
H3K27me3 levels at several classes of satellite repeats observed to lose H3K9me3
(Extended Data Fig. 4f) consistent with previous observations that H3K27me3 may
compensate for H3K9me3 loss (Peters et al., 2003). In summary, human ERH has gained
new functions in repressing genes for diverse lineages as well as satellite repeats.

srHC proteins impede gene activation during reprogramming
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To test the hypothesis that activating transcription factors may be needed for the
expression of heterochromatic genes of alternative cell fates, we repeated the siRNA
depletion of srHC proteins with the addition of the hepatic transcription factors FOXA3,
HNF1a, and HNF4a, which elicit reprogramming of fibroblasts to induced hepatocytes
(Huang et al., 2014) (hiHeps) (Fig. 1a). Strikingly, we observed far more extensive
activation of srHC genes in the presence of hiHep reprogramming factors, especially for
srHC-embedded hepatic genes (Fig. 3a). Of the 97 proteins targeted for depletion, 73
allowed an upregulation of at least 93 srHC genes (over 1% of all srHC genes). As
suspected, we observed an enrichment of DNA binding motifs for hiHep reprogramming
factors in the promoters of hepatic srHC genes that were activated by srHC protein
knockdown (Fig. 3b). Analysis of ERV, LINE and SINE sequences downloaded from
RepeatMasker for hiHep factor motifs revealed FOXA3 motifs to frequently occur in LINE
elements (Extended Data Fig. 4g), potentially accounting for the LINE activation in our
siRNA knockdowns during hiHep reprogramming (Fig. 3a). Of four srHC protein
knockdowns (SUV39H1, RBMX, ERH, XRN2) tested for increasing hiHep reprogramming
efficiency at 14 days, as measured by the percent cells expressing the hepatic cell surface
marker ASGPR1 which is encoded by a gene not located in srHC, only depleting RBMX
enhanced reprogramming, as seen previously (Becker et al., 2017) (Extended Data Figure
4h). Visualizing patterns of srHC genes across the genome that were activated by
knockdowns revealed that there are chromosomal regions where multiple srHC proteins
co-repress blocks of srHC genes, while in other chromosomal regions, srHC genes remain
recalcitrant to nearly all perturbations (Extended Data Fig. 5; see expanded example
regions), perhaps reflecting the H3K9me3-srHC subset bias from our original proteomic
study of srHC proteins.
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srHC protein groups target distinct heterochromatin types
To identify which groups of srHC proteins may exhibit specificity for common targets, we
performed a nearest neighbor clustering of the 73 most impactful proteins, based upon
the overlapping sets of srHC genes they repressed. Four clusters emerged, with 9 hub
nodes at the center of multiple peripheral nodes (Fig. 3c). Although the clustering was
based upon genetic evidence, it independently validated previously reported protein
interactions, including XIST-mediated gene silencing components RBM15, YTHDC1 (Patil
et al., 2016) and ZC3H13 (Knuckles et al., 2018) around the central hub of cluster 2, HUSH
complex interactors PPHLN1 and SETDB1 (Tchasovnikarova et al., 2015) in a sub-cluster
of cluster 2, and paraspeckle components NONO, FUS and SFPQ (Yamazaki et al., 2018)
in cluster 3 (Fig. 3c).
We assessed heterochromatin and functional parameters of the srHC genes that
were selectively regulated by each cluster. Cluster 1 proteins, which includes the hub
proteins ERH and HMGA1, as well as SUV39H1, repress srHC genes with high levels of
H3K9me3, low levels of H3K27me3, and high srHC across their gene bodies and flanking
regions (Fig. 3d, meta-analysis; Extended Fig. 6, individual gene examples). Cluster 1
represses genes relating to cell adhesion and tissue-specific processes (Extended Data
Fig. 6, 7a) and were especially enriched for B-compartment (Krietenstein et al., 2020)
localization (Extended Data Fig. 7b).
Cluster 2 proteins repress srHC genes with moderate levels of H3K9me3, low
H3K27me3, and high srHC levels across the gene body, but low in flanking regions (Fig.
3d; Extended Data Fig. 6; Supplementary Fig. 1), and elevated DNA methylation and
H4K20me1 (Extended Data Fig. 7b). srHC genes repressed by cluster 2 span a wide
range of biological functions, including metabolism and cell cycle (Extended Data Fig. 7a).
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Cluster 2 hub proteins MYBBP1A and ZNF622, as well as peripheral cluster 2 proteins,
including CBX1, RPF2, MPHOSPH10, and CCDC137, have been previously observed to
exhibit complete or partial nucleolar localization (Thul et al., 2017), and knockdown or loss
of MYBBP1A or ZNF622 has been shown to cause significant nucleolar abnormalities (Liu
et al., 2017). The KMT SETDB1 occupies a different cluster 2 subcluster, along with
PPHLN1 (Fig. 3c), a component of the HUSH complex that recruits SETDB1
(Tchasovnikarova et al., 2015).
Cluster 3, with hub proteins CEBPZ and FUS, preferentially represses srHC genes
not highly enriched for H3K9me3 or H3K27me3, corresponding to our previously
annotated srHC unmarked genes (Becker et al., 2017), yet with high srHC levels across
the gene body and with euchromatic flanking regions (Fig. 3d; Extended Data Fig. 6;
Supplementary Fig. 1) and elevated DNA methylation and H4K20me1 (Extended Data
Fig. 7b). Cluster 3 selectively represses srHC genes enriched for the biological function of
immune response including elements of interferon signaling, a known repressive target of
SFPQ (Collier et al., 2012) (Extended Data Fig. 7a). Cluster 3 also selectively represses
srHC genes encoding miRNA target genes by the TargetScan microRNA database
(Agarwal et al., 2015)(Extended Data Fig. 7c), consistent with the roles of cluster 3
proteins FUS, SFPQ, and HNRNPA2B1 in the miRNA pathway (Villarroya-Beltri et al.,
2013; Zhang et al., 2018a) and the presence of cluster 3 proteins in paraspeckles
(Yamazaki and Hirose, 2015).
Cluster 4 encompasses hub proteins GATAD2A and ZNF438, as well as the PRC2
complex member SUZ12, and represses srHC genes with high H3K9me3 and high
H3K27me3, including many of our previously annotated srHC H3K9me3/K27me3 dual
marked genes (Becker et al., 2017), and that possess high srHC across their gene bodies
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and flanking regions (Fig. 3d; Extended Data Fig. 6; Supplementary Fig. 1). Cluster 4
members GATAD2A and GATAD2B are components of the NuRD complex, which
mediates deacetylation of histones and facilitates recruitment of PRC2 for H3K27me3
methylation (Reynolds et al., 2012). Across all four clusters, we detect varying degrees of
H3K9me3 and H3K27me3 heterogeneity across the srHC gene bodies and promoters
uniquely regulated by each cluster (Extended Data Fig. 7d). This likely indicates complex
maintenance of srHC genes with various histone marks.
In summary, the distinct heterochromatin profiles targeted by each srHC protein
cluster validates the genetic method of determining the clusters by the common gene
expression changes upon srHC protein knockdown, and demonstrates that srHC proteins
selectively repress genes with particular heterochromatin subtypes and biological
functions.

Binding of srHC hub proteins to repressed srHC genes
We performed ChIP-seq on the 8 srHC hub proteins and assessed their binding profiles
over srHC genes upregulated by each of the srHC hub knockdowns during hiHep
reprograming (Fig. 4a). ERH binding was enriched at ERH-repressed genes as well as
genes repressed by HMGA1 (Fig. 4a), which clustered with ERH based upon shared
repressed genes (Fig. 3c). We observed that while several of the srHC hub proteins,
particularly HMGA1, MYBBP1A, FUS, and GATAD2A, demonstrated enrichment over the
srHC genes upregulated by their depletion, they also displayed enrichment over srHC
genes repressed by hubs of other clusters (Fig. 4a). In cases of overlapping enrichment
at srHC genes by two factors, there was enrichment over shared repressed srHC genes
but not genes functionally repressed solely by the other factor (Extended Data Figure 8a).
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ChIP-seq for endogenous ERH demonstrated that it preferentially associates with
H3K9me3 domains in a broad pattern (Fig. 4b-d), similar to its observed binding pattern
in S. pombe (Sugiyama et al., 2016), including in human euchromatic H3K9me3 domains
(Fig. 4d; Extended Data Fig. 8b), where it also represses euchromatic H3K9me3 genes
(Extended Data Fig. 8c).
We observed that the chromatin immunoprecipitations for various srHC proteins,
especially ZNF622 and CEBPz, were enriched for large chromatin fragments relative to
the input size profile (Extended Data Fig. 8d); consistent with these factors binding to srHC
regions that generate larger fragments during sonication (Becker et al., 2017). We had
performed paired-end sequencing without size selection to preserve the large fragments
in the amplified libraries and observed that large fragments were enriched in srHC
domains (Extended Data Fig. 8e). In summary, srHC hub proteins are bound to genes
that they functionally repress.

srHC protein maintenance of repressive histone modifications
Quantitative confocal H3K9me3 imaging of fibroblast cells treated with the two
independently targeting siRNAs against all 97 target proteins was used to assay global
H3K9me3 by indirect immunofluorescence at the single cell level (Extended Data Fig. 9a).
Depletion of hub node srHC proteins ERH, HMGA1, MYBBP1A, ZNF622, CEBPz, and
FUS decreased total nuclear H3K9me3 levels more than peripheral node srHC proteins,
with the exceptions of cluster 4 hub proteins GATAD2A and ZNF438, whose depletions
had limited effects on H3K9me3 levels (Fig. 5a (exemplary primary data) and 5b (
summary of single-cell analysis of all knockdowns) and Extended Data Fig. 9). Depletion
of XRN2 caused the greatest global decrease in H3K9me3 levels of any peripheral cluster
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protein (Fig. 5b), consistent with XRN2 regulating H3K9me3 heterochromatin in S. pombe
(Chalamcharla et al., 2015). XRN2 in C. elegans was recently shown to be involved in
H3K27me3 heterochromatin (Mattout et al., 2020), a mark we also observed to decrease
by siXRN2 (Extended Data Fig. 9b). YTHDC1 was the only srHC protein whose
knockdown elicited significantly elevated nuclear H3K9me3 (Fig. 5b; Extended Data Fig.
9c), likely due to its role as a regulator of mRNA stability of MAT2A, which catalyzes
production of the methyl donor S-adenosylmethionine (Shima et al., 2017) for the HMTs.
Cluster 1 knockdowns caused widespread decreases in H3K9me3 global levels
(Fig. 5a, b), but limited decreases of H3K27me3 (Extended Data Fig. 9d, e). Surprisingly,
knockdowns of cluster 2 hub proteins resulted in the greatest observed decreases in both
H3K9me3 and H3K27me3 (Fig. 5a, b; Extended Data Fig. 9d, e), despite not activating
srHC genes with high H3K9me3 and H3K27me3 profiles (Fig. 3d; Extended Data Fig. 7).
Cluster 3 knockdowns caused small decreases in global H3K9me3 (Fig. 5a, b) and
H3K27me3 (Extended Data Fig. 9d, e). Cluster 4, which contains the hub nodes
GATAD2A and ZNF438, as well as SUZ12, exhibited no appreciable effect on H3K9me3
levels (Fig. 5b), consistent with enrichment for repressing H3K27me3-marked srHC genes
(Fig. 3d). Despite causing the greatest activation of H3K27me3-marked srHC genes,
depletion of cluster 4 node proteins GATAD2A and ZNF438 caused the smallest decrease
in H3K27me3 levels globally by immunofluorescence, indicating that the de-repression
observed in these knockdowns apparently does not function through global loss of K27
methylation (Extended Data Fig. 9d, e). The extent to which global H3K9me3 levels were
depleted after srHC protein knockdown correlates (R=-0.31, p=0.006) with increasing
numbers of hepatic srHC genes that could be activated during hiHep reprogramming
(Extended Data Fig. 9f).
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ERH globally maintains chromatin states at srHC genes
To focus on locus-specific changes caused by siRNA depletion of the cluster 1 hub protein
ERH, which represses genes with the strongest H3K9me3 signals (Fig. 3d; Extended Data
Fig. 6), we performed H3K9me3 and H3K27me3 ChIP-seq and srHC-seq (Nicetto et al.,
2019) in siControl and siERH knockdowns (Extended Data Fig. 10a). We first plotted 9,275
srHC genes based upon their mean siControl H3K9me3, H3K27me3, and srHC gene body
chromatin states in two dimensions, using t-distributed stochastic neighbor embedding (tSNE) (Fig. 6a). The graphical representation illustrates the existence of H3K9me3,
H3K27me3, H3K9me3-H3K27me3 dual marked and unmarked srHC genes, as we have
previously shown (Becker et al., 2017), as well as their relative srHC levels (Fig. 6a).
Varying levels for each mark can be found across srHC genes and drive the t-SNE
separation (Extended Data Fig. 10b). ERH depletion led to a twofold or greater decrease
in H3K9me3 at 76% of srHC genes (Fig. 6b). Unexpectedly, ERH depletion also led to a
twofold or greater loss of H3K27me3 at 67% of srHC genes, though mostly for residual
H3K27me3 genes that were not previously annotated as H3K27me3-marked (Becker et
al., 2017) (Fig. 6b). Most significantly, ERH depletion decreased srHC markedly at nearly
all srHC genes, regardless of their initial histone modification state (9274 of 9275 total)
(Fig. 6b; Extended Data Fig. 10c). Consequently, while the hiHep factors in the ERH
knockdown activated 13.4% of hepatic srHC genes, they also activated, to a lesser extent,
srHC genes in alternative lineages including neural and pluripotency/iPSC (Fig. 6c;
Extended Data Fig. 10d). Motif analysis of promoters of non-hepatic srHC genes activated
in siERH + hiHep conditions but not siERH alone identified enriched motifs corresponding
to factors expressed in hiHep treated fibroblasts (Extended Data Fig. 10e).
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With ERH knockdown, H3K9me3 loss was variable across several classes of key
hepatic genes, with H3K9me3 decreasing markedly at genes encoding cytochrome
P450s, but not at those encoding glucuronidases (Extended Data Fig. 10f), indicating
network specificity. H3K9me3 was unchanged or gained at 12% and 11% of srHC genes
respectively (Extended Data Fig. 10g), with the H3K9me3 gain highly specific for initially
unmarked srHC genes (Fig. 6a). Similarly, a H3K27me3 gain was observed at 18% of
srHC genes, primarily at srHC genes initially unmarked by H3K27me3 (Fig. 6b; Extended
Data Fig. 10h). We presume these changes to be secondary consequences of loss of
ERH at its many target genes.
At srHC genes exhibiting marked H3K9me3 loss upon ERH knockdown during
hepatic reprogramming, we observed higher rates of activation (Fig. 6d) among genes
with strong hepatic transcription factor motifs (Extended Data Fig. 10i, j). Conversely, for
a subset of srHC genes exhibiting H3K9me3 loss that also gain H3K27me3, we observed
lower rates of activation (Fig. 6e; Extended Data Fig. 10j), indicating that H3K27me3 may
compensate for H3K9me3 loss at some genes. We conclude that ERH has global roles in
maintaining chromatin states at srHC genes and modulates the interplay between
H3K9me3, H3K27me3, and srHC.

43

2.6 Discussion
We identified and deeply profiled the genetic functions of 97 heterochromatin-associated
proteins and revealed unexpected complexity in the basis for heterochromatic gene and
repeat element silencing. We also demonstrated how transiently overcoming such
silencing can enable alternative-fate genes to be accessed, providing a framework for
enhancing the ability to genetically reprogram cells. We find that srHC protein depletion
does not usually result in the activation of heterochromatin-embedded genes, but rather
imparts permissibility for relevant transcription factors to induce alternative-fate genes.
The point illustrates how a transient, global diminution of heterochromatin does not
obligatorily cause extensive nonspecific gene activation, but rather how the transcriptional
response can be largely predicted by the type of transcription factors expressed in a cell
and the exogenous factors that may be added.
We found that ERH is key to global H3K9me3 maintenance in human cells and,
remarkably, is evolutionarily conserved with S. pombe with regard to its repression of
meiotic and germ cell genes. ERH also represses many other lineage-specific genes and
satellite repeats, apparently providing a primary mechanism for heterochromatin in
metazoans, which lack the RNA-dependent RNA polymerase complex seen in S. pombe
and plants. Significantly, we found that ERH is required to maintain the H3K9me3
methyltransferase SUV39H1 on heterochromatin.
Previously we had discerned four distinct types of sonication-resistant
heterochromatin, including that which was enriched for H3K9me3, H3K27me3, both
modifications, or neither (Becker et al., 2017). Our collective knockdown analysis of srHC
proteins showed that the proteins clustered by their action on genes that grouped into
different srHC subtypes, but with a resolution and degrees of overlap not discerned in our
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original assessment (Fig. 3d). While depletion of many of the tested srHC proteins
triggered widespread changes in heterochromatin histone modifications, locus specific
analysis revealed that while H3K9me3 loss corresponded to srHC gene activation,
H3K27me3 levels remained high or even increased at transcriptionally de-repressed srHC
genes, illustrating that for those genes, the H3K9me3-based mechanisms was the
dominant repressive effector.
Our finding that clusters of proteins regulate specific srHC subtypes and different
gene classes provides a framework to explore how the srHC proteins govern
heterochromatin regulation at selective regions of the genome. Further work will address
the mechanisms governing the regulation of the srHC subtypes, enabled by the apparent
collaboration between srHC proteins predicted by our clustering. The present study has
expanded our understanding of the complexity of heterochromatin maintenance in
vertebrates, uncovered ERH as a key player in mammalian H3K9me3 regulation, and
provides a resource of srHC proteins and gene targets at heterochromatin subtypes that
can be modulated to enhance cellular reprogramming.
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2.7 Main Figures

Figure 1 | Heterochromatin-associated proteins maintain repression of genes and
repetitive elements.
a, Experimental design of the siRNA treatments and sample collection.
b, The percentage of srHC genes and repetitive elements upregulated versus siControl
(Wald test with Benjamini correction for multiple comparisons, P ≤ 0.05 and log2[fold
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change] > 0) by each knockdown for specified gene lineage category or repetitive element
class in human fibroblasts; hierarchically clustered by target gene across all lineage
categories. DESeq2 results are provided as source data.
c, The number of all repressed srHC genes shared between the eight indicated srHC
proteins.
d, The expression as transcripts per kilobase million (TPM) in human fibroblasts across
four siControl-treated replicates (Rep.) of canonical transcription factors for hepatic,
neural, pluripotent, sperm and oocyte lineages. e, Transcription factor binding site motifs
enriched in promoters of srHC genes induced or not induced by ERH knockdown and their
RNA expression in control cells.
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Figure 2 | ERH functions through conserved mechanisms to maintain H3K9
methylation and gene repression.
a, Immunofluorescence analysis of H3K9me3 (green), H3K9me2 (red) and 4,6-diamidino2-phenylindole (DAPI; blue) after siControl or siERH siRNA treatment in human
fibroblasts. The experiment was repeated independently eight times with similar results.
Scale bars, 50 µm.
b, Expression changes of 154 human gene orthologues of S. pombe meiotic genes that
were upregulated in Erh-knockout S. pombe in siERH-treated human fibroblasts
compared with other knockdowns (DESeq2; Wald test with Benjamini correction for
multiple comparisons, P ≤ 0.05 and log2[fold change] > 0). Gene names, log2 fold change
(lfc) and P values are provided as source data.
c, Gene track of an example H3K9me3 domain showing H3K9me3 levels after siControl
and siERH treatment and the locations of incident protein-coding genes and repeats. Chr.,
chromosome.
d, Heatmap of H3K9me3 ChIP–seq in siERH minus siControl at 15,154 length normalized
H3K9me3 domains, and the corresponding percentages of domains with H3K9me3 loss,
gain or no change.
e, H3K9me3 changes for domains containing at least one of the following: protein-coding
genes, pseudogenes, non-coding RNA (ncRNA), LINEs, SINEs, ERVs or satellite repeats.
Statistical analysis was performed using one sample t-tests; *P < 0.5 × 10−12. For the box
plots, the center line, bounds and whiskers represent the median, 25–75% range and
minimum to maximum values, respectively. n values are denoted in the panel and
represent the number of annotated srHC domains containing each type of gene or repeat.
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f, Analysis of H3K9me3 levels and RNA expression by RepEnrich (Criscione et al., 2014)
for classes of satellite repeats after siERH knockdown. Source data are available online.
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Figure 3 | Heterochromatin-associated proteins function cooperatively and
distinctly to regulate silencing during reprogramming.
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a, Heatmap of the fraction of srHC genes upregulated versus the siControl (DESeq2, Wald
test with Benjamini correction for multiple comparisons, P ≤ 0.05 and log2[fold change] >
0) by each knockdown for the specified gene lineage category in normal fibroblasts and
hiHep reprogrammed cells. DESeq2 results are provided as source data. Knockdown
targets ordered by the number of hepatic genes upregulated under hiHep conditions.
b, hiHep transcription factor motif enrichment in all hepatic gene promoters (black) and in
activated genes (red) by all siRNA knockdown treatments that upregulated at least 25
srHC hepatic genes during hiHep reprogramming. n = 63 independent siRNA targets.
Statistical analysis was performed using one tailed Student’s t-tests; P values are denoted
in panel. For the box plots, the center line, bounds and whiskers represent the median,
25–75% range and minimum to maximum values, respectively.
c, Nearest neighbor clustering analysis of srHC genes upregulated by each knockdown
(black nodes) during hiHep reprogramming, and a display of the fraction of total genes
shared with the connected knockdown (colored connections) represented in an
anticlockwise manner.
d, Histone profiles, input subtracted, for H3K9me3, H3K27me3 and srHC for srHC genes
upregulated uniquely by each cluster. TSS, transcription start site. TTS, transcription
termination site. Euchr., euchromatin. Source data are available online.
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Figure 4 | srHC proteins bind to repressed target genes.
a, ChIP–seq profiles of eight srHC proteins across the gene body ±10 kb of all srHC genes
(grey), srHC genes upregulated by the indicated siRNA + hiHep condition (red) and srHC
genes not upregulated by the indicated siRNA + hiHep (blue).
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b,c, Browser tracks showing H3K9me3, sonication resistance and two replicates of ERH
ChIP–seq at regions of chromosome 16 (b) and chromosome 20 (c).
d, The ERH ChIP–seq signal across srHC and euchromatin H3K9me3- and H3K27me3marked and unmarked domains.
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Figure 5 | srHC protein clusters regulate heterochromatin histone modifications.
a, Example immunofluorescence images showing H3K9me3 (green) changes and DAPI
(blue) with hub node knockdowns in human BJ fibroblasts. Scale bars, 50 µm. The images
are representative of four experiments.
b, Quantification of H3K9me3 immunofluorescence for knockdowns of hub and peripheral
node srHC proteins relative to the siControl (n > 100 nuclei for each treatment). For the
box plots, the center line, bounds and whiskers represent the median, 25–75% range and
minimum to maximum values, respectively. Source data are available online.
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Figure 6 | Locus-specific and global changes in heterochromatin drive derepression
of srHC genes.
a, t-SNE plots of H3K9me3, H3K27me3 and srHC levels across 9,275 srHC genes. The
color scale ranges from the bottom 5% to the top 95% of data points.
b, t-SNE plots of changes in H3K9me3, H3K27me3 and srHC levels in siERH relative to
the siControl.
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c, Heatmap displaying the percentage of alternative lineage srHC gene activation by
siERH during hiHep reprogramming.
d,e, Browser track showing H3K9me3, H3K27me3, srHC and expression changes for an
example srHC gene losing H3K9me3 (d) and an example srHC gene losing H3K9me3
and gaining H3K27me3 (e).
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2.8 Supplemental Figures
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Extended Data Figure 1 | Validation of siRNA efficiency and confirmation of RNAseq results by qPCR.
a, qPCR quantification of knockdown for all siRNAs used in this study. siRNAs used for
treating cells for RNA-seq analysis indicated in red. Above bar graphs show the number
of srHC genes significantly upregulated (DESeq2, Benjamini multiple test corrected Wald
test p-value ≤0.05 and log2(foldchange)>0) by each knockdown in reprogramming and
non-reprogramming conditions. (n=2 biological replicates per siRNA, two siRNAs per
target)
b, Protein depletion efficiency for select srHC proteins in study, asterisk color corresponds
to knockdown in (a). Arrows indicate location of indicated molecular weight markers.
Experiment repeated independently 2 times with similar results. Unprocessed blots are
provided as source data.
c, Quantification of cell confluency using PHANTAST55 from phase contrast images (n=4
images for each condition; two independently targeting siRNAs per target, two replicates
per siRNA). Boxplot center, bounds and whiskers represent the median, 25–75% range
and minimum to maximum values.
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Extended Data Figure 2 | Extended analysis of top noTF srHC proteins.
a, Sucrose gradient fractionation of sonicated DNA, DNA concentration of each fraction
indicated (20ul loaded per lane), followed by western blot probing for ERH with RBMX and
H3 as controls. Experiment repeated independently 2 times with similar results.
b, qRT-PCR in siControl (n=3) and siERH treated (n=3 for each of two different siRNAs)
human fibroblasts of pre-RNAs of genes upregulated at mRNA level by ERH depletion
(two tailed Student’s t-test). Boxplot center, bounds and whiskers represent the median,
25–75% range and minimum to maximum values.
c, Spermatogenic TF motif enrichment in srHC spermatogenesis genes upregulated and
not upregulated by each of the n=97 siRNA targets (two tailed Student’s t-test). Boxplot
center, bounds and whiskers represent the median, 25–75% range and minimum to
maximum values.
d, Western blots for transcription factors involved in spermatogenesis to assess levels in
fibroblast whole cell lysate.
e, Western blots for transcription factors with motifs enriched in promoters of srHC genes
activated by ERH knockdown.
f, Expanded Salmon TE heatmaps for knockdowns showing highest repeat activation
(arrows indicate subtypes with the highest percent of upregulation by indicated
knockdown). P values from b,c are denoted in the panels. Statistical information and
unprocessed blots are provided as source data.
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Extended Data Figure 3 | ERH depletion causes a global decrease in H3K9me3 but
does not decrease H3K9 HMT expression or H3K9me2 levels.
a, Quantification of H3K9me3 immunofluorescence in siControl and siERH treated human
fibroblasts (Student’s two tailed t-test). Boxplot center, bounds and whiskers represent the
median, 25–75% range and minimum to maximum values. N numbers are denoted in the
panel and represent the number of cells imaged per treatment.
b, Volcano plots showing expression change and significance of indicated H3K9 histone
methyltransferase for 97 siRNA knockdowns by RNA-seq (n=2). siRNA knockdowns
causing significant (DEseq2, Benjamini multiple test corrected Wald test p-value ≤0.05
and log2(foldchange)>0) upregulation (red) or downregulation (blue) are listed within
graph.
c, H3K9me3 immunofluorescence (left) and quantification (right) in siControl (n=352 cells)
and siERH (n=365 cells) treated HepG2 cells (two tailed Student’s t-test). Experiment
repeated independently 2 times with similar results. Boxplot center, bounds and whiskers
represent the median, 25–75% range and minimum to maximum values. P values denoted
in panel.
d, Western blots for H3K9me3 histone methyltransferases in siControl and siERH treated
human fibroblasts. Experiment repeated independently 2 times with similar results.
e, Western blots for ERH, SUV39H1 and H3K9me3 in the sonicated chromatin fraction
from siControl and siERH treated human fibroblasts. Arrows indicate location of indicated
molecular weight markers. Experiment repeated independently 2 times with similar results.
f, H3K9me3 immunofluorescence comparison between siERH and HMTs siSUV39H1 and
siSETDB1. Experiment repeated independently 2 times with similar results.
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g, H3K9me2 (green) and DAPI (blue) immunofluorescence in siControl and siERH treated
human fibroblasts using an alternative antibody. Experiment repeated independently 2
times with similar results.
h, H3K9me3 immunofluorescence in siControl and siSKIV2L2 treated human fibroblasts.
Scale bars indicate 50µm for all images. Experiment repeated independently 2 times with
similar results. Unprocessed blots are provided as source data.
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Extended Data Figure 4 | ERH regulates gametogenic genes and a subset of repeat
elements.
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a, RNA-seq tracks showing SPANX cluster expression in siERH and several additional
srHC protein knockdowns; same scale used for all mRNA-seq tracks.
b, Protein sequence alignment of the ERH interacting domain of Mmi1 (95–122) and
corresponding regions, determined by full length protein alignment, of the closest human
orthologs. Purple arrow indicates tryptophan residue previously observed in a separate
study2 to be important for ERH interaction.
c, R-Deep database showing control and RNase treated fractionation and mass
spectrometry detection of ERH. Other proteins observed to fractionate with ERH in fraction
22 which also exhibit a RNase induced shift listed in red box.
d, Correlation of RepEnrich analysis of H3K9me3 and expression changes of repeat
element classes in siERH relative to siControl. Alu and ERVK elements showed the
greatest negative correlation between H3K9me3 and expression and are plotted
separately. R correlation coefficient and p-value calculated using corrcoef in MATLAB; pvalue calculated as the corresponding two-sided p-value for the t-distribution with n-2
degrees of freedom. N numbers stated in panel and represent the number of distinct
repeat elements of indicated class.
e, Violin plots of H3K9me3 and expression fold change (log2(siERH/siControl)) as
determined by RepEnrich for the repeat element classes exhibiting significant H3K9me3
and expression changes (two tailed Student’s t-test). N numbers stated in panel and
represent the number of distinct repeat elements of indicated class.
f, H3K27me3 changes at satellite repeats in siERH relative to siControl.
g, Motif occurrence for FOXA3, HNF1a and HNF4a in ERV (n=1641 element sequences),
LINE (n=471 element sequences) and SINE (n=147 element sequences) elements (two
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tailed Student’s t-test). Boxplot center, bounds and whiskers represent the median, 25–
75% range and minimum to maximum values.
h, Quantification of flow cytometry assay of siRNA+hiHep cells stained for the hepatic
marker ASGPR1 (two tailed Student’s t-test to siControl). N numbers stated in panel and
represent the number of cells quantified to calculate percent positive per condition. P
values in d,e,g,h are denoted in the panels.
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Extended Data Figure 5 | Chromosomal positions of srHC gene activation for noTF
and hiHep.
Chromosomal positions for hiHep activation of srHC genes by indicated knockdowns.
Expanded example regions 1–3 are marked by grey background.
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Extended Data Figure 6 | Histone profiles of genes targeted by hub proteins.
a,b,c, H3K9me3 (a), H3K27me3 (b) and srHC (c) meta profiles of genes targeted by hub
proteins 2.5kb upstream of TSS to 2.5kb downstream of TTS.
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Extended Data Figure 7 | Extended cluster specific analysis.
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a, Gene Ontology analysis for statistical overrepresentation of biological processes for
srHC genes uniquely repressed by each cluster; non-redundant GO categories shown (pvalue calculated by PANTHER Statistical overrepresentation test, denoted in panel). N
numbers represent number of genes in GO category repressed by srHC protein member
of indicated cluster and are stated in panel.
b, Profiles of A/B compartment enrichment43, H4K20me1 and DNA methylation by
bisulfide sequencing across genes uniquely regulate by each cluster.
c, TargetScan database analysis for enrichment of miRNA target sequences in srHC
genes uniquely repressed by each cluster; -log2(p-value) shown for the top 55 enriched
miRNA target sequences per cluster (p-value calculated using the statistical model
developed in Agarwal et al., 2017).
d, Heatmap of H3K9me3, H3K27me3 and srHC-seq profiles of srHC genes uniquely
regulated by each srHC protein cluster and sorted by mean H3K9me3 level within each
cluster set. N numbers represent number of srHC gene profiles depicted and are stated in
the panel.
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Extended Data Figure 8 | srHC protein ChIP-seq.
a, ChIP-seq profiles of HMGA1 and MYBBP1A at srHC genes repressed by both factors
or repressed by the other factor.
b, Browser track showing ERH at a H3K9me3-marked euchromatin domain.
c, srHC and euchromatin H3K9m3 gene expression changes in siERH+hiHep. N numbers
represent the number of srHC or euchromatin srHC genes and are stated in the panel.
The number of genes in each set significantly up (red) or down (blue) are indicated.
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d, DNA fragment size profiles by BioAnalyzer of INPUT and eluted DNA after ChIP of the
indicated srHC protein.
e, Table showing the percent of DNA fragments with length>=1kb as determined by
paired-end sequencing for reads mapping with over 50% overlap with euchromatin or
srHC domains (two tailed Student’s t-test, n=3 biological replicates sequenced as INPUT).
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Extended Data Figure 9 | Quantification of confocal images and extended analysis.
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a, Methodology for defining nuclear border and quantifying fluorescence intensity.
b, H3K9me3 and H3K27me3 immunofluorescence in siControl and siXRN2 treated human
fibroblasts. Images representative of 2 experiments.
c, H3K9me3 immunofluorescence in siControl and siYTHDC1 treated human fibroblasts.
Images representative of 4 experiments.
d,e Representative images (d) and quantification (e) of H3K27me3 for cells depleted by
siRNA for hub proteins. Images representative of 2 experiments. Boxplot center, bounds
and whiskers represent the median, 25–75% range and minimum to maximum values. N
numbers for e represent the number of cells imaged and are stated in the panel.
f, Plot showing correlation of H3K9me3 immunofluorescence intensity relative to siControl
vs the number of hepatic srHC genes induced during hiHep reprogramming for the target
srHC proteins in Fig. 5b. R correlation coefficient and p-value calculated using corrcoef in
MATLAB; p-value calculated as the corresponding two-sided p-value for the t-distribution
with n-2 degrees of freedom. N numbers stated in panel and represent the number of
siRNA targets. All scale bars indicate 50 µm.
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Extended Data Fig. 10 | Expanded analysis of ChIP-seq and srHC-seq in siERH.
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a, DNA size profiles of sonicated fractions from siControl and siERH.
b, Combinatorial H3K9me3 and H3K27me3 levels for srHC genes in siControl treated
human fibroblasts.
c, Heatmap displaying enrichment of H3K9me3, H3K27me3, dual-marked, and unmarked
srHC gene subtypes in siControl and siERH from 2kp upstream of TSS to 2kp downstream
of TTS.
d, Activation of srHC alternative lineage genes in siERH relative to siControl during hiHep
reprogramming not activated by siERH without hiHep factors.
e, Percent occurrence of top 5 motifs enriched in promoters of non-hepatic genes
upregulated in siERH+hiHep conditions and corresponding expression of the putative
targeting factors in 4 siControl+hiHep replicates.
f, H3K9me3 changes at classes of key hepatic genes, cytochrome p450 (n=50), UGT
(n=21), SLC transporter (n=196) and ABC transporter (n=27), in siERH compared to
siControl. Boxplot center, bounds and whiskers represent the median, 25– 75% range and
minimum to maximum values.
g,h, Location of srHC genes gaining H3K9me3 (g) and H3K27me3 (h) on t-SNE
embedding.
i, hiHep motifs from Jaspar database and identified motifs in promoter regions (tss +/−
200) of srHC genes with motif scores >=10.
j, Table showing total gene numbers and activation rates in siERH for sets of srHC genes
defined by presence of strong hiHep motifs and specific changes in H3K9me3 and
H3K27me3 levels.
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Supplementary Figure 1 | Gene browser tracks of example genes uniquely
repressed by clusters 1, 2, 3 and 4.
a,b,c,d, Browser tracks for example srHC genes repressed by cluster 1 (a), 2, (b), 3 (c)
or 4 (d) and no other clusters.
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2.9 Supplemental Tables
Supplemental Table 1 | Table of siRNAs used in this study.
Gene
Symbol

Full Gene Name

siRNA
ID

Sense siRNA
Sequence (Thermo
Fisher Human Silencer
Select siRNA)

siRNA
#

Used for
Sequencing

UAUCGUCGCGAUUAC
AGAAtt

Antisense siRNA
Sequence (Thermo
Fisher Human
Silencer Select
siRNA)
UUCUGUAAUCGCGA
CGAUAat

BCLAF1

BCL2-associated
transcription factor 1

s18873

1

YES

BCLAF1

BCL2-associated
transcription factor 1

s18874

CAUUGAUCGCCGUAG
AAAAtt

UUUUCUACGGCGAU
CAAUGtc

2

NO

CHTOP /
C1orf77

chromatin target of
PRMT1 / chromosome
1 open reading frame
77
chromatin target of
PRMT1 / chromosome
1 open reading frame
77
chromosome 5 open
reading frame 41

s25091

GGCCUACCCAUAAUC
CAGAtt

UCUGGAUUAUGGGU
AGGCCtc

1

NO

s25092

GAUGCAUAUAUGUCG
AAAAtt

UUUUCGACAUAUAU
GCAUCca

2

YES

s45763

GGAGUAUAGUGAACA
ACUUtt

AAGUUGUUCACUAU
ACUCCca

1

YES

C5orf41

chromosome 5 open
reading frame 41

s45764

CCUCAGAAUUUGUUA
ACCAtt

UGGUUAACAAAUUC
UGAGGtt

2

NO

CBX1

s21549

ACAGCACAUGAGACA
GAUAtt

UAUCUGUCUCAUGU
GCUGUtt

1

YES

s21550

GCGCAAAGCUGAUUC
UGAUtt

AUCAGAAUCAGCUU
UGCGCtt

2

NO

CBX3

chromobox homolog 1
(HP1 beta homolog
Drosophila )
chromobox homolog 1
(HP1 beta homolog
Drosophila )
chromobox homolog 3

s22356

GACGUGUAGUGAAUG
GGAAtt

UUCCCAUUCACUACA
CGUCga

1

YES

CBX3

chromobox homolog 3

s22355

GGAGAAUUGAUGUUU
CUCAtt

UGAGAAACAUCAAUU
CUCCac

2

NO

CBX5

chromobox homolog 5
(HP1 alpha homolog,
Drosophila)
chromobox homolog 5
(HP1 alpha homolog,
Drosophila)
coiled-coil domain
containing 137

s23884

GCAGAGCAAUGAUAU
CGCUtt

AGCGAUAUCAUUGC
UCUGCtc

1

NO

s23883

GGAGCACAAUACUUG
GGAAtt

UUCCCAAGUAUUGU
GCUCCtc

2

YES

s23032
0

ACCCGAUCAGUAACA
AGAAtt

UUCUUGUUACUGAU
CGGGUtt

1

NO

CCDC137

coiled-coil domain
containing 137

s23032
1

CAGGUGACCUUCAGA
AAGAtt

UCUUUCUGAAGGUC
ACCUGgg

2

YES

CCDC59

coiled-coil domain
containing 59

s26435

GCUUUUCGAAGAAAA
CUGAtt

UCAGUUUUCUUCGA
AAAGCaa

1

NO

CCDC59

coiled-coil domain
containing 59

s26436

ACAAGAAAUUGCUAC
GGAAtt

UUCCGUAGCAAUUU
CUUGUaa

2

YES

CCDC86

coiled-coil domain
containing 86

s35537

GGACCGCUCCAAGAA
AAGAtt

UCUUUUCUUGGAGC
GGUCCtt

1

NO

CCDC86

coiled-coil domain
containing 86

s35538

AGCUUCCUGUAAUCC
CGAAtt

UUCGGGAUUACAGG
AAGCUcc

2

YES

CEBPZ

CCAAT/enhancer
binding protein
(C/EBP), zeta
CCAAT/enhancer
binding protein
(C/EBP), zeta
chromatin assembly
factor 1, subunit A
(p150)
chromatin assembly
factor 1, subunit A
(p150)
Y-box binding protein 3
/ cold shock domain
protein A
Y-box binding protein 3
/ cold shock domain
protein A

s19772

GGACAUCAGUUAAUA
AGGUtt

ACCUUAUUAACUGAU
GUCCtt

1

YES

s19773

GACAAUAUCGGAUCG
AUAUtt

AUAUCGAUCCGAUA
UUGUCtg

2

NO

s19499

GCCUGAAUCUUGUCC
CAAAtt

UUUGGGACAAGAUU
CAGGCgc

1

YES

s19500

GAAGAAGACUCUGUA
CUCAtt

UGAGUACAGAGUCU
UCUUCgg

2

NO

s16221

GAUUUAUAAAUCGAA
AUGAtt

UCAUUUCGAUUUAU
AAAUCca

1

YES

s16222

ACAGAAUACAGGCUG
GUGAtt

UCACCAGCCUGUAU
UCUGUtg

2

NO

CHTOP /
C1orf77
C5orf41

CBX1

CBX5
CCDC137

CEBPZ
CHAF1A
CHAF1A
YBX3 / CSDA
YBX3 / CSDA
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CUX1

cut-like homeobox 1

s3768

GAAAGCGGCUUAUCG
AACAtt

UGUUCGAUAAGCCG
CUUUCtg

1

NO

CUX1

cut-like homeobox 1

s3769

GCAUAAGGUUCAGAG
CCUAtt

UAGGCUCUGAACCU
UAUGCtc

2

YES

DDX17

DEAD (Asp-Glu-AlaAsp) box polypeptide
17
DEAD (Asp-Glu-AlaAsp) box polypeptide
17
DEAD (Asp-Glu-AlaAsp) box polypeptide 5

s20622

GAGAGACUCUGCAAG
CUAUtt

AUAGCUUGCAGAGU
CUCUCcg

1

YES

s20623

GGAUCGUAGUGAAAC
CGAUtt

AUCGGUUUCACUAC
GAUCCcg

2

NO

s4007

GCAAUACGGAAGUAA
UGUUtt

AACAUUACUUCCGUA
UUGCtg

1

NO

DDX5

DEAD (Asp-Glu-AlaAsp) box polypeptide 5

s4008

GAGCGUGACUGGGU
UCUAAtt

UUAGAACCCAGUCA
CGCUCtt

2

YES

EBNA1BP2

EBNA1 binding protein
2

s21591

GGAAGAAGGUGCAAA
CGGAtt

UCCGUUUGCACCUU
CUUCCcg

1

YES

EBNA1BP2

EBNA1 binding protein
2

s21592

CGACGGUAUAAAAAC
CAGAtt

UCUGGUUUUUAUAC
CGUCGtt

2

NO

ERH

enhancer of
rudimentary homolog
(Drosophila)
enhancer of
rudimentary homolog
(Drosophila)
exosome component
10

s4815

CUACGAAUCUGUGAA
UGAAtt

UUCAUUCACAGAUU
CGUAGtc

1

YES

s4814

GGAUUAAAGAGAAGA
UCUAtt

UAGAUCUUCUCUUU
AAUCCag

2

YES

s10737

GAGUAUGAUUUUUAC
CGAAtt

UUCGGUAAAAAUCAU
ACUCat

1

NO

EXOSC10

exosome component
10

s10738

GGAUCGAAGUAAAGU
GACUtt

AGUCACUUUACUUC
GAUCCtt

2

YES

FUS

fusion (involved in
t(12;16) in malignant
liposarcoma)
fusion (involved in
t(12;16) in malignant
liposarcoma)
forty-two-three domain
containing 1

s5401

AGCCCAUGAUUAAUU
UGUAtt

UACAAAUUAAUCAUG
GGCUgt

1

NO

s5402

GGUAAAGAAUUCUCC
GGAAtt

UUCCGGAGAAUUCU
UUACCat

2

YES

s38719

GAAAGUUCCUAAAGG
UGUUtt

AACACCUUUAGGAAC
UUUCtt

1

NO

FYTTD1

forty-two-three domain
containing 1

s38718

GGCCCAGUUGAAUAC
AGAAtt

UUCUGUAUUCAACU
GGGCCtg

2

YES

GATAD2A

GATA zinc finger
domain containing 2A

s29501

GCAAAACUCGUGUUG
UUGAtt

UCAACAACACGAGUU
UUGCtt

1

NO

GATAD2A

GATA zinc finger
domain containing 2A

s29502

GCGGCAGAGUCAAAU
ACAAtt

UUGUAUUUGACUCU
GCCGCaa

2

YES

GATAD2B

GATA zinc finger
domain containing 2B

s33061

CGUGAAUACCUUUUA
GACAtt

UGUCUAAAAGGUAU
UCACGct

1

NO

GATAD2B

GATA zinc finger
domain containing 2B

s33062

CGACAGCGUGAAUAC
CUUUtt

AAAGGUAUUCACGC
UGUCGgt

2

YES

GLTSCR2

glioma tumor
suppressor candidate
region gene 2
glioma tumor
suppressor candidate
region gene 2
high density lipoprotein
binding protein

s26872

GGGUUGACCUCAUCC
UCGAtt

UCGAGGAUGAGGUC
AACCCga

1

NO

s26871

GAACCAAAGUCCAGA
AGAAtt

UUCUUCUGGACUUU
GGUUCtc

2

YES

s6502

GAGCGUACCAAGGAU
CUAAtt

UUAGAUCCUUGGUA
CGCUCat

1

NO

HDLBP

high density lipoprotein
binding protein

s6503

GACCUUCACCGUUAC
GUUAtt

UAACGUAACGGUGA
AGGUCaa

2

YES

HMGA1

high mobility group AThook 1

s6667

GGACAAGGCUAACAU
CCCAtt

UGGGAUGUUAGCCU
UGUCCag

1

NO

HMGA1

high mobility group AThook 1

s6668

CCUGGGAUCUGAGUA
CAUAtt

UAUGUACUCAGAUC
CCAGGcg

2

YES

HNRNPA2B1

heterogeneous nuclear
ribonucleoprotein
A2/B1
heterogeneous nuclear
ribonucleoprotein
A2/B1
heterogeneous nuclear
ribonucleoprotein K

s6713

GCAACCUUCUAACUA
CGGUtt

ACCGUAGUUAGAAG
GUUGCtg

1

YES

s6714

CAUCAAUGGUCAUAA
UGCAtt

UGCAUUAUGACCAU
UGAUGgt

2

NO

s6738

GGUCAGCGGAUUAAA
CAAAtt

UUUGUUUAAUCCGC
UGACCac

1

NO

HNRNPK

heterogeneous nuclear
ribonucleoprotein K

s6737

CGAUGAAACCUAUGA
UUAUtt

AUAAUCAUAGGUUU
CAUCGta

2

YES

HNRNPL

heterogeneous nuclear
ribonucleoprotein L

s6741

GCACUCUGAAGAUCG
AAUAtt

UAUUCGAUCUUCAG
AGUGCaa

1

YES

DDX17
DDX5

ERH
EXOSC10

FUS
FYTTD1

GLTSCR2
HDLBP

HNRNPA2B1
HNRNPK
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HNRNPL

heterogeneous nuclear
ribonucleoprotein L

s6740

GGCUUGGAUCAAUCU
AAGAtt

UCUUAGAUUGAUCC
AAGCCat

2

NO

HP1BP3

s27106

GUGCAUCAGUGGUU
GCUAUtt

AUAGCAACCACUGAU
GCACca

1

YES

s27105

GUGUCUCAGUAUUAU
CCUAtt

UAGGAUAAUACUGA
GACACat

2

NO

s20951

GAAGAUUCUUGGACC
ACAAtt

UUGUGGUCCAAGAA
UCUUCcc

1

NO

s20952

CAUACGCAGAACAAA
GUUAtt

UAACUUUGUUCUGC
GUAUGta

2

YES

s20949

CUAUGAUUACGGACA
UGGAtt

UCCAUGUCCGUAAU
CAUAGta

1

YES

s20948

GGGACAUGCUUUGG
AAGAAtt

UUCUUCCAAAGCAU
GUCCCat

2

NO

s38852

AAAGUAUUCUCAAAC
UAGAtt

UCUAGUUUGAGAAU
ACUUUta

1

YES

s38853

GCAUGGACAGUACCC
AAUAtt

UAUUGGGUACUGUC
CAUGCtg

2

NO

LOXL1

heterochromatin
protein 1, binding
protein 3
heterochromatin
protein 1, binding
protein 3
KH domain containing,
RNA binding, signal
transduction
associated 1
KH domain containing,
RNA binding, signal
transduction
associated 1
KH domain containing,
RNA binding, signal
transduction
associated 3
KH domain containing,
RNA binding, signal
transduction
associated 3
LLP homolog, longterm synaptic
facilitation (Aplysia)
LLP homolog, longterm synaptic
facilitation (Aplysia)
lysyl oxidase-like 1

s8258

ACAACGUGGUGAGAU
GCAAtt

UUGCAUCUCACCAC
GUUGUtg

1

YES

LOXL1

lysyl oxidase-like 1

s8257

CGUGAACCCAAAGUA
UAUUtt

AAUAUACUUUGGGU
UCACGtg

2

NO

LOXL2

lysyl oxidase-like 2

s8260

CAUACAAUACCAAAG
UGUAtt

UACACUUUGGUAUU
GUAUGtc

1

NO

LOXL2

lysyl oxidase-like 2

s8261

GGGUGGAGGUGUAC
UAUGAtt

UCAUAGUACACCUC
CACCCgg

2

YES

LTBP2

s8319

GGAGUGUCAAGAUAU
CAAUtt

AUUGAUAUCUUGAC
ACUCCtg

1

YES

s8320

CCACUGUAUCAAACC
CGUUtt

AACGGGUUUGAUAC
AGUGGtt

2

NO

MATR3

latent transforming
growth factor beta
binding protein 2
latent transforming
growth factor beta
binding protein 2
matrin 3

s18898

GACUCUUACCGAAGG
GUUAtt

UAACCCUUCGGUAA
GAGUCca

1

NO

MATR3

matrin 3

s18897

CGAUCUUGCUAAUUU
AGGUtt

ACCUAAAUUAGCAAG
AUCGgt

2

YES

MBD3

methyl-CpG binding
domain protein 3

s28737

GGCGUAGUUUUGAAA
CUCAtt

UGAGUUUCAAAACUA
CGCCtc

1

YES

MBD3

methyl-CpG binding
domain protein 3

s28736

CGGUGACCAAGAUUA
CCAAtt

UUGGUAAUCUUGGU
CACCGgc

2

NO

MBNL1

muscleblind-like
splicing regulator 1

s8553

GGAGAUAAAUGGACG
CAAUtt

AUUGCGUCCAUUUA
UCUCCaa

1

NO

MBNL1

muscleblind-like
splicing regulator 1

s8554

CCAUAAUAUCUGCCG
AACAtt

UGUUCGGCAGAUAU
UAUGGgt

2

YES

MPHOSPH10

M-phase
phosphoprotein 10 (U3
small nucleolar
ribonucleoprotein)
M-phase
phosphoprotein 10 (U3
small nucleolar
ribonucleoprotein)
mRNA turnover 4
homolog (S.
cerevisiae)
mRNA turnover 4
homolog (S.
cerevisiae)
MYB binding protein
(P160) 1a

s19877

GAACUAAGUAUUUCG
GAAAtt

UUUCCGAAAUACUUA
GUUCtt

1

YES

s19878

GACCUUGACUUUGAU
AUCAtt

UGAUAUCAAAGUCAA
GGUCag

2

NO

s27568

CCUGCACCAGGUCAG
CAAAtt

UUUGCUGACCUGGU
GCAGGtt

1

YES

s27566

GAGUGGUUCACGAAA
UACAtt

UGUAUUUCGUGAAC
CACUCat

2

YES

s20604

AAGCCGACUUGAAUA
UAAUtt

AUUAUAUUCAAGUC
GGCUUtg

1

YES

MYB binding protein
(P160) 1a

s20605

ACUCGUUCUUUGUCA
CAAAtt

UUUGUGACAAAGAA
CGAGUgg

2

NO

HP1BP3
KHDRBS1

KHDRBS1

KHDRBS3

KHDRBS3

LLPH
LLPH

LTBP2

MPHOSPH10

MRTO4
MRTO4
MYBBP1A
MYBBP1A
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MYEF2

myelin expression
factor 2

s27094

GGGUCCAAAUCGUAA
CAGAtt

UCUGUUACGAUUUG
GACCCtt

1

YES

MYEF2

myelin expression
factor 2

s27093

GGCAAGCUAUUAAAG
AUCUtt

AGAUCUUUAAUAGC
UUGCCat

2

NO

NCOA5

nuclear receptor
coactivator 5

s33688

GGACCACAGACAUAG
UAGAtt

UCUACUAUGUCUGU
GGUCCcg

1

YES

NCOA5

nuclear receptor
coactivator 5

s33689

CCGUUACAGAGAUAG
CUUUtt

AAAGCUAUCUCUGU
AACGGtc

2

NO

NCOA7

nuclear receptor
coactivator 7

s43909

CCAUAACUGAGGGCA
AUAAtt

UUAUUGCCCUCAGU
UAUGGga

1

YES

NCOA7

nuclear receptor
coactivator 7

s43908

GAAAGAGUCUUAUCG
UCUAtt

UAGACGAUAAGACU
CUUUCaa

2

NO

NONO

s9612

CCAGCAAUUUCACAA
GGAAtt

UUCCUUGUGAAAUU
GCUGGtt

1

YES

s9613

CCAACGAAGCCGUCU
UUUUtt

AAAAAGACGGCUUC
GUUGGgt

2

NO

s23914

CUACAUCACCCGGAA
CAAAtt

UUUGUUCCGGGUGA
UGUAGtt

1

NO

s23913

CAAUAAGCCCAACUA
CAAAtt

UUUGUAGUUGGGCU
UAUUGtc

2

YES

PHB

non-POU domain
containing, octamerbinding
non-POU domain
containing, octamerbinding
pescadillo homolog 1,
containing BRCT
domain (zebrafish)
pescadillo homolog 1,
containing BRCT
domain (zebrafish)
prohibitin

s10425

GCAUCGGAGAGGACU
AUGAtt

UCAUAGUCCUCUCC
GAUGCtg

1

YES

PHB

prohibitin

s10424

CGUGGGUACAGAAAC
CAAUtt

AUUGGUUUCUGUAC
CCACGgg

2

NO

PIAS2

protein inhibitor of
activated STAT, 2

s17286

CAUCACCUGUAGAAC
CUGAtt

UCAGGUUCUACAGG
UGAUGag

1

YES

PIAS2

protein inhibitor of
activated STAT, 2

s17285

CUGUAUAUCUUGUAC
GGCAtt

UGCCGUACAAGAUA
UACAGac

2

NO

POLDIP3

s38777

GGCUCAAACUGGGAG
UCAAtt

UUGACUCCCAGUUU
GAGCCgg

1

NO

s38778

CCCUUCCUCUAUUCG
AACAtt

UGUUCGAAUAGAGG
AAGGGag

2

YES

PPAN

polymerase (DNAdirected), delta
interacting protein 3
polymerase (DNAdirected), delta
interacting protein 3
peter pan homolog

s50159
3

GGUUUCCUUUCAUAA
AGGAtt

UCCUUUAUGAAAGG
AAACCga

1

YES

PPAN

peter pan homolog

s50159
4

GAGCAGCGGCUGGA
UUGAAtt

UUCAAUCCAGCCGC
UGCUCcg

2

NO

PPHLN1

periphilin 1

s28288

GUUUCUACUCUUCCC
AUUAtt

UAAUGGGAAGAGUA
GAAACtt

1

NO

PPHLN1

periphilin 1

s28289

GGGACGAUAUGAAUA
UGAAtt

UUCAUAUUCAUAUC
GUCCCtc

2

YES

PRDM15

PR domain containing
15

s34349

GCCCAUUUCAUCAAC
CUGAtt

UCAGGUUGAUGAAA
UGGGCca

1

YES

PRDM15

PR domain containing
15

s34350

UCCUGACCGUGACCU
UUGAtt

UCAAAGGUCACGGU
CAGGAtt

2

NO

PRMT1

protein arginine
methyltransferase 1

s6917

GCAACUCCAUGUUUC
AUAAtt

UUAUGAAACAUGGA
GUUGCgg

1

YES

PRMT1

protein arginine
methyltransferase 1

s6918

CGAGGACCGGCAGUA
CAAAtt

UUUGUACUGCCGGU
CCUCGat

2

NO

PRRX2

paired related
homeobox 2

s19522
2

GUUUGUGUAUUAAAA
CCAAtt

UUGGUUUUAAUACA
CAAACta

1

YES

PRRX2

paired related
homeobox 2

s19522
3

UCAUUUAGUUUGUGU
AUUAtt

UAAUACACAAACUAA
AUGAgg

2

NO

PTBP1

polypyrimidine tract
binding protein 1

s11434

CAAAGCCUCUUUAUU
CUUUtt

AAAGAAUAAAGAGGC
UUUGgg

1

YES

PTBP1

polypyrimidine tract
binding protein 1

s11435

CAGUUUACCUGUUUU
UAAAtt

UUUAAAAACAGGUAA
ACUGat

2

NO

QKI

quaking homolog, KH
domain RNA binding
(mouse)
quaking homolog, KH
domain RNA binding
(mouse)
RNA binding motif
protein 12B

s18084

GCAGAAAUCAAAUUG
AAGAtt

UCUUCAAUUUGAUU
UCUGCtc

1

NO

s18083

GGACGAAGAAAUUAG
CAGAtt

UCUGCUAAUUUCUU
CGUCCag

2

YES

s52539

GGUCUUAAAUGUCAU
AGAAtt

UUCUAUGACAUUUAA
GACCtc

1

YES

NONO
PES1
PES1

POLDIP3

QKI
RBM12B
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RBM12B

RNA binding motif
protein 12B

s52538

CCUCAGUAUUGACGA
AAGAtt

UCUUUCGUCAAUAC
UGAGGga

2

NO

RBM15

RNA binding motif
protein 15

s34935

GGUGAUAGUUGGGC
AUAUAtt

UAUAUGCCCAACUAU
CACCtt

1

YES

RBM15

RNA binding motif
protein 15

s34936

GCACCAUAGACUACC
GAAAtt

UUUCGGUAGUCUAU
GGUGCgt

2

NO

RBM26

RNA binding motif
protein 26

s34367

CCAUAACUCUUACGU
AAGAtt

UCUUACGUAAGAGU
UAUGGtc

1

YES

RBM26

RNA binding motif
protein 26

s22459
4

GGAUAGUAGUGGACU
CAGAtt

UCUGAGUCCACUAC
UAUCCtc

2

NO

RBM6

RNA binding motif
protein 6

s19838

CAACGAGACUUAUCG
AGAUtt

AUCUCGAUAAGUCU
CGUUGga

1

NO

RBM6

RNA binding motif
protein 6

s19839

CUAUCAUGCUAAAGC
GUAUtt

AUACGCUUUAGCAU
GAUAGtt

2

YES

RBMX_RBM
XL1

similar to RNA binding
motif protein, X-linked

s56033

GGCUUAAUACGGAAA
CAAAtt

UUUGUUUCCGUAUU
AAGCCca

1

YES

RBMX_RBM
XL1

similar to RNA binding
motif protein, X-linked

s56035

GGAAAGUCAUUAGAU
GGAAtt

UUCCAUCUAAUGAC
UUUCCat

2

YES

RELA

v-rel
reticuloendotheliosis
viral oncogene
homolog A (avian)
v-rel
reticuloendotheliosis
viral oncogene
homolog A (avian)
replication timing
regularoty factor 1

s11914

CCCUUUACGUCAUCC
CUGAtt

UCAGGGAUGACGUA
AAGGGat

1

NO

s11915

GGAGUACCCUGAGG
CUAUAtt

UAUAGCCUCAGGGU
ACUCCat

2

YES

s30377

CAAAUCGUGUGGUA
CAGAAtt

UUCUGUACCACACG
AUUUGgg

1

YES

RIF1

replication timing
regularoty factor 1

s30378

CACCGGAACUUAUGA
UAGUtt

ACUAUCAUAAGUUCC
GGUGta

2

NO

RPF1

ribosome production
factor 1 homolog (S.
cerevisiae)
ribosome production
factor 1 homolog (S.
cerevisiae)
ribosome production
factor 2 homolog (S.
cerevisiae)
ribosome production
factor 2 homolog (S.
cerevisiae)
ribosomal protein S19
binding protein 1

s36946

GGCUUUAGCAUUUCG
GAGAtt

UCUCCGAAAUGCUA
AAGCCtg

1

YES

s36947

GGACCACGUUUUACC
UUAAtt

UUAAGGUAAAACGU
GGUCCaa

2

NO

s38576

GGUGUACUAUAUAAA
AAGAtt

UCUUUUUAUAUAGU
ACACCgt

1

YES

s38577

GCAAGACCUAAGCAA
ACUAtt

UAGUUUGCUUAGGU
CUUGCtt

2

NO

s40693

GAGUAAACCUGAAGU
UUCUtt

AGAAACUUCAGGUU
UACUCtg

1

YES

RPS19BP1

ribosomal protein S19
binding protein 1

s40694

GAGACCACCUCAGAG
UAAAtt

UUUACUCUGAGGUG
GUCUCga

2

NO

SAFB

scaffold attachment
factor B

s12453

GGAUGAUAAAUGUGA
CAGAtt

UCUGUCACAUUUAU
CAUCCct

1

YES

SAFB

scaffold attachment
factor B

s12452

GGACCAAGAUGAUCA
GAAAtt

UUUCUGAUCAUCUU
GGUCCtt

2

NO

SAFB2

scaffold attachment
factor B2

s18599

GGACGGUCGUGAUG
GAUAAtt

UUAUCCAUCACGAC
CGUCCgc

1

YES

SAFB2

scaffold attachment
factor B2

s18600

CGGCCUUCUCGAUUC
CUUUtt

AAAGGAAUCGAGAA
GGCCGtc

2

NO

SETDB1

SET domain,
bifurcated 1

s19111

CAACCAGACAUAUAG
AUCAtt

UGAUCUAUAUGUCU
GGUUGat

1

NO

SETDB1

SET domain,
bifurcated 1

s19110

GGACAAUGCAGGAGA
UAGAtt

UCUAUCUCCUGCAU
UGUCCga

2

YES

SFPQ

splicing factor
proline/glutamine-rich
(polypyrimidine tract
binding protein
associated)
splicing factor
proline/glutamine-rich
(polypyrimidine tract
binding protein
associated)
Transformer 2 beta
homolog /splicing
factor, arginine/serinerich 10

s12711

GCACGUUUGAGUACG
AAUAtt

UAUUCGUACUCAAAC
GUGCca

1

YES

s12710

GGAUGAUCGUGGAA
GAUCUtt

AGAUCUUCCACGAU
CAUCCac

2

NO

s12750

CAGUCGAGAUUAUCG
UAGAtt

UCUACGAUAAUCUC
GACUGta

1

YES

RELA

RIF1

RPF1
RPF2
RPF2
RPS19BP1

SFPQ

TRA2B/SFRS
10
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TRA2B/SFRS
10

Transformer 2 beta
homolog /splicing
factor, arginine/serinerich 10
Silencer Select
Negative Control #1
siRNA
Silencer Select
Negative Control #2
siRNA
SAFB-like,
transcription modulator

s12749

GGAGGAUACAGAUCA
CGUUtt

AACGUGAUCUGUAU
CCUCCac

2

NO

s813

UAACGACGCGACGAC
GUAAtt

UUACGUCGUCGCGU
CGUUAtt

1

YES

s814

UCGUAAGUAAGCGCA
ACCCtt

GGGUUGCGCUUACU
UACGAtt

2

NO

s36384

GCAUUAGAAUAAUUC
GUGAtt

UCACGAAUUAUUCUA
AUGCgt

1

YES

SLTM

SAFB-like,
transcription modulator

s36385

GGAAGAUCCAAGCUU
CGAAtt

UUCGAAGCUUGGAU
CUUCCct

2

NO

SUMO2

Small ubiquitin like
modifier 2

s13179

AGAACAACGAUCAUA
UUAAtt

UUAAUAUGAUCGUU
GUUCUca

1

YES

SUMO2

Small ubiquitin like
modifier 2

s13180

CAUCCUGACUACUAC
CGUAtt

UACGGUAGUAGUCA
GGAUGtg

2

NO

SUV39H1

suppressor of
variegation 3-9
homolog 1 (Drosophila)
suppressor of
variegation 3-9
homolog 1 (Drosophila)
Suppressor Of
Variegation 3-9
Homolog 2
Suppressor Of
Variegation 3-9
Homolog 2
Suppressor Of Zeste
12 Protein Homolog

s13660

CAAAUCGUGUGGUAC
AGAAtt

UUCUGUACCACACG
AUUUGgg

1

YES

s13660

CAAAUCGUGUGGUAC
AGAAtt

UUCUGUACCACACG
AUUUGgg

2

YES

s36183

GAAUGAGUUUUGUCA
UGGAtt

UCCAUGACAAAACUC
AUUCtt

1

NO

s36185

GAAUCAGCUUAGUCA
AUGAtt

UCAUUGACUAAGCU
GAUUCca

2

YES

s23967

GGAUGUAAGUUGUCC
AAUAtt

UAUUGGACAACUUA
CAUCCtt

1

YES

SUZ12

Suppressor Of Zeste
12 Protein Homolog

s23969

GGAUAGAUGUUUCUA
UCAAtt

UUGAUAGAAACAUCU
AUCCta

2

NO

TAF15

TAF15 RNA
polymerase II, TATA
box binding protein
(TBP)-associated
factor, 68kDa
TAF15 RNA
polymerase II, TATA
box binding protein
(TBP)-associated
factor, 68kDa
TAR DNA binding
protein

s15656

GGUUUGCCCUAAUCC
GUCAtt

UGACGGAUUAGGGC
AAACCca

1

YES

s15657

GUCGUGAUGUGAGU
AGGUAtt

UACCUACUCACAUCA
CGACgg

2

NO

s23829

GGAUGAACUUUGGU
GCGUUtt

AACGCACCAAAGUUC
AUCCca

1

YES

TARDBP

TAR DNA binding
protein

s23830

CAUCCGAUUUAAUAG
UGUUtt

AACACUAUUAAAUCG
GAUGtt

2

NO

TCF25

transcription factor 25
(basic helix-loop-helix)

s22761

CCCUUACCACGUUGA
CUCAtt

UGAGUCAACGUGGU
AAGGGct

1

YES

TCF25

transcription factor 25
(basic helix-loop-helix)

s22760

GACGAGCCCUUACCA
CGUUtt

AACGUGGUAAGGGC
UCGUCtg

2

NO

THRAP3

thyroid hormone
receptor associated
protein 3
thyroid hormone
receptor associated
protein 3
transformer 2 alpha
homolog (Drosophila)

s19360

GAGUAUAUCAGAAUC
GGGAtt

UCCCGAUUCUGAUA
UACUCtt

1

YES

s19359

CAUAAGGAGAGAGAU
CUUAtt

UAAGAUCUCUCUCC
UUAUGtt

2

NO

s26665

CUCUCACUCUCAUAG
GAGAtt

UCUCCUAUGAGAGU
GAGAGtg

1

NO

TRA2A

transformer 2 alpha
homolog (Drosophila)

s26664

GGAUCUUCGUGAAGU
AUUUtt

AAAUACUUCACGAAG
AUCCct

2

YES

KAP1
/TRIM28

KRAB interacting
protein 1 / tripartite
motif containing 28
KRAB interacting
protein 1 / tripartite
motif containing 28
ubiquitin-conjugating
enzyme E2I (UBC9
homolog, yeast)
ubiquitin-conjugating
enzyme E2I (UBC9
homolog, yeast)

s19778

GCGGAAAUGUGAGC
GUGUAtt

UACACGCUCACAUU
UCCGCtg

1

NO

s19779

GGCCCUAUUCUGUCA
CGAAtt

UUCGUGACAGAAUA
GGGCCag

2

YES

s14589

AAACAGAUCCUAUUA
GGAAtt

UUCCUAAUAGGAUC
UGUUUga

1

NO

s14590

GGAAUACAGGAACUU
CUAAtt

UUAGAAGUUCCUGU
AUUCCta

2

YES

SiSel_NC1
SiSel_NC2
SLTM

SUV39H1
SUV39H2
SUV39H2
SUZ12

TAF15

TARDBP

THRAP3
TRA2A

KAP1 /
TRIM28
UBE2I
UBE2I
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UTP3

s32619

CCCUAGAUAUGGACG
AUGAtt

UCAUCGUCCAUAUC
UAGGGct

1

YES

s32618

GGACAUCCUGUCAUA
GAAAtt

UUUCUAUGACAGGA
UGUCCat

2

NO

WDR46

UTP3, small subunit
(SSU) processome
component, homolog
(S. cerevisiae)
UTP3, small subunit
(SSU) processome
component, homolog
(S. cerevisiae)
WD repeat domain 46

s17740

AGACUAAACUACUCU
CGAAtt

UUCGAGAGUAGUUU
AGUCUgt

1

YES

WDR46

WD repeat domain 46

s17739

CCCUUGAUUGGGUAA
CAAAtt

UUUGUUACCCAAUC
AAGGGca

2

NO

XRN2

5'-3' exoribonuclease 2

s22413

GGAACUGAAUUCAUG
GACAtt

UGUCCAUGAAUUCA
GUUCCtg

1

YES

XRN2

5'-3' exoribonuclease 2

s22414

GAACCGAACUUUACC
AUUAtt

UAAUGGUAAAGUUC
GGUUCat

2

YES

YBX1

Y box binding protein 1

s9732

CGAAGGUUUUGGGAA
CAGUtt

ACUGUUCCCAAAACC
UUCGtt

1

YES

YBX1

Y box binding protein 1

s9731

GUAAAAUGGUUCAAU
GUAAtt

UUACAUUGAACCAUU
UUACtg

2

NO

YLPM1

YLP motif containing 1

s32080

GCCUUAUUUUGAUCG
UCAAtt

UUGACGAUCAAAAUA
AGGCtc

1

NO

YLPM1

YLP motif containing 1

s32081

CGAUGAUUAUGAUAC
UCGUtt

ACGAGUAUCAUAAUC
AUCGgg

2

YES

YTHDC1

YTH domain containing
1

s40757

CAGUAAAGAUCGGAC
GUGAtt

UCACGUCCGAUCUU
UACUGgt

1

YES

YTHDC1

YTH domain containing
1

s40756

GGAAUUUCAUAACAU
GGGAtt

UCCCAUGUUAUGAA
AUUCCct

2

NO

YY2

YY2 transcription factor

s53862

AGCUUUUCUUGAGAG
CUCAtt

UGAGCUCUCAAGAA
AAGCUtt

1

NO

YY2

YY2 transcription factor

s53863

GAUUAUUCCGAGUAC
UUGAtt

UCAAGUACUCGGAA
UAAUCag

2

YES

ZC3H13

zinc finger CCCH-type
containing 13

s23010

GGAAAGAGGAGGAUC
GUAAtt

UUACGAUCCUCCUC
UUUCCat

1

YES

ZC3H13

zinc finger CCCH-type
containing 13

s23011

GGUUAUAGCAGCAAU
UAUAtt

UAUAAUUGCUGCUA
UAACCtt

2

NO

ZNF207

zinc finger protein 207

s15278

CAACUAGUGCAACCA
GUAAtt

UUACUGGUUGCACU
AGUUGtt

1

YES

ZNF207

zinc finger protein 207

s15279

GACGACUUCUUGAAC
AGAAtt

UUCUGUUCAAGAAG
UCGUCgt

2

YES

ZNF326

zinc finger protein 326

s19597
1

GGAUCGUGAUUAUG
GCCCUtt

AGGGCCAUAAUCAC
GAUCCat

1

YES

ZNF326

zinc finger protein 326

s19597
2

UAUCAGGGCUUUAAU
GGAAtt

UUCCAUUAAAGCCC
UGAUAag

2

NO

ZNF438

zinc finger protein 438

s47911

GCAUUAUGCCCAAAC
CUAUtt

AUAGGUUUGGGCAU
AAUGCta

1

YES

ZNF438

zinc finger protein 438

s47912

CCCUUACAGUUGUCG
GAUUtt

AAUCCGACAACUGUA
AGGGcg

2

NO

ZNF512

zinc finger protein 512

s39029

GGGAUGAAGUAUCAU
GUCAtt

UGACAUGAUACUUC
AUCCCtg

1

YES

ZNF512

zinc finger protein 512

s39028

GGAUCGUGGGAGCU
AAGAAtt

UUCUUAGCUCCCAC
GAUCCtc

2

NO

ZNF598

zinc finger protein 598

s40510

GGACUACUACAGCGA
CUAUtt

AUAGUCGCUGUAGU
AGUCCtg

1

YES

ZNF598

zinc finger protein 598

s40509

GCAGCAAGAAGGUAG
CACAtt

UGUGCUACCUUCUU
GCUGCta

2

YES

ZNF622

zinc finger protein 622

s40388

GGAGACGAUUGGGAA
GAUAtt

UAUCUUCCCAAUCG
UCUCCat

1

NO

ZNF622

zinc finger protein 622

s40389

GAAUUGGAAUGUGAG
GAUAtt

UAUCCUCACAUUCCA
AUUCtt

2

YES

ZNF638

zinc finger protein 638

s26166

GACUUACCAGAGGUG
CAAAtt

UUUGCACCUCUGGU
AAGUCta

1

NO

ZNF638

zinc finger protein 638

s26167

CAACACCUCUUACGA
UAAAtt

UUUAUCGUAAGAGG
UGUUGtt

2

YES

UTP3
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Supplementary Table 2 | Table of qRT-PCR forward and reverse primers used in
study for assessing RNAi efficiency.
Sequence Name
ADAL-F
ADAL-R
BCLAF1-F
BCLAF1-R
C1orf77(CHTOP)-F
C1orf77(CHTOP)-R
C5orf41-F
C5orf41-R
CBX1-F
CBX1-R
CBX3-F
CBX3-R
CBX5-F
CBX5-R
CCDC137-F
CCDC137-R
CCDC59-F
CCDC59-R
CCDC86-F
CCDC86-R
CEBPZ-F
CEBPZ-R
CHAF1A-F
CHAF1A-R
CSDA(YBX3)-F
CSDA(YBX3)-R
CUX1-F
CUX1-R
DDX17-F
DDX17-R

Sequence
CAT GGC CAG AAG AGA CTC AGG
GTA TTT GCT TCC ACC GAG GTC
AGA AGC GAT ACA GTT CTA GGT C
ACC CTC TAC CCC TTC CTC TG
AAC TTA AGC AGG TCG GGG TAT G
TCA ATA CAG GGC GAG CAA GG
TGG AAG CAC TCT GGG GAA AC
CCG CTT ACA CTA GGC TGA GG
GGC TTG AGG CTT GGA TAG GC
TAA AGG GTG ACG CTG CTT GTG
TGA GGA GAC TCC GGT CAC TG
GAG CTA TTA CGT TCG CGG C
CTG GGG CGA TCC GGG AC
CAC TTG TCC CTT AAC CAC GC
GTG TCC AGG GTG CAG GC
CTT TCT TCT TCT CTT TGC TGC G
AAG ACA TGG CGG CCT AAC C
GAA AAG CAA AGC CTT GTC CCT CG
GGA CCG CTC CAA GAA AAG ATT C
GCT TCC TCT CCT GTC GTT CC
GAG GAG GCA GTA GAA GAT CCG
CAT AAG GTA ATC TTG CTT GGT GC
CTG AAG AGG AAG TCA GCG GG
CTT GGA CCT CCG CAG CAT C
GAG GGA GCA CAA CTT CAG GG
GAG GAG GTC CCC TGC TAC G
CTG GGA CAC AGG ATG CGG
TTT CCC TTT CCT CCT GGC TG
AGT GCT GGA AGA GGC CAA TC
GAG AAC GAC CAC CCC CG
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DDX5-F
DDX5-R
EBNA1BP2-F
EBNA1BP2-R
ERH-F
ERH-R
EWSR1-F
EWSR1-R
EXOSC10-F
EXOSC10-R
FUS-F

GTC ATC GGT GTC CTT CCT CC
GAG GTG CAC CAA ACC CTC G
CTC TGC TAG CCG CTT GGG TC
CAT CCT GCA ACT CTC TGT CTG TG
GTT AAG CTC GTG TAA CGG CG
TGT GAG ACA TCG CGC CAA AC
CCT CCC ACT GTA GAA GGG AC
TAA GCA CCA GTG CCA TAC CC
TTA GGA TGA TCA GCA ACC GC
CCT GTT CTG CTG CAG CTT TG
TTA AGC TTC GAC GCA GGA GG

FUS-R
FYTTD1-F
FYTTD1-R
GATAD2A-F
GATAD2A-R

TGT TGG GTA TAA TCG TTT GAG GC
ACT CGT CAA TGG CGG ACT TC
GTC ACT TTG CTC CCG CTT TG
CTA CTG GAG ACA CAA GGC AG
TGG TTG GTT GTC ATG CAG TTC

GATAD2B-F
GATAD2B-R
GLTSCR2-F
GLTSCR2-R
HDLBP-F
HDLBP-R
HMGA1-F
HMGA1-R
HNRNPA1-F
HNRNPA1-R
HNRNPA2B1-F
HNRNPA2B1-R

GCC ACC GCC AGG ATG G
TTC AGA CGT TCC ATG GCC TC
CTC CAA GGA AAA AGG GCT GAC
GGA TGA GGT CAA CCC GAA GG
CGA CTT CCA GAA CTT GCA AAA G
TTG GGT CAA AAC TGC AAC GG
TTT TAA GCT CCC CTG AGC CG
ATG CGG ATG CCT TCT TGG AG
GCC GAA GAA GCA TCG TTA AAG TC
TCT CTC ATT ACC ACA CAG TCC G
CCG CGG AGA TCT CTC TCA TC
TTT CTC TCT CCA TCG CGG AC

HNRNPK-F
HNRNPK-R
HNRNPL-F
HNRNPL-R

TGT CCC ACT TGT TCG CGG
GGG CGT TTA CCA AAT TCA CC
CTC TTT TCG ATC CGG GAC GG
ACC ACA TAG CTG ATG GGT CC

HP1BP3-F
HP1BP3-R
hu-CYP2B6-F
hu-CYP2B6-R

TGA TCC ACG CGG ACA AGT TAG
CTG AAC TTA TGT CTG GTT CTG GC
CCA CCT TCC TCT TCC AGT CC
GAA GAG CTC AAA CAG CTG GC
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hu-CYP2C19-F
hu-CYP2C19-R
hu-CYP2C9_prom1-F
hu-CYP2C9_prom1-R
hu-CYP2C9_prom2-F
hu-CYP2C9_prom2-R
hu-CYP4A11-F
hu-CYP4A11-R
hu-DPPA5_prom1-F
hu-DPPA5_prom1-R
hu-DPPA5_prom2-F

AAT GGA GAA GGA AAA GCA AAA CC
GTC AGC TGC AGT GAT TAC CAA G
TTA GGG TGC CAA GAC TCA GC
CAA AGC TGG GAG CCA GAT AC
CTT GGG GTT TTT GTG GAT TG
TTA GCC AGC TTG CTT TAG GC
GCT CAT TCT GCT TCT GCT GC
TGT TGG AGC TCC TGG ATG TG
ACC CTC ACA ACC AAG ACC AC
GAG GCT TTA TCG CCC CTG AG
GAC CAC TCT CCA GCG CAA A

hu-DPPA5_prom2-R
hu-DPPA5_prom3-F
hu-DPPA5_prom3-R
hu-GDF3_prom1-F
hu-GDF3_prom1-R

ACC AGG TGC GAG GCT TTA TC
GGA TAT GTC TAC GTG CCG GG
CTC GGC CGG CGT GAT TAG
GGT TGG AAC TTC TGG GGT GA
GGC CAG GCA GTC CAA TTT CA

hu-GDF3_prom2-F
hu-GDF3_prom2-R
hu-GDF3_prom3-F
hu-GDF3_prom3-R
hu-NANOG_prom1-F
hu-NANOG_prom1-R
hu-NANOG_prom2-F
hu-NANOG_prom2-R
hu-NANOG_prom3-F
hu-NANOG_prom3-R
hu-REX1_prom1-F
hu-REX1_prom1-R

TGC CCA ACA ATT CAG AGG CT
TCC AAT GGC CTT TGA GGA GC
GAA ACG AAG CAT GGC CTC TG
AGC CTC TGA ATT GTT GGG CA
AGG GGT GGG TCT AAG GTG AT
CAT GAG GCA ACC AGC TCA GT
GTG AGA CTG GTA GAC GGG AT
ATC ACC TTA GAC CCA CCC CTC
GGA TCC AGC TTG TCC CCA AA
TCA GGC CCA CAA ATC ACA GG
TTT ACG TTT GGG AGG AGG TGG
CCA TGA AAC AAG ACT CAC CCC

hu-REX1_prom2-F
hu-REX1_prom2-R
hu-REX1_prom3-F
hu-REX1_prom3-R

CTC CGG GCA GAG AGT GAA C
TCC GCC AGG GTT AGG GAG
TAA CCC TGG CGG AGC TGA T
TCC CAA GAC CCA CCC TCC

KHDRBS1-F
KHDRBS1-R
KHDRBS3-F
KHDRBS3-R

GTA TAA AGG CTG GCC TGA GGG
ATC CTG ACT GGC TTT CTG TGG
CTG ATG GCG GAG AAG GAC TC
TCT ATT TCT TGG TTC ACC AGG CG
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LLPH-F
LLPH-R
LOXL1-F
LOXL1-R
LOXL2-F
LOXL2-R
LTBP2-F
LTBP2-R
MATR3-F
MATR3-R
MBD3-F

CGT TTC TCA GGT AAA ACA TGG C
TGG CAA TGT TTG GGT TTG GG
TTA TGT GCA GAG AGC CCA CC
GGG CAT AGG CTG TGC TGG
AGA GAA ACG GGT CCC TTG TG
ATA CCA GGT CTC CTG GAA GGC
ACG CGG AGT GTG TGA ATA CC
ATT GCC TTG TCC GAC ACA CAG
TGA AGG GAG GAA ATA GTG GCA G
GAA CCA GCA GAC AAC TGT TAC
GGA AGA AGT GCC CAG AAG GTC

MBD3-R
MBNL1-F
MBNL1-R
MPHOSPH10-F
MPHOSPH10-R

TCC CGC TCG GGC TAT AGT AAA AG
AGA GAG TTC CAG AGG GGG AC
GGA GCA ACG GCC TTT CAA TG
AAG TCA GGT AAA AGT TCC AGA AAT C
GTC ATC ATC TTC ATC CGT TTC CG

MRTO4-F
MRTO4-R
MYBBP1A-F
MYBBP1A-R
MYEF2-F
MYEF2-R
NCOA5-F
NCOA5-R
NCOA7-F
NCOA7-R
NONO-F
NONO-R

TGC AGT GCA CAT TGG GTC AG
GGT TAA GGA GAC TTT CTT GTC GC
GGC TGG TGA ATG TGC TGA AG
CAC AGG TAG CTG GCT GGC
TGG TGA GGT TAC ATA CGT GGA G
TTC AAC CAC ACC ACA ACC CC
GGT GGC GCC TTT GTC CTA C
GCC ATA TGG ATC CCG CTA CC
GCT GCA AGA TGG AAG GAA GC
AGC CAT CCT GCA ACT AAT TTT GTG
CTC CGA GGA GAT ACC AGT CG
CAT TTT TGC ACC CTC AAC TTC

PES1-F
PES1-R
PHB-F
PHB-R

TAT GGA GAA ACT GGC AGC CC
GGA AAC TCA TCC ACC TCG GC
CTA TGA TGA GCG TGT GCT GC
TGG CAG GTA GGT GAT TAG TTC

PIAS2-F
PIAS2-R
POLDIP3-F
POLDIP3-R

TGT TCT CAT CAA GCC CAC GAG
GCC AGG CAA AGT CTC AAC TG
GTT GAA CTC TCG CAA GCA GC
TCC ACA TGC ATT CTC TGG ATG
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PPAN-F
PPAN-R
PPHLN1-F
PPHLN1-R
PRDM15-F
PRDM15-R
PRMT1-F
PRMT1-R
PRRX2-F
PRRX2-R
PTBP1-F

CAG GGA GGT CCC GGC
GCG TGA ACA CGA ACG AGT G
GCC AGA GTC GTG GCT TAC AG
GCC TGC TTG CAG AAT GAT CG
GTT CAT CTG GTG TGA AGA CTG C
GTC CTC ATA ACC CCG CAT CC
CTG CAT CAT GGA GGT GTC CTG
TGG ATG TCA TGT CCT CAG CG
GCA AGA ACT TCT CGG TGA GC
CTG GGA CAC TCA CCA TCC TG
GGG TCG GTT CCT GCT ATT CC

PTBP1-R
QKI-F
QKI-R
RBM12B-F
RBM12B-R

TAT CTG GGA CAA TGC CGT CC
AAC GGA ACT CCT CAC CCA AC
AGC CAC CGC ACC TAA TAC AC
TGG GCT CAC TGA GGG TCT AC
AGC AAC TTA ACA CTG CTG CC

RBM15-F
RBM15-R
RBM26-F
RBM26-R
RBM6-F
RBM6-R
RBMX-F
RBMX-R
RELA-F
RELA-R
RPF1-F
RPF1-R

GTC CGT GGG TTT GGT TTT CAG
ATA ACA GGG TCA GCG CCA AG
AGT TAC AAA CTA CTT CTC CAA AGC C
ACA ACA CCT GAG GAA GGT CTG
TGG ACC TTT TCG TGG GAG C
CCA GGA AAG TTG CCA GAG TG
GTC ACC TTT GAA AGC CCA GC
CGT GAT ACA GGA GCT TTC CAT TC
ACC GCT GCA TCC ACA GTT TC
AGG GGT TGT TGT TGG TCT GG
GCG GAA GGA AAA GTT GGC AG
TTG GGT ACA GGC TTT GGT GG

RPF2-F
RPF2-R
RPS19BP1-F
RPS19BP1-R

CAC TCT GGA TCG AGT AGT AAA GC
ACT GTT GCA TTT GCA TTT CCC C
GGC AAT TCA GGC CCA GAA AC
CTT CCG GTA CTC GTC CAG TG

SAFB2-F
SAFB2-R
SAFB-F
SAFB-R

GTG GCA AGG TGG CGA GAG
CCG CCA CTC CAC CGC
TGA TGG AGC GGC TGA AGA AG
CTT CTG GTT TGC GCC CTT TG
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SETDB1-F
SETDB1-R
SFPQ-F
SFPQ-R
SFRS10(TRA2B)-F
SFRS10(TRA2B)-R
SLTM-F
SLTM-R
SUV39H1-F
SUV39H1-R
SUZ12-F

GCA GGT GAC AGT GAC TTG GAA AG
GAG GAA TGA CCA GAG CCC AC
AGC TAA TCC TGG CGT TCC AC
AAG CGC TCA GTA CGC ATG TC
TTC GAT TGA AGC ACA TCG ACC
TCT GGA TCT AGA CCC GCT CG
CAG CCC AAG ATG GTG AGG AAG
TGA GCT GTG TGA TCA GCC TC
GGC GGA AAA TTT AAA AGG CTG C
TAG AGA TAC CGA GGG CAG GG
GAA GCC GAA AAT GGA GCA CG

SUZ12-R
TAF15-F
TAF15-R
TARDBP-F
TARDBP-R

CTG TGT TGG CTT CTC AAA GGC
ACA GCG GTT ACT CCA GTT ATG G
TGC TCT TCC ACC TTG GCT TC
AAG GGG TTT GGC TTT GTT CG
GGC TCA TCT TGG CTT TGC TTA G

TCF25-F
TCF25-R
THRAP3-F
THRAP3-R
TRA2A-F
TRA2A-R
TRIM28-F
TRIM28-R
UBE2I-F
UBE2I-R
UTP3-F
UTP3-R

GTG GGA GGC TCA TCG GAA C
GGA CTC CAG GGA ACA TGG TG
TAG GCC CAG AAG TGT ATG CTG
TCT TGA GCG AGA AGA GCG AG
AGG CAT CTA CAT GGG CAG AC
AGG TGA TCG TCT TCT GTA TCG G
GCC AAC CAG CGG AAA TGT G
GAG TCG GTA GCC AGC TGA TG
GCC CGA AGG GGA GTT TAC AG
CAG CCA CGA AAC CAA ATG GG
CTG AGA CAC GGG TCG TGA AG
CCG GGT GGA ATG ATC CCT TG

WDR46-F
WDR46-R
XRN2-F
XRN2-R

ACC AAG AGA AAG AAA CCC CGA G
GGA ATG GAT CTT GGG TCC CG
TCC CGT CTC TTT GGT TAC GC
CTT TTG GCT TCT CTT CCA CGC

YBX1-F
YBX1-R
YLPM1-F
YLPM1-R

AAG GAG AAA AGG GTG CGG AG
TGG TAA TTG CGT GGA GGA CC
AAG GAA ACG TGA CTG GGA GG
GCC CAT CTG ACC CTC TTC TTC
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YTHDC1-F
YTHDC1-R
YY2-F
YY2-R
ZC3H13-F
ZC3H13-R
ZNF207-F
ZNF207-R
ZNF287-F
ZNF287-R
ZNF326-F

TCT GGT TCA GGC ACA GAT GG
TGG TTT GAT CTG CAT ATG ACT CTG
TTC ACG AAC ACG GGC TAT GG
TAG CTG GTT GTC TGA GTC GC
AGG AAC AGG GCA AAC CTC TG
ACA TTT TGT ACT ACA GGC CGC
CAT GCC ACC TGG AAT GAT GC
GCT GAA ACA GCC TGT GCT TG
CAG CGA CAG GGT CTC TTA TC
GAG CCA ACT GCT TGA AGT CTC
TAT GGA GGG ATG GAT CGT GAC

ZNF326-R
ZNF438-F
ZNF438-R
ZNF512-F
ZNF512-R

TGA TTA AGC AAT TTA CCT GCT ACC
GAC TCT ACA GGA GCC TTG GG
CAG GAT GAG CTT CCT GAA GTG
TGC TGT ACC CGC CAC TTC G
GAG CAC TGG GTC CTG CTA TTC

ZNF560-F
ZNF560-R
ZNF578-F
ZNF578-R
ZNF598-F
ZNF598-R
ZNF622-F
ZNF622-R
ZNF638-F
ZNF638-R
ZNF665-F
ZNF665-R

GTG GCC AAA GTA GGA TTT CAG C
CTT GGA GAA CTC CTT GCT GC
TCT TGG AGC AGC GGG ATT AG
TCC TCT TCC TCC TCT TCT AGG C
CTG CAA GTT CTG TGA CGA GC
CAG GTA GGC ATA GTC GCT GTA G
ATT GAT TCT GCC TTC TGG TGC
CAA CTG CCA CAG CTC TTG AC
AGA GGC CTT CCA GAT GAG TG
TTG CTT TTT CAC CCT CAG GGA C
TGT TAG TCG CCG CAA CCC
AAA GTC TTC TGA GCA GGG TCC

ZNF695-F
ZNF695-R
ZNF714-F
ZNF714-R

CCA AAA GCT GGG AAA TGG GAC
CCT CAC CAA GGG AGA TCA GG
GCT GGA GCG GAC AGG AC
CAG GTC GCC CAT TTC TAG GC
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Supplementary Table 3 | Primers for quantifying pre-RNA expression.
Sequence Name
hu-SPANXD_preRNA-F
hu-SPANXD_preRNA-R
hu-SLAMF7_preRNA-F
hu-SLAMF7_preRNA-R
hu-PEG3_preRNA-F
hu-PEG3_preRNA-R

Sequence
TAC ATA GGG AGG GCA AGA GC
CTC GCC TTC ACT TCA GAA CC
CTC CCT GAA GCT CAG CAA AC
GTC AAG GAG CTC ACC ACC TC
TCC TGT TCC CAG ACA GGT CC
GGT GGC AGA CAA GTG CTT TG
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2.10 Materials and Methods
Cell culture
Human BJ foreskin fibroblasts were obtained from Stemgent (08-0027) at passage 6 and
cultured in Eagle’s Minimum Essential Medium (EMEM) (Sigma-Aldrich M2279)
supplemented with 10% fetal bovine serum (FBS, Hyclone SH30071) and 2mM Lglutamine (GIBCO 25030149) at 37oC and 5% CO2. HepG2 cells were obtained from
ATCC (HB-8065) and cultured in Dulbecco’s Modified Eagle Medium (Hyclone
SH30022.02) supplemented with 10% fetal bovine serum (FBS, Hyclone SH30071) and
2mM L-glutamine (GIBCO 25030149) at 37oC and 5% CO2. Published reports with HepG2
cells have been previously noted as being of various origins (van Pelt et al., 2003). For
our assays only HepG2 cells directly from ATCC were used and the reported differences
in liver specific function between real and misidentified HepG2 lines would not be expected
to impact the H3K9me3 levels we measured in these cells.
Lentivirus production
Lentiviral plasmids pWPI.1-FOXA3, pWPI.1-HNF1a, and pWPI.1-HNF4a were kindly
provided by the laboratory of Lihian Hui (Huang et al., 2014). 293T cells were seeded in
10-cm dishes at a density of 8*10^5 cells and cultured in DMEM High Glucose (Thermo
Fisher Scientific 11995) supplemented with 10% FBS (Hyclone SH30071). After 24 hours,
each dish of cells was co-transfected with a total of 5 µg of DNA, 2.5 µg of expression
vector, 1.7 µg of packaging plasmid psPAX2 (Addgene 12260) and 0.8 µg of envelope
plasmid PMD2.G (Addgene 12259), and 30 µL of transfection reagent Fugene6 (Promega
E2691) along with 570 µL of OptiMEM-I Reduced Serum Media (Thermo Fisher Scientific
31985070). Fugene6 was first diluted in OptiMEM, vortexed for 1 second, and incubated
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for 5 minutes at room temperature. Transfection mixes were generated by adding the DNA
to the diluted Fugene6, vortexing for one second, and incubating for 15 minutes at room
temperature. The mix was then added to the cells in a dropwise manner. 16 hours posttransfection, the media was replaced with 10 mL of fresh culture media. 60 hours post
media change, the media containing the viral particles was collected, and centrifuged for
10 minutes at 2000 rpm at 4°C to remove cell debris, and filtered on a 0.45 uM syringe
filter

(Millipore

SLHV033RS).

Next,

the

supernatant

was

concentrated

using

ultracentrifugation at 25,000 rpm at 4°C for 1.5 hours with an SW-32 swinging bucket
centrifuge (Beckman Coulter). The viral pellet was resuspended in 1:100 volume of plain
high glucose DMEM overnight at 4°C, and then stored at -80°C. Viral titer was determined
by immunostaining of FOXA3, HNF1a, and HNF4a in BJ fibroblasts 3 days post infection
at various serial dilutions of concentrated virus. Dilutions producing 10-35% of cells
expressing the transgene were used to calculate the multiplicity of infection (MOI), and the
titer was calculated using the relationship MOI = (−1) ∗ ln(1 - [proportion infected]).

hiHep reprogramming
hiHep reprogramming was conducted as previously described (Becker et al., 2017; Huang
et al., 2014)

siRNA transfection experiments
All knockdown experiments were performed using two cycles of siRNA transfection, three
days apart as previously described (Becker et al., 2017). All Silencer Select siRNAs from
Thermo Fisher used in experiments can be found in Supplementary Table 1. For hiHep
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reprogramming experiments the first cycle of siRNA transfection was performed one day
after the initial treatment with the hiHep lentivirus cocktail.

Western blotting
Whole-cell protein extracts were prepared by resuspending cells in RIPA extraction buffer
(25 mM Tris, pH 7.5, 150 mM NaCl, 1% Na-deoxycholate, 1% IGEPAL CA-630, 0.1%
SDS) supplemented with Protease Inhibitor Cocktail (Roche 11873580001). Suspensions
were incubated on ice for 10 min and sonicated for 15 seconds on HI using a Diagenode
Bioruptor UCD-200. Samples were centrifuged at 20,000 g for 10 min (4°C) to pellet
debris, and the supernatant was transferred to new tubes. Protein content was quantified
by BCA assay (Thermo Fisher Scientific 23227). Protein samples were mixed with 4X
NuPAGE LDS Sample Buffer (Thermo Fisher Scientific NP0007) and 10X NuPAGE
Sample Reducing Agent (Thermo Fisher Scientific NP0009), and were denatured at 70°C
for 10 min. Samples were loaded in NuPAGE Novex 4%–12% Bis-Tris Protein Gels
(NP0335), and run using NuPAGE Running Buffers (NP0001; NP0002). Wet transfer to
PVDF membranes (100V for 1.5 hr) was performed using NuPAGE Transfer Buffer
(NP0006) containing 20% methanol, and membranes were blocked overnight in 5% nonfat
dairy milk in TBS-T (20 mM Tris, pH 7.5, 150 mM NaCl, 0.1% Tween-20). Primary
antibodies were diluted in 1% milk/TBS-T at the following concentrations: anti-GAPDH
(1:1000, Santa Cruz Biotechnology sc-365062), anti-CREM (1:1000, ThermoFisher PA581971), anti-MAZ (1:1000, ThermoFisher PA5-61710), anti-ETV5 (1:1000, ThermoFisher
PA5-30023), anti-NFYB (1:1000, ThermoFisher PA5-31913), anti-H3K9me3 (1:1000,
Abcam ab8898), anti-ERH (1:1000, Millipore Sigma HPA002567), anti-SUV39H1 (1:1000,
Bethyl A302-127A), anti-SUV39H2 (1:1000, Cell Signaling 8729S) or anti-SETDB1
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(1:1000, Cell Signaling 93212S). HRP-conjugated secondary antibodies (BioRad
1706515, 1706516) were diluted 1:15,000 in 1% milk/TBS-T. Blots were developed using
Super- Signal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific 34080)
and visualized with an Amersham Imager 600 (GE Healthcare Life Sciences).

Immunofluorescence
Cells were grown on 96 well glass bottom plates (MatTek PBK96G-1.5-5-F) coated with
collagen I (Corning 354236) and were plated at 3,000 cells per well 7 days prior to fixation.
At least 2 wells of siControl treated fibroblasts were included on all 96 well plates
processed for imaging to allow normalization and minimize variation in staining intensity.
To prepare for immunofluorescence cells were washed twice briefly with PBS, and fixed
in 4% paraformaldehyde (Electron Microscopy Sciences 15714) in PBS for 10 min at room
temperature. Fixed cells were washed twice with PBS, permeabilized with ice-cold 0.1%
Triton X-100 in PBS for 1 minute and washed twice with TBS-T (20mM Tris-HCL pH 7.4,
150 mM NaCl, 0.05% Tween-20). Samples were blocked with 4% donkey serum (SigmaAldrich D9663) in PBS for 1-2 hours at room temperature. Primary antibody staining was
performed in 4% donkey serum in PBS for 1-2 hours at room temperature, using the
following concentrations: anti-H3K9me3 (1:500, Abcam ab8898), anti-H3K9me2 (1:500,
Active Motif 39683;1:500, Thermo Fisher 49-1007). Cells were washed 3 times with TBST and then incubated with AlexaFluor 488- or 594-conjugated secondary antibodies raised
in donkey (1:500, Thermo Fisher Scientific A32790, A32754) in PBS for 1 hour at room
temperature, protected from light. Samples were washed 3 times with PBS,
counterstained with 1 µg/mL DAPI (Thermo Fisher, D1306) in PBS for 10 min. Cell were
washed once more with PBS and stored at 4oC protected from light until imaging.
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Imaging and analysis
Images were taken on a Zeiss LSM800 confocal microscope using a Plan-Apochromat
63x oil immersion objective. Complete images were composed of stitching together nine
512x512 16-bit images taken using bidirectional scanning. A stack ranging from 10 to 20
z slices with a step size of 0.52um was used. Between 100-300 cells were imaged per
sample condition for quantitative analysis. Image analysis was performed using MATLAB
(R2018a). Images were first manually corrected to remove cells that overlapped. The
DAPI channel was then binarized using Otsu’s method to create a mask of each nuclei.
The nuclei mask gave the total number of nuclei for each condition as well as location and
size for each nucleus. Objects smaller than 1500 pixels and partially imaged nuclei on the
border of the image were removed leaving only complete, non-overlapping nuclei. Using
the mask, the signal and location of every pixel within the nuclei mask was extracted from
the H3K9me3 channel. For each nucleus, the average H3K9me3 signal was taken.
Intensity values for each cell was normalized to the average intensity from cells on the
same plate treated with siControl non-targeting siRNAs. Two independently targeting
siRNAs, each performed in duplicate were used for each target for quantification.

Confluency quantification
Images for quantification of confluency were taken using a Nikon TE2000 inverted
microscope. For each siRNA target two independently targeting siRNAs were used and
two images were collected per siRNA. Images were processed using the PHANTAST
library for MATLAB to perform local contrast thresholding and cell density estimation
(Jaccard et al., 2014). Default parameters for PHANTAST were used and confluency
values were normalized to the mean values measured for siControl.
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Flow cytometry
Two biological replicates of day 14 hiHep cells for each treatment were washed with PBS
and dissociated from the plate into a single-cell suspension with Accutase (Stem Cell
Technologies, 07922) at 37 °C for 5 min. Cells were washed twice with PBS and fixed in
4% paraformaldehyde in PBS for 15 min at room temperature. Cells were blocked in
blocking solution (3% donkey serum in PBS) for 1 h. Staining was performed in blocking
solution for 1 h at room temperature with anti-ASGPR1 antibodies (1:200, BD Biosciences
563655, 7097548). Cells were washed three times with PBS, resuspended in water and
then analyzed using Accuri C6 system and data were collected for all cells. All gating and
quantification of populations was performed in FlowJo (v.10.5). Initial FSC/SSC gating
was performed and applied uniformly to all samples.

RNA isolation and quantitative reverse transcription PCR assessing siRNA
knockdown efficiency and expression of pre-RNAs
Total RNA was isolated using the ZR-96 Quick-RNA kit (Zymo Research R1052), this
includes an on-column DNAse I digestion. The samples were then eluted in 30 µL RNAseq
Free ddH2O. cDNA was prepared using the High Capacity cDNA Reverse Transcription
Kit (Thermo Fisher 4368814). Primers were designed for each transcript targeted by an
siRNA (Supplementary Table 2). For assessing the expression of pre-RNAs primers were
designed with one primer targeting an intron. qPCR was performed using Power SYBR
Green PCR Master Mix (Thermo Fisher 4367659), and data were normalized using the
GAPDH primer as an endogenous control (Supplementary Table 2). qPCR reactions were
run in 384-well format on an 7900HT Real-Time PCR machine (Thermo Fisher 4329001),
using the following thermal cycler protocol: 50°C for 2 min, 95°C for 10 min, followed by
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45 cycles of 95°C for 15s then 60°C for 1 min. For SYBR-based qPCR reactions, a
dissociation curve was generated to verify that a single PCR product was generated.

RNA-seq library preparation
75-100 ng of isolated RNA was used to prepare RNA-seq libraries for sequencing. All
custom primers used in cDNA synthesis are listed below. An oligo-dT primer was used to
perform poly-A enrichment and was incubated with the sample for 5 minutes. First-stand
cDNA synthesis was performed with Superscript II Reverse Transcriptase (Invitrogen
18064022) and a template switch oligo by incubating for 1.5 hours. Second-strand cDNA
synthesis was performed with the KAPA HiFi HotStart Ready Mix (Roche 7958927001)
and an IS primer with 3 cycles of PCR amplification. 5ng of cDNA was fragmented using
the Tn5 enzyme-adaptor compound. 15 cycles of PCR were then carried out with
barcoded primers compatible with the BGISEQ-500. The 300-500bp DNA fragments were
selected and purified. The fragments were then heat-denatured and one of the single
strands was circularized with DNA ligase to obtain a single strand circular DNA library.
The remaining single strand was digested with the exonuclease. The sequencing process
was conducted according to the BGISEQ-500 protocol as described (Huang et al., 2017).
Primers used in cDNA prep:
Oligo-dT: 5′-AAGCAGTGGTATCAACGCAGAGTACT30VN-3′
TSO: 5′-AAGCAGTGGTATCAACGCAGAGTACrGrG+G-3′
(rG= riboguanosine, +G= locked-nucleic acid)
IS Primer: 5′-AAGCAGTGGTATCAACGCAGAGTAC-3′
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RNA-seq data processing
Reads with low quality, adapter, high N rate or poly-A sequences were filtered out from
the raw FASTQ data before alignment using SOAPnuke (Chen et al., 2018). After filtering,
we obtained ~33 million paired 50 base reads per sample on average. Clean reads were
aligned to the hg38 reference and gene expression levels were quantified using RSEM (Li
and Dewey, 2011).

Batch effect correction of RNA-seq data
Due to the large number of samples sequenced batch effect differences were detected
and adjusted for using Combat batch effect correction algorithm (Johnson et al., 2007) in
R (v.3.5.2) Per gene reads were normalized to total sample reads and Combat batch effect
correction algorithm was applied to normalized data to ensure that relative gene
expression distributions were the same between sequencing batches. To minimize the
chance that batch effect correction would lead to false positive expression gene models
with 1 or fewer mapping reads were set to a value of 0 after batch effect correction.

RNA-seq data analysis
Batch effect corrected read counts were analyzed by the DESeq2 (v.1.22.2) package in R
(v.3.5.2). Differentially expressed genes were determined in a pairwise manner. srHC
genes were considered upregulated if they had a log fold change value>0 and an adjusted
p-value<=0.05.

Clustering of proteins by shared repressed genes and analysis of clusters
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73 proteins were selected for clustering analysis based upon the results from siRNA
depletion during hiHep reprogramming showing that their depletion resulting in the
upregulation of at least 93 (>1% of the total 9275) srHC genes. A pairwise distance score
was calculated between all 73 proteins as the number of common repressed genes
multiplied by the mean fraction of shared genes for each member of the pair; with higher
scores indicating greater similarity. Clustering was performed by merging each protein into
the cluster of its nearest neighbor. Proteins were called as hubs if they had at least 4 direct
nearest neighbor connections and their depletion upregulated at least 300 srHC genes
during hiHep reprogramming. GO analysis of gene sets regulated by each cluster was
performed using the PANTHER Classification system tool (Mi et al., 2013) for statistical
overrepresentation test and a list of all srHC genes as background. Enrichment analysis
of miRNA target sequences was performed using the TargetScan tool (Agarwal et al.,
2015).

Repeat analysis by SALMONTE
Expression of transposable elements genome wide were analyzed from the RNA-seq data
using SalmonTE (Jeong et al., 2018). Salmon was run using Python (v.3.6.3) with the
parameter –exprtype TPM. The quantification files produced were then analyzed for
differential expression between knockdown samples and non-targeting controls samples
in R (v.3.4.2) using EdgeR (v.3.20.9) and the GLM method.

Repeat analysis by RepEnrich
RepEnrich (Criscione et al., 2014) was used to perform repeat expression analysis on the
RNA-seq samples, and to quantify reads from repetitive elements in the H3K9me3 ChIP105

seq samples. Samples were first aligned to the hg19 genome using bowtie1 v0.12.9
(parameters -t -m 1 -S –max) which outputs unique mapping and multimapping reads into
separate files. The output Sam files was then converted to a bam file with Samtools
v0.1.19. RepEnrich was run using python v2.7.3 and a repeatMasker annotation retrieved
from UCSC with simple repeats removed. The fractional counts produced were then
analyzed for differential expression between knockdown samples and non-targeting
controls samples in R (v.3.4.2) using EdgeR (v3.20.9) and the generalized linear model
method.

ChIP-seq chromatin isolation, immunoprecipitation, and library preparation
Chromatin was prepared from 10 cm plates of ~80% confluent BJ fibroblasts with and
without siRNA knockdowns. Crosslinking, processing and sonication of cells was
performed as described previously (Becker et al., 2017).
To perform the chromatin immunoprecipitation, Protein G magnetic Dynabeads
(Thermo Fisher, 10004D) were used along with the antibody of interest, either antiH3K9me3 (Abcam ab8898, Lot GR3291043 -1) anti-H3K27me3 (Active Motif 39155, Lot
31618020), anti-ERH (Millipore Sigma HPA002567), anti-HMGA1 (Cell Signaling 7777S),
anti-MYBBP1A (Millipore Sigma HPA005466), anti-ZNF622 (Bethyl A304-075A), antiCEBPz (Bethyl A303-153A), anti-FUS (ThermoFisher PA5-52610), anti-GATAD2A (Bethyl
A302-356A) or anti-ZNF438 (Millipore Sigma HPA039843). Additionally, for H3K9me3 and
H3K27me3 ChIP, Drosophila spike-in chromatin (Active Motif cat 53083) and Drosophila
H2Av antibody (Active Motif 104597, Lot 00419007) were added in order to normalize for
global changes in histone modification levels during computational analysis. Per ChIP, 3
µg of human chromatin were used, along with 2 µg of the antibody of interest, additionally
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12.5 ng of Drosophila chromatin and 1 µg of H2Av antibody were used along with 25 µL
of Dynabeads. 1/10th of the samples were saved to be used as input. Antibody
conjugation, binding, washing, elution and purification was performed as described
previously (Becker et al., 2017).
The NEBNext Ultra II DNA Library Prep Kit for Illumina (NEB E7103) was used to
prepare the libraries for sequencing following the manufacturer’s protocol, with the
following modifications. The size selection step was performed by selecting first with 15
µL of Ampure XP beads (Beckman Coulter A63881), and next by selecting with 60 µL of
Ampure XP beads. For ChIP of the srHC proteins no size selection was performed. The
libraries were eluted in 17 µL of 0.1X TE buffer. 10 rounds of PCR amplification were
performed. The libraries were eluted in 33 µL of TE during the final elution.

srHC-seq sample preparation and library preparation
The srHC-seq sample preparation was performed as previously described (Nicetto et al.,
2019) with the following modifications. Chromatin was prepared from 10 cm plates of
~80% confluent BJ fibroblasts with and without siRNA knockdowns. Additionally, a threepart fragment separation of the sonicated DNA was performed using AMPure XP beads
(Beckman Coulter A63881). For small sonication-sensitive fragment isolation, 0.7 volumes
(14 µL) of beads were added to the isolated, sonicated DNA, incubated, and the small
fragments were saved in the supernatant. The large sonication-resistant and medium
sized fraction were isolated from the beads, and then resuspended in 50 µL of TE. 0.2
volumes (10 µL) of beads were added to the large sonication-sensitive fragments and
medium size fragments. Medium DNA was isolated from the beads, and the large
fragments were saved in the supernatant and subjected to further sonication. The medium
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fragments were not sequenced. Size selection efficacy was confirmed (Agilent 50674626). The NEBNext Ultra II DNA Library Prep Kit for Illumina (NEB E7103) was used to
prepare the large and small fragment libraries for sequencing following the manufacturer’s
protocol.

Alignment and visualization of ChIP-seq and srHC-seq data
Sequenced read were aligned to the human hg38 genome assembly and to the Drosophila
melanogaster dm6 genome assembly (to identify reads from the spike in) using STAR
(v.2.3.0e). STAR output files were converted to .bam files using samtools v1.1, and then
to .bed files using bedtools (v.2.20.1; bamtobed). To generate input-normalized genome
coverage

tracks,

BED

files

were

converted

to

bedgraph

using

bedtools

(genomecoverageBed) and normalized to the number of millions of reads sequenced
(rpm). The fraction of reads from the spike-in drosophila chromatin was calculated from
the aligned .bed files as the number of reads aligning to dm6 divided by the number of
reads aligning to hg38 and the ratio of the input to the IP spike-in fractions were used to
scale the global signal. For ChIP-seq, input subtraction was performed on a basepair by
basepair basis by subtracting the corresponding input sample from each sample’s
normalized bedgraph. srHC-seq normalized bedgraphs were further processed by dividing
the large fragment file by the corresponding small fragment file on a basepair by basepair
basis then taking the log2 of the resulting ratio to assess the relative sonication resistance
of the region. Normalization of ChIP-seq data across domains of variable length was
performed by subdividing the domain into 500 bins then calculating the average signal for
each bin. t-Distributed Stochastic Neighbor Embedding of ChIP-seq and srHC-seq data
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was performed in Matlab (R. 2019a) using the tsne function with mean gene body
H3K9me3, H3K27me3 and srHC signals as input.

Analysis of published ChIP-seq data.
For this analysis (Fig. 3d; Fig. 6f, g; Extended Data Fig. 4a; Supplementary Fig. 1;
Extended Data Fig. 6; Extended Data Fig. 10j) H3K9me3 ChIP-seq data from untreated
BJ fibroblasts was downloaded from GEO accession GSE87039. For this analysis (Fig.
3d; Fig. 5f, g; Supplementary Fig. 1; Extended Data Fig. 6; Extended Data Fig. 9b)
Gradient-seq data from untreated BJ fibroblasts was downloaded from GEO accession
GSE87039. For this analysis (Fig. 3d; Supplementary Fig. 1; Extended Data Fig. 6)
H3K27me3 ChIP-seq data from Human foreskin fibroblasts was downloaded from GEO
accessions GSM817237, GSM817240 and GSM958154. For this analysis (Extended Data
Figure 8b) the A/B compartment enrichment was downloaded from the 4D nucleome data
portal (accession 4DNFID41C3X7), the H4K20me1 ChIP-seq was downloaded from the
GEO accessions GSM521917 and GSM521915 and DNA methylation data were
downloaded from GEO accession GSM1127120.

Motif analysis
Analysis of gene promoters for enriched motifs was performed in HOMER (v.4.10). For
finding positions of known motifs, position weight matrices were downloaded from Jaspar
(Fornes et al., 2020) FOXA3(MA1683.1), HNF1a(MA0046.2), HNF4a(MA114.2),
MAZ(MA1522.1) and CREM(MA0609.2). Motif identification was performed the
findMotifs.pl command in HOMER (v.4.10; parameters -start -200 -end 200 -find) using
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the indicated position weight matrices. A threshold score of 4.5 was used for identifying
motif occurrence except where otherwise noted.

Sucrose gradient separation
Cells fixed in 4% paraformaldehyde were incubated in hypotonic lysis buffer (10mM
HEPES pH 7.4, 10mM KCl, 0.05% NP-40) for 30 minutes. Nuclei were collected by
centrifugation at 300g for 10 minutes. Nuclei was then incubated in low salt buffer (10mM
Tris-HCl pH 7.4, 0.2 MgCl2, 1% Triton x-100) for 30 minutes. Chromatin was collected by
centrifugation at 13,000xg for 10 minutes. Sucrose gradient separation was performed as
previously described (Becker et al., 2017).

Data visualization
All heat maps, violin plots, box plots, and clustering diagrams were generated using
Matlab (R. 2019a). All boxplots show the median as the center line with box limits
corresponding to upper and lower quartiles and whiskers covering 1.5x the interquartile
range.

Statistics and reproducibility
No statistical method was used to predetermine sample size. No data were excluded from
the analyses. The experiments were not randomized. The investigators were not blided to
allocation during and experiments and outcome assessment. Repeated measurements
between two samples were analyzed for significance by two-tailed Student’s t-tests. All
statistical tests, resulting P values and observation numbers are indicated in the figure
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panels or in the figure legends. Western blot experiments where one replicate is shown
were repeated twice with similar results.

Data availability
RNA-seq, ChIP-seq and srHC-seq data that support the findings of this study have been
deposited in the Gene Expression Omnibus (GEO) under accession code GSE154233.
Previously published sequencing data that were re-analyzed here are available from GEO
under

accession

codes

GSE87039,

GSM817237,

GSM817240,

GSM958154,

GSM521917, GSM521915 and GSM1127120 or from the 4D nucleome under accession
code 4DNFID41C3X7. All other data supporting the finding of this study are available from
the corresponding author on reasonable request. Source data are provided with this
paper.

Code availability
No novel programs or algorithms were utilized. All code for data analysis and visualization
is available by request.
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CHAPTER 3: ZNF695 REPRESSES HEPATIC GENES AND
REGULATES H3K9ME3-MARKED HETEROCHROAMTIN
3.1 Preface
This chapter represents a manuscript that is currently in preparation and has not yet
been submitted to a journal for peer review and publication. It has been reformatted here
in accordance with University of Pennsylvania dissertation formatting guidelines. I
designed this study, carried out many of the experiments, and wrote the manuscript with
assistance from my thesis advisor Dr. Kenneth Zaret.
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3.2 Respective Contributions
This manuscript is currently in preparation and has not yet been submitted to a journal for
peer review and publication. The majority of the experiments, analysis, and writing
presented in this chapter were conducted by myself with the guidance of my thesis advisor
Kenneth S. Zaret. Ryan L. McCarthy assisted with RNA-seq data analysis and performed
the NSG-PiZ experiments. Samuel H. Keller, Yong Hou, and Bomyi Lim performed
confocal imaging, quantification and analysis. Jonathan Lerner and Claire Makowski
performed the single-molecule imaging and data analysis. The Beijing Genomics Institute
provided support to allow for high throughput sequencing and quality control conducted
by Yu Zhong and Liqin Xu. Greg Donahue provided additional support on bioinformatics
analyses design.
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3.3 Abstract
In any given cell type, alternative lineage genes and repetitive elements are
silenced in part by heterochromatin which is typically marked by histone H3 trimethylation
at lysine 9 (H3K9me3) or lysine 27 (H3K27me3). During cellular reprogramming, genes
marked by H3K9me3 have been shown to be difficult to activate. KRAB domain-containing
zinc finger proteins (KRAB-ZFPs) are known to play a role in directing repressive histone
H3K9me3 at genes and transposable elements, but specific gene targets of individual
KRAB-ZFPs remain poorly studied. We were interested in indentifying KRAB-ZFPs that
are responsible for silencing liver genes in alternative lineages that could then be
modulated during human fibroblast to hepatocyte (hiHep) reprogramming. We identified
six putative liver lineage antagonistic KRAB-ZFPs. As H3K9me3 can block cellular
reprogramming, we used the hiHep reprogramming model to uncover diverse genes and
repetitive elements silenced by each KRAB-ZFP in fibroblasts. We conducted RNA-seq
experiments both with and without the addition of hiHep reprogramming factors while
knocking down each KRAB-ZFP. A mostly unstudied primate-specific KRAB-ZFP known
as ZNF695 became the top candidate by allowing hundreds of genes, including hepatic
genes, to be derepressed following knockdown in the hiHep reprogramming model and
facilitated the widespread loss of H3K9me3. I mapped ZNF695 localization throughout the
genome and found many binding sites at introns which were linked to observed gene
expression changes. Additionally, we were able to see that depletion of ZNF695 in hiHeps
transplanted into a diseased liver mouse model were able to produce higher levels of
human albumin that hiHeps without the knockdown. Together, these findings provided a
novel picture of ZNF695 regulatory capabilities.
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3.4 Introduction
Establishing and maintaining cell identity through gene repression is an essential cellular
function. Genes that antagonize a differentiated cell’s function must be kept off. This is
accomplished by the absence of relevant transcriptional activators of alternate cell fates,
and through the establishment of gene silencing heterochromatin at alternative fate genes
throughout the genome. The two key markers of mammalian heterochromatin are histone
3 lysine 27 trimethylation (H3K27me3) and histone 3 lysine 9 trimethylation (H3K9me3).
Classically, H3K27me3 was thought of as the more dynamic mark that rearranges
throughout development, is able to silence cell-type and lineage specific genes and
enhancers (Beisel and Paro, 2011; Margueron and Reinberg, 2011), and is variable
throughout the cell cycle (Trojer and Reinberg, 2007). H3K27me3 is deposited by the
Polycomb repressive complex 2 (Boyer et al., 2006; Ezhkova et al., 2009; Lee et al., 2006;
Xu et al., 2014). H3K9me3 has long been known to play a role in silencing repetitive
regions of the genome and transposable elements and has long been thought to be stable
in different cell types (Beisel and Paro, 2011; Hawkins et al., 2010b; Peters et al., 2001).
However, H3K9me3 has now been shown to be remodeled during development and to
play a key role in silencing lineage inappropriate protein coding genes in different cell
types (Nicetto et al., 2019; Nielsen et al., 2001; Peters et al., 2002; Wang et al., 2018; Zhu
et al., 2013). This study focuses on H3K9me3.
Cell identity is so tightly guarded that transcription factor based transdifferentiation
and reprogramming methods, such as the conversion of fibroblasts to induced pluripotent
stem cells are highly inefficient (Takahashi and Yamanaka, 2006). Reprogrammed iPSCs
impressively recapitulate true ESCs with very similar transcriptomes, functions, and
epigenetic landscapes (Cahan et al., 2014; Maherali et al., 2007; Wernig et al., 2007).
116

However, the classic iPSC reprogramming methods are highly inefficient with less than
1% of cells successfully reprogramming (Papp and Plath, 2013; Vierbuchen and Wernig,
2012). Our lab uncovered that large megabase scale domains of the genome enriched for
H3K9me3 are refractory to binding of the iPSC reprogramming transcription factors during
the first 48 hours of reprogramming which plays a role in the inefficiencies of the
reprogramming process (Soufi et al., 2012; Soufi and Zaret, 2013). In an effort to uncover
the most tightly compacted heterochromatin in the genome, our lab developed a method
known as Gradient-seq that relies upon sonication of formaldehyde crosslinked chromatin
to separate tightly compacted sonication-resistant heterochromatin (srHC) from loosely
compacted sonication-sensitive euchromatin that is then separated by size on a sucrose
gradient (Becker et al., 2017). srHC-marked genes as defined in this study are noneuchromatic genes in BJ fibroblasts as previously described (Becker et al., 2017). 60.8%
of srHC domains are also called as H3K9me3 domains, 32.8% are H3K27me3 domains
and 7.0% of domains have both marks (Becker et al., 2017) as seen elsewhere (Chandra
et al., 2012; Hawkins et al., 2010a).
Our lab showed that in part, this barrier to reprogramming can be partially
overcome by depletion of key H3K9me3 methyltransferases (Becker et al., 2017; Chen et
al., 2013; Onder et al., 2012; Soufi et al., 2012; Sridharan et al., 2013). Our lab has
extended these findings to the human induced hepatocyte (hiHep) system where human
BJ fibroblasts are transdifferentiated into hiHeps through ectopic expression of HNF1a,
HNF4a, and FOXA3 (Huang et al., 2014). In this system, many key liver genes marked by
srHC in the fibroblast fail to activate during reprogramming, especially those also marked
by H3K9me3 (Becker et al., 2017).
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We aimed to uncover how specificity is obtained in the regulation and maintenance
of gene spanning heterochromatic domains. It is now known that a vast array of
heterochromatin-associated proteins are present in human and other mammalian cells
(Alajem et al., 2015; Becker et al., 2017; Dutta et al., 2014; Federation et al., 2020; Ji et
al., 2015; Kulej et al., 2017; Kustatscher et al., 2014; Torrente et al., 2011). However, the
individual mechanisms by which many of these proteins act on heterochromatin remains
elusive.
We focused our study on H3K9me3 methyltransferase recruiting Krüppelassociated box domain containing zinc finger proteins (KRAB-ZFPs) that are known to
play a role in H3K9me3 mediated gene silencing. This class of transcription factors has
frequently been implicated in silencing and regulation of endogenous retroviruses (ERVs)
and other transposable elements (TEs) both during embryonic development and
throughout evolution by interacting with the co-repressor KAP1(TRIM28/TIF1beta) (Bruno
et al., 2019; Jacobs et al., 2014; Najafabadi et al., 2015; Turelli et al., 2014; Wolf and Goff,
2009; Wolf et al., 2015) and the methyltransferase SETDB1, enabling deposition of
repressive H3K9me3 across kilobase scale domains (Schultz et al., 2002). Members of
the KRAB-ZFP family are constantly expanding throughout the genome, evolving, and
gaining new functions (Nowick et al., 2010). KRAB-ZFPs have also been implicated in
maintaining heterochromatin and DNA methylation at imprinting control regions (Li et al.,
2008) (Coluccio et al., 2018) (Shi et al., 2019), directing histone deacetylases and the
NuRD complex to gene promoters (Schultz et al., 2001), and impactfully modulating gene
expression for as few as one gene (Gebelein and Urrutia, 2001; Groner et al., 2010;
Johansson et al., 2022).
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KRAB-ZFP silencing at genes by individual KRAB-ZFP family members remains
to be further explored as there are currently limited studies that define the repressive
activities of individual KRAB-ZFPs in detail. We were inspired by the zinc finger protein
complex RE-1 silencing transcription factor/neuronal restricted silencing factor
(REST/NRSF) that is able to silence neuronal genes in non-neuronal cells and is
ubiquitously expressed outside of the nervous system (Chen et al., 1998b; Chong et al.,
1995; Schoenherr and Anderson, 1995). REST/NRSF can mediate cell-type specific
neuronal gene silencing either through recruitment of the corepressor (CoREST) or
through the recruitment of HDACs (Ballas et al., 2001; Lunyak et al., 2002). Using these
findings from REST as a model, we generated the hypothesis that some KRAB-ZFPs
might have the ability to act as silencers of specific lineages, such as the liver lineage. We
aimed to understand if KRAB-ZFPs can act as lineage specific gene silencers, and to
understand where these factors act throughout the genome.
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3.5 Results
Identification of KRAB-ZFPs expressed in many cell types, but not liver
We first sought to identify KRAB-ZFPs that may be playing a role in silencing liver-specific
genes. KRAB-ZFPs are very abundant in mammals with over 350 members annotated in
humans and about 1/3 of known KRAB-ZFPs are primate specific (Huntley et al., 2006;
Imbeault et al., 2017). Based on the model for REST (Chen et al., 1998a; Chong et al.,
1995; Schoenherr and Anderson, 1995), we hypothesized these KRAB-ZFPs would show
a pattern of ubiquitous expression in most cell types where they have a repressive function
at liver genes, but be very lowly expressed or silent in adult human liver where their
repressive function would be silenced. We used previously generated human BJ fibroblast
RNA-seq data and compared it to ENCODE human adult liver RNA-seq data to identify
six significantly differentially expressed KRAB-ZFPs that met this criteria, ZNF695,
ZNF578, ZNF714, ZNF665, ZNF287, ZNF560 (Figure 1A) (Becker et al., 2017) . We
further used The Genotype-Tissue Expression (GTEx) Project to explore expression in
other lineages which revealed expression across multiple tissue types with extremely low
expression in the liver (Figure 1B, Supplemental Figure 1A). We also saw that each KRABZFP has unique patterns of expression across many different tissue types (Figure 1B,
Supplemental Figure 1A). We used RT-qPCR to confirm very low expression of the KRABZFPs in human liver RNA compared to BJ fibroblasts (Supplemental Figure 1B). These
studies resulted in six candidate KRAB-ZFPs to further explore as repressors of the liver
lineage.
To determine if any of the six candidate ZNFs functioned as a repressor of liver
genes, we transdifferentiated human BJ fibroblasts into hiHeps (Huang et al., 2014)
(Figure 1C). During the differentiation protocol we used two rounds of siRNAs to deplete
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individual KRAB-ZFPs and confirmed high knockdown efficiency (Supplemental Figure
1C). We carried out this differentiation protocol for seven days instead of the full 14-day
protocol to identify as many direct targets of repression by the KRAB-ZFPs as possible.
We first were interested in exploring the expression of liver genes marked by srHC,
including key hepatic genes such as bile acid receptor NR1H4, liver transcription factor
FOXA2, cytochrome P450 gene CYP2C9, and adhesion protein DSC2. We assayed five
key liver srHC genes as well as albumin by RT-qPCR following the knockdown of
individual KRAB-ZFPs in hiHeps compared to hiHeps with a non-targeting control siRNA
hiHep (Figure 1D). Knockdown of ZNF695 allowed for the most efficient de-repression of
these genes, especially DSC2, as well as greatly increased expression of albumin which
may indicate an earlier upregulation of this key marker of liver function. Interestingly, these
same findings were not replicated by potential ZNF695 co-factor KAP1 (Figure 1D). This
aligns with an earlier finding that the repressive activity of the KRAB domain does not
correlate with the ability to recruit KAP1, nor is this recruitment sufficient to explain
repressive activity (Murphy et al., 2016). These findings indicated that there do seem to
be KRAB-ZFPs that play a role in silencing liver genes, and that knockdown of these
repressors can activate hepatic genes.

ZNF695 regulates large numbers of srHC-marked genes and has minor effects on
repeat element expression
We proceeded to perform RNA-seq both with and without the addition of the hiHep
reprogramming transcription factors upon depletion of the by six curated KRAB-ZFPs at
day seven following two rounds of siRNA depletion. We assayed srHC genes (defined as
non-euchromatin marked genes in BJ fibroblasts as defined by (Becker et al., 2017)) for
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total numbers of upregulated genes in the no transcription factor condition and hiHep
reprogramming conditions with the various KRAB-ZFP knockdowns (Figure 2A). We found
that of all KRAB-ZFPs assayed, ZNF695 depletion by siRNA allowed for the largest
number of liver srHC genes to be activated and, in fact, when compared to all 97
heterochromatin associated proteins assayed in our previous study, allowed for the third
highest number of srHC genes to be derepressed following knockdown (Figure 2A, 2B)
(McCarthy and Kaeding et al., 2021). Thus, ZNF695, which is expressed in many tissues,
except liver, functionally represses many liver genes in human fibroblasts.
We previously published transcriptome based clustering of genes derepressed
following heterochromatin-associated protein depletion in hiHep conditions which included
known H3K9me3 methyltransferases and factors determined to be physically associated
with heterochromatin (McCarthy and Kaeding et al., 2021). Here we have incorporated
our additional liver repressive identified KRAB-ZFPs into that clustering analysis, based
upon the genes de-repressed by the knockdown of each of these factors during hiHep
reprogramming where each depleted gene is shown clustered with the other factor that
repressed the highest number of the same genes (Supplemental Figure 2A). Interestingly,
our 6 KRAB-ZFPs fall into multiple clusters, potentially indicating they play a role in diverse
regulation of different gene types. We also noted the diverse protein domain structure of
each of the KRAB-ZFPs in each identified repressive cluster (Supplemental Figure 2B),
including a SCAN domain on ZNF287 that can indicate function through KAP1
independent mechanisms (Itokawa et al., 2009). ZNF695 clusters with two other KRABZFPs, ZNF714 and ZNF578, indicating that they regulate overlapping gene sets
(Supplementary Figure 2A). However, upon close examination of ZNF695, KAP1, and
ZNF578, we see that the total genes derepressed by each knockdown vary considerably,
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with ZNF695 regulating over 2000 genes while KAP1 and ZNF578 each regulate only a
few hundred genes, and that there is minimal overlap between each subset of genes
(Figure 2C). This indicates that the different KRAB-ZFPS target different genes for
repression.
Knockdowns of the 5 other identified KRAB-ZFPs either reduced the expression
of srHC genes or left the vast majority of genes unchanged, with only a small number
being upregulated (Figure 2D). We did a gene ontology for tissue-specific genes only
using the total set of genes upregulated by siZNF695 hiHeps compared to siNT hiHeps
which revealed that 70 of the upregulated genes are identified as genes expressed
uniquely in liver and that was by far the most significantly represented tissue type (Figure
2E). With this additional analysis, it is clear that many of the activated genes are liver srHC
genes or even liver specific genes as shown here, indicating that ZNF695 does have a
preference for silencing genes of the liver lineage.
We used SalmonTE to evaluate changes in repeat element families following
depletion of the KRAB-ZFPs (Jeong et al., 2018). Although ZNF695 is a member of the
transposable element silencing KRAB-ZFP family, depletion of ZNF695 causes derepression of SINEs and ERV1s (Figure 3A). Considering SINEs make up about 15% of
the human genome, this slight increase in expression could represent activation at
thousands of sites (BNID 106934, (Milo et al., 2010)). We also saw that different KRABZFPs target different transposable elements, such as ZNF665 which represses LINE-1
elements which are both abundant and active in the human genome (Figure 3A).

ZN695 depletion causes widespread loss of H3K9me3
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We wanted to assess the cellular localization of ZNF695. We engineered a lentiviral
construct with a V5 tag on the C-terminus of ZNF695 (Supplemental Figure 3A).
Immunofluorescence showed that ZNF695 localizes to the nucleus in BJ fibroblasts
(Figure 4A). As ZNF695 is predicted to be a DNA binding protein with a possible role in
directing H3K9me3 methyltransferases, we used quantitative immunofluorescence
coupled with confocal microscopy to measure H3K9me3 in nuclei following siRNA
mediated depletion of ZNF695, SETDB1, SUV39H1, and the other KRAB-ZFPS ZNF578
and ZNF665 (Figure 4B, C). Interestingly, depletion of ZNF695 leads to a global reduction
of H3K9me3 and in fact has an even greater effect on total H3K9me3 levels than depletion
of the H3K9me3 methyltransferases SUV39H1 or SETDB1 alone (Figure 4B, C). The
small effects of SUV39H1 and SETDB1 depletion are likely due to compensation between
the various methyltransferases (Nicetto et al., 2019; Peters et al., 2003). Depletion of
KRAB-ZFP ZNF578 also had a profound effect on the depletion of H3K9me3 globally,
though ZNF665 did not have much of an effect (Figure 4B, C).
The clear reduction in H3K9me3 following ZNF695 depletion led us to wonder
which types of chromatin ZNF695 interacts with. Using single molecule tracking, our lab
previously showed that heterochromatin constituents in human cells interact with very low
and low mobility chromatin using single molecule tracking (Lerner et al., 2020). Here, we
created a ZNF695 and ZNF578 lentiviral expression constructs with C-terminal Halo tags
(Supplementary Figure 3B). We were able to confirm the nuclear expression of both
ZNF695 and ZNF578 with the presence of the HALO tag (Supplementary Figure 3C, D).
We then used highly inclined and laminated optical sheet microscopy to track single
molecules of ZNF695-Halo and ZNF578-HALO in human BJ fibroblasts (Chen et al., 2014;
Lerner et al., 2020). We measured the radius of confinement and the average
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displacement (Lerner et al., 2020) for both ZNF695-HALO and ZNF578-HALO (Figure
4D). We found that ZNF695-HALO associates strongly with very low and low mobility
chromatin while ZNF578-HALO does not. This agrees with our finding that ZNF695
depletion disrupts H3K9me3 (Figure 3B,C). It also complements our finding that ZNF695
has a much more robust effect on gene expression than ZNF578 (Figure 2C,D).

ZNF695 targets compacted chromatin and introns
After observing the impact of ZNF695 on H3K9me3 and repression of gene expression,
we used Cleavage Under Targets & Release Using Nuclease (CUT&RUN) to profile the
localization of ZNF695 throughout the genome. We created a lentiviral ZNF695 expression
construct with a linker and a C-terminus V5 tag (Supplemental Figure 3A). ZNF695 has
previously been tagged and subjected to ChIP-exo in human HEK293 cells (Imbeault et
al., 2017) these data were later reanalyzed which resulted in a larger peak set
(Barazandeh et al., 2018). We performed CUT&RUN with expression of ZNF695-V5 in
human BJ fibroblasts and ultimately uncovered 5,298 or 13,945 peaks depending on if we
used a threshold cutoff of 7 or 8, but ultimately decided to focus on the 5,298 peaks with
a threshold above 7 which have more well-defined peaks (Supplemental Figure 4A). We
overlapped these peaks sets with those found in the HEK293 cell reanalysis (Barazandeh
et al., 2018) and found that 5,298 peaks found in BJ fibroblasts were largely different from
the 32,115 peaks found in HEK293 cells with only 148 peaks in common between the two
peak sets, which may be due to cell type specific differences in ZNF695 targeting (Figure
5A). We next asked where in the genome ZNF695 is binding. We used HOMER to analyze
the type of genomic elements that ZNF695 binds to and found that both our data set and
reanalyzed ZNF695 peaks (Barazandeh et al., 2018) are largely at introns (Figure 5B).
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Our data set also showed significant binding at LINEs (Figure 5B). Considering that LINEs
make up about 17% of the human genome and there are over 850,000 in the human
genome, it is possible that the 861 binding sites that we uncovered across LINEs represent
many more peaks throughout the genome that fail to be individually mapped due to the
repetitive nature of these sequences (Supplemental Figure 4B). Widespread loss of
H3K9me3 across LINEs would explain why we see such dramatic loss of H3K9me3 in
immunofluorescence assays (Figure 4B). Interestingly, we saw more activation of ERV1s
and SINEs at the transcript level following ZNF695 depletion in the hiHep condition, and
no activation in the no transcription factor condition, so there is not a clear connection
between ZNF695 binding sites and TE activation (Supplemental Figure 4B, Figure 5B).
We then confirmed that our called peaks show a high level of ZNF695-V5 coverage (Figure
5C). These findings indicate the ZNF695 binds at LINEs and introns, and the widespread
loss of H3K9me3 we see following ZNF695 depletion could be due to binding at thousands
of repetitive LINEs throughout the genome.

ZNF695 binds near sites that lose H3K9me3 and gain gene expression following
ZNF695 depletion
We were particularly interested in understanding the interplay between ZNF695-V5
binding, H3K9me3 domains, and gene expression. Therefore, we performed H3K9me3
CUT&RUN in BJ fibroblasts with and without depletion of ZNF695. We analyzed regions
1.5kb upstream and downstream of the 5,298 ZNF695 binding sites and were also able to
observe localized loss of H3K9me3 across many of these regions (Figure 5D). To tie
H3K9me3 levels to the observed gene expression changes following ZNF695 knockdown,
we plotted local H3K9me3 domains up and downstream of ZNF695-V5 peaks that overlap
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a gene that was either upregulated or down regulated following ZNF695 depletion (note
that upregulation as defined here is different than in Figure 2, upregulated for all Figure 4
and Supplemental Figure 5 panels means log2>=0.585. (1.5x fold) and p-value is not
considered) (Figure 5E, Supplemental Figure 4C). Interestingly, we found that the
upregulated genes were much more heavily marked by H3K9me3 prior to ZNF695
depletion than the downregulated genes (Figure 5E). Looking at the regions that lost
H3K9me3 genome wide following ZNF695 knockdown, 11,004 regions were uncovered
with an average size of about 10.8kb (Figure 5F). Expanding to look at the overlap
between the ZNF695-V5 peaks, domains that lose H3K9me3, and upregulated genes, we
find that there are over 1300 upregulated genes that lose H3K9me3 coverage across part
of the gene body, and over 500 peaks within 5kb upstream or downstream of an
upregulated gene body, we ultimately uncover 32 genes with a ZNF695-V5 peak, loss of
H3K9me3 following ZNF695 knockdown, and upregulation (Figure 5G, H, Supplemental
Figure 4D). We were able to uncover many genes that have an ZNF695 peak and lose
H3K9me3 or gain gene expression or both following ZNF695 depletion.

ZNF695 depletion allows for increased human albumin expression in transplanted
cells
As a further challenge to the functional consequences of reprogrammed hiHeps with
depletion of ZNF695, we chose to test their function in vivo. We transplanted 7 day
reprogrammed hiHeps with knockdown of ZNF695 in the immune deficient NSG-PiZ
mouse model (Borel et al., 2017) which readily engrafts high levels of human
xenotransplants (Figure 6A). PiZ is a mutant allele of α-1 antitrypsin (AAT), in which a
glutamate to lysine substitution has occurred (Glu342Lys) (Brantly et al., 1988). This is the
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characteristic mutation of the human disease AAT deﬁciency. Accumulation of misfolded
PiZ mutant AAT protein triggers hepatocyte injury by aggregating in the endoplasmic
reticulum, ultimately leading to inﬂammation and cirrhosis (Lomas et al., 1992). Here we
used intrasplenic injection to transplant 1 million reprogrammed hiHeps into the NSG-PIZ
model, and then proceeded to collect serum for human serum albumin ELISAs at 4-, 8-,
and 12-weeks post-transplant (Figure 6A). We also included primary human hepatocytes
(PHH) as a positive control. By 12 weeks post-transplant, we observed that ZNF695
depleted hiHeps produced significantly more human albumin than hiHeps with a nontargeting control siRNA (Figure 6B). However, the average albumin secretion was still
lower than that of the primary human hepatocytes (Figure 6B). This finding suggests that
ZNF695 depletion has a lasting effect on the chromatin environment post transplantation
and allows for a more permissive reprogramming environment once the cells are
implanted into the mouse.

3.6 Discussion
In an effort to identify KRAB-ZFPs that suppress lineage expression in non-liver cells, we
uncovered six KRAB-ZFPs including ZNF695 that are ubiquitously expressed across
tissue types but absent from human liver. Depletion of ZNF695 in hiHeps leads to the
ability to activate hundreds of tightly compacted srHC genes including many liver genes.
However, it is also clear that ZNF695 plays a role in gene silencing outside of the liver
lineage, though we must also consider that some of this gene activation may be driven
both by the hiHep transcription factors and endogenous BJ fibroblast transcription factors
that may activate alternate fate genes. We also see that ZNF695 depletion leads to a
robust reduction in H3K9me3. Through single molecule tracking and ZNF695-V5
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CUT&RUN, we were able to see the association of ZNF695 with tightly compacted
heterochromatin. Interestingly, ZNF578 did not show the same strong association with
very low mobility chromatin, indicating the diversity of KRAB-ZFP binding to chromatin.
While dCAS9-KRAB has been used in some single molecule tracking experiments (Gilbert
et al., 2013), to our knowledge this is the first single molecule tracking study performed on
a human KRAB-ZFP. At the RNA level, we saw that depletion of ZNF695 allows for
activation of SINEs and ERV1s, and we saw ZNF695 binding at LINEs. Considering the
abundance of SINEs and LINEs in the human genome, these finding indicate
decompaction of these regions which aligns with our finding that depletion of ZNF695
leads to widespread loss of H3K9me3.
Our RNA-seq findings indicate that ZNF695 likely acts through a KAP1
independent mechanism as ZNF695 and KAP1 do not seem to suppress common targets
at genes or repetitive elements. In fact, KAP1 does not seem to play a strong repressive
role in this cell type at all. Interestingly, we know that ZNF695 is primate specific, indicating
that it is recently evolved (Florio et al., 2018). Ancient KRAB-ZFPs like PRDM9 do not
interact with KAP1 (Helleboid et al., 2019) suggesting that many KRAB-ZFPs could act
through yet unknown mechanisms, however it seems unusual for a more recently evolved
KRAB-ZFP such as ZNF695 to not interact with KAP1. It is also thought that differences
in binding sites are associated with the age of KRAB-ZFPs, where ancient KRAB-ZFPs
do not bind recognizable TEs but are rather found at promoters or over gene bodies and
some are known to be able to activate or repress genes, however ZNF695 also seems to
bind primarily at introns that do not directly overlap a known TE so perhaps age of the
KRAB-ZFP is not the only defining factor (Frietze et al., 2010a; Frietze et al., 2010b;
Imbeault et al., 2017; Liu et al., 2014). These findings align with an earlier study showing
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that the repressive activity of the KRAB domain does not correlate with the ability to recruit
KAP1, nor is this recruitment sufficient to explain repressive activity (Murphy et al., 2016).
Other studies have indicated that there may be other roles for ZNF695 that could
be a subject of future investigation. It has been shown that ZNF695 is dynamically
regulated throughout development with high expression in human ESCs (Oleksiewicz et
al., 2017) possibly indicating an important role for ZNF695 in development. ZNF695 was
also shown to be growth restricting in human iPSCs by CRISPR-Cas9 screening in haploid
cells (Yilmaz et al., 2018). ZNF695 in the most highly upregulated KRAB-ZFP across many
cancer types (Machnik et al., 2019). ZNF695 upregulation has previously been associated
with HER2-enriched and basal-like human breast cancer (Li et al., 2015) hepatocellular
carcinoma (Sun et al., 2018) and as an acute lymphoblastic leukemia prognostic risk factor
(Li et al., 2017). ZNF695 methylation predicts a response of esophageal squamous cell
carcinoma to definitive chemoradiotherapy (Takahashi et al., 2015).
Ultimately, we have uncovered novel activities for a KRAB-ZFP that allow it to
regulate H3K9me3 across genes and even allow for low but increased reprogramming
ability as evidenced by increased albumin protein secretion following ZNF695 depleted
hiHep transplantation into the PiZ mouse model compared to hiHep factors alone. This
study sets a framework for future studies of KRAB-ZFPs in reprogramming experiments
and understanding their individual targets.
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3.7 Main Figures

Figure 1 | Identification of predicted liver lineage repressive KRAB-ZFPs.
A, Schematic to identify KRAB-ZFPs of interest from RNA-seq data.
B, Median tags per million (TPM) expression of ZNF695 across different tissues from
GTEX.
C, Schematic to show protocol for knockdown of KRAB-ZFPs and with 2 rounds of siRNA,
addition of reprogramming transcription factors, and day of RNA harvest.
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D, RT-qPCR data showing expression of six different genes following knockdown of the
six KRAB-ZFPs or KAP1. Expression level in siNT Control sample is normalized to 1 and
other samples are normalized accordingly.

132

Figure 2 | RNA-seq evaluation of 6 KRAB-ZFPs reveal ZNF695 as the most
repressive the liver lineage.
A, An expanded view of an analysis originally presented in figure 3a of McCarthy and
Kaeding et al., 2021. Heatmap of the fraction of srHC genes upregulated versus the
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siControl (DESeq2, Wald test with Benjamini correction for multiple comparisons, P ≤ 0.05
and log2[fold change] > 0) by each knockdown for the specified gene lineage category in
normal fibroblasts and hiHep reprogrammed cells.
B, Volcano plot displaying all up and down regulated genes in siZNF695 hiHep condition
compared to hiHep siNT Control (DESeq2, Wald test with Benjamini correction for multiple
comparisons, adjusted P ≤ 0.1 and log2[fold change] > 0.5) double check.
C, Venn diagram overlap of all genes upregulated by siZNF695, siZNF578, and siKAP1
hiHeps (DESeq2, Wald test with Benjamini correction for multiple comparisons, adjusted
P ≤ 0.1 and log2[fold change] > 0.5).
D, Volcano plots displaying all up and down regulated srHC-marked genes in siZNF695
hiHep condition compared to hiHep siNT Control (DESeq2, Wald test with Benjamini
correction for multiple comparisons, adjusted P ≤ 0.1 and log2[fold change] > 0.5) double
check.
E, Tissue specific gene enrichment analysis from TissueEnrich (Jain and Tuteja, 2019)
using all types of tissue-specific genes and the Human Protein Atlas (HPA) database.
Imported list was all 2070 genes upregulated in siZNF695 hiHeps.
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Figure 3 | Depletion of KRAB-ZFPs allow for activation of different repeat classes.
A, Upregulation of different families of repeat elements. The number of clades in each
family are displayed and the scale is represented as the proportion of the family
significantly induced.
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Figure 4 | ZNF695 associates with very low mobility chromatin and knockdown of
ZNF695 causes a global depletion of H3K9me3.
A, Immunofluorescence images showing ZNF695 expression (green) and 4,6-diamidino2-phenylindole (DAPI; blue) with hub node knockdowns in human BJ fibroblasts.
B, Immunofluorescence images showing H3K9me3 (green) changes and DAPI (blue) with
KRAB-ZFP and methyltransferase knockdowns in human BJ fibroblasts.
C, Quantification of H3K9me3 mean immunofluorescence for knockdowns of KRAB-ZFPs
relative to the siNT Control (WT) (n > 100 nuclei for each treatment). For the box plots,
the center line, bounds and whiskers represent the median, 25–75% range and minimum
to maximum values, respectively. The dense heterochromatin signal represents the
percentage of pixels above pixel intensity of 8000.
D, Single molecule tracking plots of ZNF578-Halo (7 cells, n=6182 molecules) and
ZNF695-Halo (10 cells, n=5935 molecules). Scatter density plot of radius of confinement
versus average displacement assigned to n = 104,602 histone H2B motion tracks. Motion
states as defined in (Lerner et al., 2020). Very low-mobility chromatin (vL); low-mobility
chromatin (L); intermediate-mobility chromatin (I); high-mobility chromatin (H); very highmobility chromatin (vH).
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Figure 5 | ZNF695 binds primarily at introns and LINEs and loss of specific H3K9me3
domains following ZNF695 depletion can be corelated with gene expression
changes.
A, Comparison of my called 695-V5 CUT&RUN peaks in BJ fibroblasts and ZNF695 ChIPexo peaks from HEK293 cells from (Barazandeh et al., 2018).
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B, Annotation of my 695-V5 CUT&RUN peaks in BJ fibroblasts and ZNF695 ChIP-exo
peaks from HEK293 cells from (Barazandeh et al., 2018) conducted with HOMER.
C, Heatmap showing coverage of ZNF695-V5 CUT&RUN across the 5,298 called peaks,
1kb upstream and downstream of peak center.
D, H3K9me3 CUT&RUN coverage across BJ fibroblasts with siNT control knockdown
(KD) or siZNF695 knockdown across the 5,298 called peaks, length normalized 1.5kb
upstream and downstream of peak, z-score normalized. The third column in the change
between the two conditions, and all columns are sorted on this condition in ascending
order.
E, H3K9me3 across ZNF695-V5 peaks that overlap a differentially expressed gene, length
normalized, 1.5kb upstream and downstream. Differentially expressed genes defined as
log2(Fold Change)>=0.585 for upregulated genes or log2(Fold Change)<=-0.585 for down
regulated genes, p-value was not considered. Up and downregulated genes are sorted in
descending order based on gene expression. 608 peaks across upregulated genes, 533
peaks across downregulated genes.
F, Plot of domain sizes of CUT&RUN H3K9me3 domains that are 1.5x or more higher in
the siNT control BJ fibroblasts compared to the siZNF695 BJ fibroblasts.
G, Genome browsers tracks showing coverage of ZNF695-V5 CUT&RUN in BJ fibroblasts
(2 replicates), H3K9me3 CUT&RUN with siZNF695 or siNT Control (3 replicates each),
called regions that lose H3K9me3 with ZNF695 knockdown, and siNT Control hiHep RNA
and siZNF695 hiHep RNA (2 replicates). This region is across liver srHC gene ACMSD,
lost an H3K9me3 domain, and significantly gained gene expression following ZNF695
depletion.
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H, Genome browsers tracks showing coverage of ZNF695-V5 CUT&RUN in BJ fibroblasts
(2 replicates), called ZNF695-V5 peaks, H3K9me3 CUT&RUN with siZNF695 or siNT
Control (3 replicates each), called regions that lose H3K9me3 with ZNF695 knockdown,
and siNT Control hiHep RNA and siZNF695 hiHep RNA (2 replicates). This region is
across RefSeq genes XR_001748165.1 and SNORA88 and has a ZNF695 peaks and
loss of an H3K9me3 domain following ZNF695 depletion.
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Figure 6 | Depletion of ZNF695 in hiHeps before transplant in NSG-PiZ mice leads
to increased albumin secretion.
A, Schematic of timeline from production of 7-day hiHeps with siRNA knockdowns, to
intrasplenic injection of hiHeps into NSG-PiZ mice, to serum collection times for human
albumin (ALB) ELISAs.
B, Human serum albumin levels from ELISAs calculated from hiHeps with siZNF695 or
siNT Control treatments at 4-, 8-, and 12-weeks post-transplant into NSG-PiZ mice. PHH
(n=7), siNT Control hiHep (n=5), siZNF695 hiHep (n=4).
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3.8 Supplemental Figures
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Supplemental Figure 1 | Evaluation of expression of KRAB-ZFPs and validation of
siRNAs.
A, Median tags per million (TPM) expression of KRAB-ZFPs from GTEx, accessed
04/29/2022.
B, Expression of the KRAB-ZFPs verified in a human liver RNA sample (n=1 sample) and
BJ fibroblast samples (n=2 samples).
C, RT-qPCR based calculation of knockdown efficiency of KAP1 and each of the KRABZFPs (n=2 samples per siRNA) in BJ Fibroblasts. Samples normalized to expression level
in BJ Fibroblast with siNT Control and level set to 1.
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Supplemental Figure 2 | KRAB-ZFPs repress specific gene targets and cluster into
different repressive groups.
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A, An extended version of the clustering analysis presented in (McCarthy and Kaeding et
al., 2021) with the addition of the 6 KRAB-ZFPs (circled in red). Nearest neighbor
clustering analysis of srHC genes upregulated by each knockdown (black nodes) during
hiHep reprogramming, and a display of the fraction of total genes shared with the
connected knockdown (colored connections) represented in an anticlockwise manner
(DESeq2, Wald test with Benjamini correction for multiple comparisons, adjusted P ≤ 0.1
and log2[fold change] > 0.5).
B, Domain structures of each of the KRAB-ZFPs organized by their regulatory cluster. The
domains include SCAN, KRAB A, KRAB B, and zinc fingers. The purple boxes represent
zinc finger domains with “A” representing atypical domains and “D” representing
degenerate domains.
C, Figure 3d from (McCarthy and Kaeding et al., 2021). Annotated to indicate which cluster
each KRAB-ZFP belongs in. Histone profiles, input subtracted, for H3K9me3, H3K27me3
and srHC for srHC genes upregulated uniquely by each cluster. TSS, transcription start
site. TTS, transcription termination site. Euchr., euchromatin.
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Supplemental Figure 3 | Schematics of ZNF695 lentiviral construction and HALOtagged proteins display nuclear expression.
A, Schematic of c-term ZNF695 V5 construct used for imaging and CUT&RUN (ZNF695V5).
B, Schematic of c-term ZNF695 and ZNF578 HALO-tag constructs used for single
molecule tracking experiments (ZNF695-HALO and ZNF578-HALO).
C, Representative images of ZNF695-HALO and ZNF578-HALO expression in BJ
fibroblasts and brightfield images. 30s exposure for immunofluorescence.
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Supplemental Figure 4 | ZNF695 binds near genes that also lose H3K9me3 and has
many binding sites at transposable elements with hundreds of thousands of copies
in the human genome.
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A, Table of approximate abundance of transposable elements throughout the human
genome, along with counts of each peak type that ZNF695-V5 binds. From BNID 106934
(Milo et al., 2010).
B, Browser tracks of ZNF695-V5 CUT&RUN used to determine cutoff peak height of 7 or
8.
C, Proportion of ZNF695-V5 peaks called at different threshold that overlap different types
of genes.
D, Venn diagram comparison of upregulated genes following ZNF695 depletion
[Upregulated = log2(fold change)>=0.585 (p-value ignored)], ZNF695-V5 peaks that
overlap genes, and H3K9me3 regions that lose H3K9me3 following ZNF695 depletion.
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3.9 Supplemental Tables
Supplementary Table 1 | Two ThermoFisher human silencer select siRNAs used for
each gene.
Gene
Symbol

Full Gene Name

siRNA
ID

Sense siRNA
Sequence

Antisense
siRNA
Sequence

siRNA
#

Used for
Sequencing

SiSel_N
C1

Silencer Select Negative
Control #1 siRNA

s813

UAACGACGC
GACGACGUA
Att

UUACGUCGU
CGCGUCGUU
Att

1

YES

SiSel_N
C2

Silencer Select Negative
Control #2 siRNA

s814

UCGUAAGUA
AGCGCAACC
Ctt

GGGUUGCGC
UUACUUACGA
tt

2

NO

KAP1
/TRIM28

KRAB interacting protein 1 /
tripartite motif containing 28

s19778

GCGGAAAUG
UGAGCGUGU
Att

UACACGCUCA
CAUUUCCGCt
g

1

NO

KAP1 /
TRIM28

KRAB interacting protein 1 /
tripartite motif containing 28

s19779

GGCCCUAUU
CUGUCACGA
Att

UUCGUGACA
GAAUAGGGC
Cag

2

YES

ZNF578

zinc finger protein 578

s45021

GGAAGACUU
UUAAUGUAC
Att

UGUACAUUAA
AAGUCUUCCc
a

1

YES

ZNF578

zinc finger protein 578

s45022

GUAGCUCAU
UUGUAAGGA
Att

UUCCUUACAA
AUGAGCUACa
a

2

NO

ZNF287

zinc finger protein 287

s32956

GAACCAUGG
AUGGUGAUA
Att

UUAUCACCAU
CCAUGGUUCtt

1

NO

ZNF287

zinc finger protein 287

s32957

GUACUUACC
UUAUUCGAC
Att

UGUCGAAUAA
GGUAAGUACt
c

2

YES

ZNF560

zinc finger protein 560

s45048

GCUCAUAUC
UUACCAAAC
Att

UGUUUGGUA
AGAUAUGAGC
ac

1

YES

ZNF560

zinc finger protein 560

s45049

CCUCCAGUC
UAGUUGAUC
Att

UGAUCAACUA
GACUGGAGGa
g

2

NO

ZNF714

zinc finger protein 714

s45138

CACCUACAU
CAACAUAAAA
tt

UUUUAUGUU
GAUGUAGGU
Gta

1

YES

ZNF714

zinc finger protein 714

s45139

ACAAAGUGU
UUAAGCGGU
Utt

AACCGCUUAA
ACACUUUGUc
a

2

NO
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ZNF665

zinc finger protein 665

s36330

CAUUUAGUG
UACAUUCAA
Att

UUUGAAUGUA
CACUAAAUGct

1

YES

ZNF665

zinc finger protein 665

s36331

GGCAAGUGC
UUCACUCAA
Att

UUUGAGUGAA
GCACUUGCCa
c

2

NO

ZNF695

zinc finger protein 695

s32709

GACCUAUGC
UCAGCAACU
Att

UAGUUGCUG
AGCAUAGGUC
aa

1

YES

ZNF695

zinc finger protein 695

s32710

CAAAAACUU
UCAAUGCAA
Utt

AUUGCAUUGA
AAGUUUUUGc
t

2

NO
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Supplementary Table 2 | TaqMan primers/probes used.
Product Name

Company

human GAPDH TaqMan primers and
probe
human FOXA2 TaqMan primers and
probe
human NR1H4 TaqMan primers and
probe
human DSC2 TaqMan primers and
probe
human DSG2 TaqMan primers and
probe
human ONECUT1 TaqMan primers and
probe

Thermo Fisher Scientific

Product
Number
Hs02758991_g1

Thermo Fisher Scientific

Hs00232764_m1

Thermo Fisher Scientific

Hs01026590_m1

Thermo Fisher Scientific

Hs00951428_m1

Thermo Fisher Scientific

Hs00170071_m1

Thermo Fisher Scientific

Hs00413554_m1

human CYP2C9 TaqMan primers and
probe
human CYP2C19 TaqMan primers and
probe

Thermo Fisher Scientific

Hs04260376_m1

Thermo Fisher Scientific

Hs00426380_m1

human SERPINA7 TaqMan primers and Thermo Fisher Scientific
probe

Hs02384980_m1

Supplementary Table 3 | RT-qPCR primers for checking knockdown efficiency.
Gene

Forward Primer

Reverse Primer

ZNF560

GCTGGCGCCTGTTTCCT

GAAAGACCCGAACACGGTGG

ZNF578

TCTTGGAGCAGCGGGATTAG

TCCTCTTCCTCCTCTTCTAGGC

ZNF665

TGTTAGTCGCCGCAACCC

AAAGTCTTCTGAGCAGGGTCC

ZNF695

CCAAAAGCTGGGAAATGGGAC

CCTCACCAAGGGAGATCAGG

ZNF714

GCTGGAGCGGACAGGAC

CAGGTCGCCCATTTCTAGGC

ZNF287

AAAACCCACCACGGTGTTCC

ATTTCTGGCCTTCTTTGTTGCC

TRIM28

AGGCCTTTGGCAAGATTGTG

ACCCAAAGCCATAGCCTTCC

GAPDH

CCAGGTGGTCTCCTCTGACTTC TCATACCAGGAAATGAGCTTGACA
151

3.10 Materials and Methods
Cell culture
Human BJ foreskin fibroblasts were obtained from Stemgent (08-0027) at passage 6 and
cultured in Eagle’s Minimum Essential Medium (EMEM) (Sigma-Aldrich M2279)
supplemented with 10% fetal bovine serum (FBS, Hyclone SH30071) and 2mM Lglutamine (GIBCO 25030149) at 37oC and 5% CO2.

Lentivirus production
Lentiviral plasmids pWPI.1-FOXA3, pWPI.1-HNF1a, and pWPI.1-HNF4a were kindly
provided by the laboratory of Lihian Hui (Huang et al., 2014). The ZNF695-V5 lentiviral
construct was created as described below. 293T cells were seeded in 10-cm dishes at a
density of 8*10^5 cells and cultured in DMEM High Glucose (Thermo Fisher Scientific
11995) supplemented with 10% FBS (Hyclone SH30071). After 24 hours, each dish of
cells was co-transfected with a total of 5 µg of DNA, 2.5 µg of expression vector, 1.7 µg of
packaging plasmid psPAX2 (Addgene 12260) and 0.8 µg of envelope plasmid PMD2.G
(Addgene 12259), and 30 µL of transfection reagent Fugene6 (Promega E2691) along
with 570 µL of OptiMEM-I Reduced Serum Media (Thermo Fisher Scientific 31985070).
Fugene6 was first diluted in OptiMEM, vortexed for 1 second, and incubated for 5 minutes
at room temperature. Transfection mixes were generated by adding the DNA to the diluted
Fugene6, vortexing for one second, and incubating for 15 minutes at room temperature.
The mix was then added to the cells in a dropwise manner. 16 hours post-transfection, the
media was replaced with 10 mL of fresh culture media. 60 hours post media change, the
media containing the viral particles was collected, and centrifuged for 10 minutes at 2000
rpm at 4°C to remove cell debris, and filtered on a 0.45 uM syringe filter (Millipore
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SLHV033RS). Next, the supernatant was concentrated using ultracentrifugation at 25,000
rpm at 4°C for 1.5 hours with an SW-32 swinging bucket centrifuge (Beckman Coulter).
The viral pellet was resuspended in 1:100 volume of plain high glucose DMEM overnight
at 4°C, and then stored at -80°C. Viral titer was determined by immunostaining of FOXA3,
HNF1A, HNF4A and ZNF695-V5 in BJ fibroblasts 3 days post infection at various serial
dilutions of concentrated virus. Dilutions producing 10-35% of cells expressing the
transgene were used to calculate the multiplicity of infection (MOI), and the titer was
calculated using the relationship MOI = (−1) ∗ ln(1 - [proportion infected]).

hiHep reprogramming
hiHep reprogramming was conducted as previously described (Becker et al., 2017; Huang
et al., 2014). BJ fibroblasts were grown in complete EMEM Eagle’s Minimum Essential
Medium (EMEM) (Sigma-Aldrich M2279) supplemented with 10% fetal bovine serum
(FBS, Hyclone SH30071) and 2mM L-glutamine (Gibco) at 37°C and 5% CO2 were plated
on collagen I-coated plates at a density of 3 x 104 cells per well in 12-well format (larger
or smaller plates were occasionally used, and cell numbers were scaled to match plate
surface area). One day after plating, cells were infected with a cocktail of three lentiviruses
(pWPI.1-FOXA3, pWPI.1-HNF1a, and pWPI.1-HNF4a), with an MOI of 1.25 per virus, in
media containing 4.5 μg/mL polybrene. One day after infection, virus-containing media
was removed, cells were washed twice with PBS, and fresh complete EMEM was added.
On the second day after infection, medium was switched to Human Maintenance Medium
(HMM): DMEM/F12 (Hyclone SH30023.01) supplemented with 0.544 mg/L ZnCl2, 0.75
mg/L ZnSO4·7H2O, 0.2 mg/L CuSO4·5H2O, 0.025 mg/L MnSO4·1H2O, 2 g/L Bovine serum
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albumin (Sigma-Aldrich), 2 g/L galactose (Sigma-Aldrich G0750), 0.1 g/L ornithine (SigmaAldrich O2375), 0.03 g/L proline (Sigma-Aldrich P5607), 0.61 g/L nicotinamide (N0636),
1X Insulin-transferrin-sodium selenite media supplement (Sigma-Aldrich I1884), 40 ng/ml
TGF-α (Peprotech AF-100-16A), 40 ng/ml EGF (Peprotech AF-100-15), 10 μM
dexamethasone (Sigma-Aldrich D4902), and 1% FBS (Hyclone SH30071). Media was
changed with fresh HMM every 48 hours. Cells were analyzed for hepatic markers at 1214 days after lentiviral infection.

siRNA transfection experiments
All knockdown experiments were performed using two cycles of siRNA transfection, three
days apart as previously described (Becker et al., 2017). All Silencer Select siRNAs from
ThermoFisher used in experiments can be found in Supplementary Table 1.
All knockdown experiments were performed with two cycles siRNA transfection,
three days apart. Transfections were performed using 10 nM final concentration of siRNA
and 2.5 μl/ml final concentration Lipofectamine RNAiMAX (Thermo Fisher Scientific
#13778150). 10X transfection mixtures were prepared by adding 100 nM siRNA and 25
μl/ml Lipofectamine to OptiMEM-I Reduced Serum Medium (Thermo Fisher Scientific
#31985070) and incubating for 10 min at room temperature. On day 0, cells were reverse
transfected by seeding a 0.9X volume of cells/media into wells containing 0.1X volume of
10X transfection mixture. After 24 hours, siRNA-containing media was replaced with
normal culture media. After 3 days, forward transfections were performed on adherent
cells by adding 0.1X volume of 10X transfection mixture drop-wise to 0.9X volume of
culture media. Media was again replaced 24 hours after transfection. RNA or protein was
harvested on day 6, three days after the second siRNA transfection. For experiments
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performed with uninfected, proliferating fibroblasts, cells were passaged over the course
of this six-day time-course, as needed to prevent over-growth.
Knockdown experiments in cells expressing hepatic transcription factors were
performed as follows. First, on day -1, cells were infected as a batch (single well or plate)
with pWPI.1-FOXA3, pWPI.1-HNF1a, and pWPI.1-HNF4a lentiviruses (MOI of 1.25 per
virus), in media containing 4.5 μg/ml polybrene. 24 hours after infection, on day 0, viruscontaining media was removed, cells were washed twice with PBS, and cells were
detached from the plate and split for reverse siRNA transfection. The remainder of the sixday siRNA time-course was performed as described as above, except that, on day 4,
media was changed to HMM (see above under “hiHep reprogramming”) to promote
hepatic induction. By infecting cells with factors prior to splitting for transfection with
specific siRNAs, we ensure similar dosage of factors across the conditions being
compared.

Immunofluorescence
Cells were grown on 96 well glass bottom plates (MatTek PBK96G-1.5-5-F) coated with
collagen I (Corning 354236) and were plated at 3,000 cells per well 7 days prior to fixation.
At least 2 wells of siControl treated fibroblasts were included on all 96 well plates
processed for imaging to allow normalization and minimize variation in staining intensity.
To prepare for immunofluorescence cells were washed twice briefly with PBS, and fixed
in 4% paraformaldehyde (Electron Microscopy Sciences 15714) in PBS for 10 min at room
temperature. Fixed cells were washed twice with PBS, permeabilized with ice-cold 0.1%
Triton X-100 in PBS for 1 minute and washed twice with TBS-T (20mM Tris-HCL pH 7.4,
150 mM NaCl, 0.05% Tween-20). Samples were blocked with 4% donkey serum (Sigma155

Aldrich D9663) in PBS for 1-2 hours at room temperature. Primary antibody staining was
performed in 4% donkey serum in PBS for 1 hours at room temperature, using the
following concentrations: anti-H3K9me3 (1:500, Abcam ab8898) anti-V5 (1:250,
Invitrogen 14-6796-82). Cells were washed 3 times with TBS-T and then incubated with
AlexaFluor 488- or 594-conjugated secondary antibodies raised in donkey (1:500, Thermo
Fisher Scientific A32790, A32754) in PBS for 45 min at room temperature, protected from
light. Samples were washed 3 times with PBS, counterstained with 1 µg/mL DAPI (Thermo
Fisher, D1306) in PBS for 10 min. Cell were washed once more with PBS and stored at
4oC protected from light until imaging.

Imaging and analysis
Images were taken on a Zeiss LSM800 confocal microscope using a Plan-Apochromat
63x oil immersion objective. Complete images were composed of stitching together nine
512x512 16-bit images taken using bidirectional scanning. A stack ranging from 10 to 20
z slices with a step size of 0.52um was used. Between 100-300 cells were imaged per
sample condition for quantitative analysis. Image analysis was performed using MATLAB
(R2018a). Images were first manually corrected to remove cells that overlapped. The
DAPI channel was then binarized using Otsu’s method to create a mask of each nuclei.
The nuclei mask gave the total number of nuclei for each condition as well as location and
size for each nucleus. Objects smaller than 1500 pixels and partially imaged nuclei on the
border of the image were removed leaving only complete, non-overlapping nuclei. Using
the mask, the signal and location of every pixel within the nuclei mask was extracted from
the H3K9me3 channel. For each nucleus, the average H3K9me3 signal was taken.
Intensity values for each cell was normalized to the average intensity from cells on the
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same plate treated with siControl non-targeting siRNAs. Two independently targeting
siRNAs, each performed in duplicate were used for each target for quantification.

RNA isolation and Reverse Transcription-PCR
Total RNA was isolated using the ZR-96 Quick-RNA kit (Zymo Research, R1052), which
includes an on-column DNase I treatment step, and eluted in 30 μL RNase-free dH2O.
cDNA was prepared using the High Capacity cDNA Reverse Transcription Kit (Thermo
Fisher #4368814). For detection of transcripts from liver genes in hiHeps, TaqMan-based
quantitative PCR was performed using the TaqMan Gene Expression Master Mix (Thermo
Fisher #4369016), and data was normalized to an average of GAPDH. To check siRNA
knockdown efficiency, qPCR was performed using Power SYBR Green PCR Master Mix
(Thermo Fisher #4367659), and data was normalized using the GAPDH primer as an
endogenous control. qPCR reactions were run in 384-well format on an 7900HT RealTime PCR machine (Thermo Fisher #4329001), using the following thermal cycler
protocol: 50°C for 2 min, 95°C for 10 min, followed by 45 cycles of 95°C for 15 s then 60°C
for 1 min. See Supplementary Table 2 for TaqMan primers/probes used. See
Supplementary Table 3 for SYBR knockdown efficiency primers.

RNA-seq library preparation
75-100 ng of isolated RNA was used to prepare RNA-seq libraries for sequencing. All
custom primers used in cDNA synthesis are listed below. An oligo-dT primer was used to
perform poly-A enrichment and was incubated with the sample for 5 minutes. First-stand
cDNA synthesis was performed with Superscript II Reverse Transcriptase (Invitrogen
18064022) and a template switch oligo by incubating for 1.5 hours. Second-strand cDNA
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synthesis was performed with the KAPA HiFi HotStart Ready Mix (Roche 7958927001)
and an IS primer with 3 cycles of PCR amplification. 5ng of cDNA was fragmented using
the Tn5 enzyme-adaptor compound. 15 cycles of PCR were then carried out with
barcoded primers compatible with the BGISEQ-500. The 300-500bp DNA fragments were
selected and purified. The fragments were then heat-denatured and one of the single
strands was circularized with DNA ligase to obtain a single strand circular DNA library.
The remaining single strand was digested with the exonuclease. The sequencing process
was conducted according to the BGISEQ-500 protocol as described (Huang et al., 2017).
Primers used in cDNA prep:
Oligo-dT: 5′-AAGCAGTGGTATCAACGCAGAGTACT30VN-3′
TSO: 5′-AAGCAGTGGTATCAACGCAGAGTACrGrG+G-3′
(rG= riboguanosine, +G= locked-nucleic acid)
IS Primer: 5′-AAGCAGTGGTATCAACGCAGAGTAC-3′

RNA-seq data processing
Reads with low quality, adapter, high N rate or poly-A sequences were filtered out from
the raw FASTQ data before alignment using SOAPnuke (Chen et al., 2018). After filtering,
we obtained ~33 million paired 50 base reads per sample on average. Clean reads were
aligned to the hg38 reference and gene expression levels were quantified using RSEM (Li
and Dewey, 2011).

Batch effect correction of RNA-seq data
Batch effect differences were detected and adjusted for using Combat batch effect
correction algorithm (Johnson et al., 2007) in R (v.3.5.2). Per gene reads were normalized
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to total sample reads and Combat batch effect correction algorithm was applied to
normalized data to ensure that relative gene expression distributions were the same
between sequencing batches. To minimize the chance that batch effect correction would
lead to false positive expression gene models with 1 or fewer mapping reads were set to
a value of 0 after batch effect correction.

RNA-seq data analysis
Batch effect corrected read counts were analyzed by the DESeq2 (v.1.22.2) package in R
(v.3.5.2). Differentially expressed genes were determined in a pairwise manner. srHC
genes were considered upregulated if they had a log fold change value>0 and an adjusted
p-value<=0.05.

Clustering of proteins by shared repressed genes and analysis of clusters
Clustering analysis was performed as described in (McCarthy and Kaeding et al., 2021)
with the addition of the 6 KRAB-ZFPs identified here. A pairwise distance score was
calculated between all 79 total proteins as the number of common repressed genes
multiplied by the mean fraction of shared genes for each member of the pair; with higher
scores indicating greater similarity. Clustering was performed by merging each protein into
the cluster of its nearest neighbor.

Repeat analysis by SALMONTE
Expression of transposable elements genome wide were analyzed from the RNA-seq data
using SalmonTE (Jeong et al., 2018). Salmon was run using Python (v.3.6.3) with the
parameter –exprtype TPM. The quantification files produced were then analyzed for
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differential expression between knockdown samples and non-targeting controls samples
in R (v.3.4.2) using EdgeR (v.3.20.9) and the GLM method.

ZNF695-V5, ZNF578-HALO, ZNF695-HALO plasmid generation
To create a ZNF695 lentiviral construct with an c-term V5 tag, the lentiviral back bone
used was MYC_pLX307 [a gift from William Hahn & Sefi Rosenbluh (Addgene plasmid #
98363 ; http://n2t.net/addgene:98363 ; RRID:Addgene_98363)], MYC was excised from
the backbone using NheI (NEB) and SpeI (NEB). The V5 tag and flexible linker were PCR
amplified from pLenti6.2-ccdB-3xFLAG-V5 [ a gift from Susan Lindquist & Mikko Taipale
(Addgene plasmid # 87071 ; http://n2t.net/addgene:87071 ; RRID:Addgene_87071)]. The
ZNF695 sequence was amplified from a custom GenScript plasmid. The ZNF695 ORF
was cloned into pcDNA3.1+/C-(K)-DYK, immediately after the Kozak sequence.
Fragments were assembled using Gibson Assembly Master Mix (NEB E2611L).
Halo-Tag lentiviral constructs were cloned as described in (Lerner et al., 2020).
The gene of interest (ZNF578 or ZNF695) was PCR amplified with appropriate primers.
ZNF695 was amplified from the GenScript ZNF695 plasmid described above and ZNF578
was amplified from BJ Fibroblast cDNA. ORFs of interest were PCR amplified with the
adequate primers and assembled using Gibson Assembly Master Mix kit (NEB E2611L)
with EcoRI (NEB) digested TETO-FUW-OCT4 [a gift from Rudolf Jaenisch (Addgene
plasmid # 20323 ; http://n2t.net/addgene:20323 ; RRID:Addgene_20323)].

ZNF695-V5 and H3K9me3 CUT&RUN methods, library preparation, and sequencing
CUT&RUN was performed as described in (Meers et al., 2019a). An interactive version of
this protocol is available on protocols.io at dx.doi.org/10.17504/protocols.io.zcpf2vn. The
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following modifications were made: 500,000 BJ fibroblast cells per replicate were used.
Accutase was used to dissociate cells. The Wash Buffer was altered to final
concentrations of 20mM HEPES pH 7.5, 0.5mM spermidine, 75 mM NaCl, and Roche
Complete Protease Inhibitor EDTA-free. The digitonin concentration was altered to 0.05%
for the Dig-wash buffer, the Antibody buffer and the 2x Stop buffer. Binding of primary
antibodies was always carried out overnight. For H3K9me3, the antibody used was Abcam
ab8898. For V5, the antibody used was ThermoFisher Ref#46-0705, Lot# 2378586.
Secondary antibodies and associated wash steps were not used for histones. When
binding the protein A/G-MNase fusion protein only 50uL of DIG-wash buffer and MNase
was used. The standard chromatin and digestion option 1: standard CUT&RUN protocol
was used. During the elution of CUT&RUN fragments from insoluble nuclear fragments
the elution was carried out for 20 minutes. The final samples were resuspended in 30uL
of 0.1x TE.
The libraries were prepped using the following protocol: Nan Liu 2021, Library
Prep for CUT&RUN with NEBNext® Ultra™ II DNA Library Prep Kit for Illumina® (E7645)
found at protocols.io: https://dx.doi.org/10.17504/protocols.io.bagaibse. The protocol was
also described in (Liu et al., 2018) and is optimized for small fragments 25-150 bp. 15 µL
of each sample was used for library preparation. 13 cycles of PCR amplification were
used. The first round of size selection during cleanup of PCR amplification was skipped
for H3K9me3 samples and 30uL of AmpureXP beads were used for the second round of
size selection for histone profiles. Library profiles were checked using the Agilent High
Sensitivity DNA TAPESTATION and library size was determined. Library concentrations
were determined using Qubit.
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Diluted libraries were denatured in 0.2 M NaOH, loaded into the cartridge of the
NextSeq 500/550 High Output v2 kit (Illumina FC-404-2005, 75 cycles) at a concentration
of 3.2 pM in the kit’s Hybridization Buffer, and sequenced in an Illumina NextSeq 500
machine.

Alignment and visualization of CUT&RUN experiments
To analyze the CUT&RUN data, first, paired-end fastq files were trimmed using
TrimGalore v0.6.6 with the options --illumina --paired -q 33. They were aligned to hg38
with bowtie2 v.2.3.4.1 and the options --local --very-sensitive --no-unal --no-mixed --nodiscordant -I 10 -X 700. Reads greater than 700 bp were removed. Other required
packages used: FastQC v.0.11.2, cutadapt v.3.7, samtools v.1.1. Bigwig files were
visualized using IGV.

ZNF695-V5 CUT&RUN peak calling method
Peaks were called using SEACR v1.3 with both replicates combined as described in
(Meers et al., 2019b) with the options --0.01 non stringent. Blacklisted peaks were
removed. Peaks with scores below 8 were removed as they did not stand out beyond
background, and peaks above 13 were removed as they appeared in all samples
regardless of antibody.
Peaks were annotated for the type of genomic regions that they overlap with
HOMER v4.6 following a liftover to hg19.

H3K9me3 CUT&RUN domain calling method
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H3K9me3 domains were called using the zdomain-caller v.June2018 as described in
(Becker et al., 2017). The options used were 10kb windows and 0.5kb sliding bins. A log2
division score of 0.585 was used in which H3K9me3 coverage in the siNT Control BJ
Fibroblast samples was 1.5x higher or more than in the siZNF695 BJ Fibroblast samples.

Live cell single molecule tracking imaging experiments
The live cell single molecule imaging experiments were done as described in (Lerner et
al., 2020). All single molecule live cell imaging was carried out on a Nanoimager S from
Oxford Nanoimaging Limited (ONI), in a temperature and humidity controlled chamber, a
scientific Complementary metal–oxide–semiconductor (sCMOS) camera with a 2.3
electrons rms read noise at standard scan, a 100X, 1.49 NA oil immersion objective and
a 561 nm green laser. Images were acquired with the included Nanoimager software.
30,000 BJ Fibroblast cells were cultured in LabTek-II chambered 8 well plates (Lab-Tek
155049), transfected with the appropriate tetracycline-inducible lentivirus when necessary
(without rtTA or doxycycline to keep low levels of expression) and then incubated at 37C
5% CO2 for 3 days. Before imaging, cells were treated with 5nM of Janelia Fluor 549
(JF549) HaloTag ligand (a kind gift from Luke Lavis, HHMI) for 15 minutes. Cells were
subsequently washed three times in PBS at 37C, and Phenol Red-free Low Glucose
medium was added to each well. All imaging was carried out under HILO conditions
(Tokunaga et al., 2008). For imaging experiments, one frame was acquired with 100ms of
exposure time (10 Hz) to measure the intensity of fluorescence of the nuclei. Acquisition
were realized over a field of 50380mm with a depth of 0.2mm. All quantification and
analysis was conducted as described in (Lerner et al., 2020).
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NSG-PiZ mouse transplant experiments
1 million reprogrammed hiHeps at day 7 of reprogramming or primary human hepatocytes
resuspended in 50uL of PBS were intraspleenically injected into NSG-PiZ mice. These
injections were conducted by the University of Pennsylvania Stem Cell and Xenograft
Core located in the Smilow Center for Translational Research. At 4-, 8-, and 12-weeks
post transplantation, 100ul of blood were collected as well as blood from untransplanted
mice. The blood was coagulated and spun down to collect serum. The serum was used
for Human Albumin Elisa using the Bethyl kit (A88-129). The readings were compared to
standard control and non-transplanted NSG-PiZ mice (reading = 0). 2 technical replicates
per mouse per measurement, average of technical replicates reported.

Statistics and reproducibility
No statistical method was used to predetermine sample size. No data were excluded from
the analyses. The experiments were not randomized. The investigators were not blinded
to allocation during and experiments and outcome assessment. Repeated measurements
between two samples were analyzed for significance by two-tailed Student’s t test. All
statistical tests, resulting P values and observation numbers are indicated in the figure
panels or in the figure legends.
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CHAPTER 4: PERSPECTIVES AND FUTURE DIRECTIONS
4.1 Summary of major conclusions
The foundational hypothesis behind both major studies presented in this thesis is that the
maintenance of heterochromatin is more complicated than generally thought, and that by
better understanding how heterochromatin is maintained at specific loci, we may be able
modulate specific regions of compacted chromatin to allow to for increased gene
expression and enhanced cellular reprogramming.
Before I began my studies, our lab uncovered large megabase scale domains in
human induced pluripotent stem cells that were enriched for H3K9me3 and refractory to
the binding of the transcription factors Oct4, Sox2, Klf4, and cMyc during the first 48 hours
of iPSC reprogramming, yet the domains were able to be bound in human embryonic stem
cells (Soufi et al., 2012). These same domains include pluripotency genes that are
activated late during reprogramming in rare cell populations (Buganim et al., 2012). This
led to a desire to better understand if H3K9me3 was also an impediment to
transdifferentiation protocols such as fibroblast to human induced hepatocyte (hiHep)
reprogramming. Our hiHep transdifferentiation protocol requires lentiviral expression of
HNF4α, HNF1α, and FOXA3.
Our lab developed a biophysical method to isolate heterochromatin based on
physical compaction that relies on the sonication of chromatin then size-based separation
of fragments on a sucrose gradient termed Gradient-seq presented in Appendix B of this
thesis (Becker et al., 2017). While it was known that heterochromatic regions were
typically marked by H3K9me3 or H3K27me3 prior to this study, it was also clear that there
are instances where these marks could instead be found at actively transcribed genes
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(Blahnik et al., 2011; Riddle et al., 2012; Vakoc et al., 2005) and accessible promoters
(Breiling et al., 2001; Dellino et al., 2004). Therefore, there was a need for a histone markagnostic way to isolate tightly compacted, highly repressive chromatin that is resistant to
cellular reprogramming. With the advent of Gradient-seq, our lab was able to clearly show
that while H3K9me3 and H3K27me3-marked domains exist in both heterochromatin and
euchromatin, the heterochromatic H3K9me3 domains pose the strongest barrier to cellular
reprogramming (Becker et al., 2017). Gradient-seq was used to map sonication-resistant
heterochromatin (srHC), throughout the human genome in BJ fibroblasts. Our lab
uncovered that of the most tightly compacted heterochromatin regions in the genome,
srHC, 60.8% are also called as H3K9me3 domains, 32.8% are H3K27me3 domains and
7.0% of domains have both marks (Becker et al., 2017) as seen elsewhere (Chandra et
al., 2012; Hawkins et al., 2010a). Following isolation of the srHC regions of the genome,
proteomics was conducted to determine novel proteins that associate with this highly
compacted chromatin. This led to the discovery of 172 proteins that associate with highly
compacted chromatin.
In the beginning of my PhD, I contributed to this study by asking if we could activate
gene expression of highly repressed srHC-marked genes that generally remain silent and
are unable to be activated through cellular reprogramming, by using siRNAs to deplete
specific factors during hiHep reprogramming. Indeed we found that depletion of different
proteins had very different effects on induction of three different srHC gene transcripts
(Becker et al., 2017). From these early studies, it became clear that there is much more
diversity in the proteins responsible for regulating human heterochromatin than was
previously thought.
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As presented in Chapter 2 of this thesis, the primary focus of this study was to
uncover the genomic loci, including genes and repetitive elements, of many of the
heterochromatin associated proteins previously identified in human BJ fibroblasts. While
there are some known mechanisms of targeting the H3K9me3 methyltransferases,
SUV39H1, SUV39H2, and SETDB1, to specific loci, including through KRAB-ZFPs
(Schultz et al., 2002) or RNA-dependent mechanisms (Johnson et al., 2017). However,
for a majority of loci in the genome, it is not understood how they are targeted for
repression, or how this targeting may differ in different cell types. We deeply profiled 97
heterochromatin-associated proteins and found highly complex regulatory targets for each
factor by examining genome wide transcriptomic profiles based on RNA-seq data during
depletion of each factor both with and without the addition of hiHep reprogramming factors.
In fact, our findings indicate that essentially every factor profiled targets common and
unique loci, both at genes and repetitive elements. We demonstrated that transient
depletion of heterochromatin-associated proteins can be used to open compacted
chromatin and allow for enhanced gene expression. This finding could be used to enhance
reprogramming cells to alternate fates that extend far beyond the hiHep model presented
here.
We also found that simply removing heterochromatin-associated proteins is not
enough to elicit gene expression changes, but rather their depletion creates a more
permissive chromatin environment that can allow for gene expression changes when
perturbed, such as through the addition of ectopic transcription factors as shown here. By
clustering the heterochromatin-associated proteins by common ability to repress srHC
genes, we were able predict novel protein complexes which could be used as the focus of
future studies. We also saw that different heterochromatin associated proteins were more
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likely to target H3K9me3, H3K27me3, both modifications, or neither which resulted in four
distinct clusters of proteins that may functionally interact. Each cluster is also
characterized by key hub proteins. Interestingly, we also noted that while H3K9me3 loss
corresponded to srHC gene de-repression, we also saw that some of these same genes
actually gained H3K27me3 indicating the complexity of histone mark dynamics.
Though not a major focus of this thesis, we also found that ERH is a key player in
global heterochromatin maintenance in human cells and ERH depletion has marked
effects on global H3K9me3 levels. Interestingly, we also saw that ERH represses meiotic
and germ cell genes, indicating conserved function with S. pombe. We found that ERH is
required to maintain SUV39H1 on heterochromatin, which may explain its ability to repress
lineage-specific genes and satellite repeats. Further elucidating the role of ERH in the
regulation of human heterochromatin will certainly prove to be an interesting area for
further investigation.
As presented in Chapter 3 of this thesis, I became interested in KRAB-ZFPs that
are able to recruit H3K9me3 methyltransferase machinery and I predicted some of them
may be playing a role in specifically silencing liver genes. In an effort to identify KRABZFPs that suppress lineage expression in non-liver cells, we uncovered six KRAB-ZFPs
including ZNF695 that are ubiquitously expressed across tissue types but absent from
human liver. Of these identified factors, ZNF695 became the target of primary interest.
Depletion of ZNF695 in hiHeps leads to the ability to activate hundreds of srHC genes and
the total collection of upregulated genes includes many liver genes. We also saw that
ZNF695 depletion leads to widespread loss of H3K9me3. Using single molecule tracking,
we saw that ZNF695 associates with very low mobility chromatin, indicating that it is
binding to highly repressed regions. ZNF695 seems to be a slightly unusual KRAB-ZFP
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that binds largely to introns instead of specific TEs, though each instance of TE binding
could represent multiple instances across the genome due to their repetitive nature. Some
studies have predicted that differences in KRAB-ZFP binding sites are associated with the
evolutionary age of the KRAB-ZFP, where ancient KRAB-ZFPs do not bind recognizable
TEs but are rather found at promoters or over gene bodies, however ZNF695 seems to
bind primarily at introns and LINE elements, so age of the KRAB-ZFP is not the only
defining factor (Frietze et al., 2010a; Frietze et al., 2010b; Imbeault et al., 2017; Liu et al.,
2014). Depletion of ZNF695 even allows for increased reprogramming ability as evidenced
by increased albumin protein secretion following siZNF695 hiHep transplantation into the
PiZ mouse model. This finding was particularly interesting because it shows a lasting
epigenetic change as a result of ZNF695 depletion that persists for at least 12 weeks.
Ultimately, we have uncovered novel activities for a KRAB-ZFP that allow it to regulate
H3K9me3 across genes and transposable elements.

4.2 Selectively unlocking heterochromatin
My research, as noted, has led to many open questions that could lead to additional paths
of investigation. Previous proteomics work from our lab and others has shown the vast
array of nuclear and heterochromatin-associated proteins that exist in human and other
mammalian cells (Alajem et al., 2015; Becker et al., 2017; Dutta et al., 2014; Federation
et al., 2020; Ji et al., 2015; Kulej et al., 2017; Kustatscher et al., 2014; Torrente et al.,
2011). My work presented in Chapter 2 of this thesis explores targets transcriptionally
regulated by 97 of these factors, and my work in Chapter 3 explored 6 additional KRABZFPs, however, the individual mechanisms through which many of these proteins act on
heterochromatin remains elusive. Known mechanisms of KRAB-ZFP H3K9me3
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methyltransferase recruitment require KRAB-ZFP to recruit the co-repressor KAP1 and
then SETDB1, but whether some KRAB-ZFPs may be able to engage with SUV39H1/2
through alternate mechanisms is unknown. The mechanism of specificity to promote
KRAB-ZFP binding to specific sites is also not well understood. It is also unclear if the
identified heterochromatin-associated proteins act primarily in fibroblasts, or if they work
ubiquitously in most cell types. Expanding studies of these identified factors into other cell
types could certainly be of interest. Additionally, it would be interesting to selectively study
factors to understand if they are playing a role in establishment versus maintenance of
heterochromatin.
A logical next step could be to try different types of cellular reprogramming models,
such as to neuronal or macrophage lineages, and ask if different heterochromatinassociated factor depletions allow for increased reprogramming with functional outcomes
towards different lineages. Considering our studies have only been carried out in fibroblast
to hiHep conversions, it is certainly possible that other factors might create more
permissive environments for alternate lineages. Conversely, perhaps depletion of the
same factors is useful for other conversions. Our findings with ERH suggest it could
potentially be a more general factor since it plays a role in overall H3K9me3 regulation.
ZNF695 on the other hand, predicted to be relevant specifically for the liver lineage, may
be less useful for other conversions. We found that while depletion of the heterochromatinassociated factors creates a more permissive environment for reprogramming factors and
gene expression, the addition of the hiHep factors were required to truly see a change,
and we were able to see increased motif occurrences of HNF4a, HNF1a, and FOXA3 at
the upregulated genes. Therefore, it may be possible to predict lineages that may be more
easily converted first by knocking down the associated factor, then mapping the H3K9me3
170

change, and then performing motif analysis at regions that change H3K9me3 and see if
there are enriched motifs for transcription factors of a specific lineage. The reprogramming
process could then be carried out to the appropriate lineage and assayed for gene
expression or evaluated by functional assays for the cell type of interest. This type of
analysis would confirm that these findings are universally relevant and provide a
potentially useful modulation strategy for those interested in the growing field of cell
therapies.

4.3 In vitro and in vivo studies of reprogrammed cells and epigenetic
inheritance
In the ZNF695 study, we reprogrammed human BJ fibroblasts to hiHeps for 7 days while
depleting ZNF695, then implanted them into NSG-PiZ mice through intrasplenic injection
to allow for engraftment into the liver. The NSG-PiZ mouse model (Borel et al., 2017)
which readily engrafts high levels of human xenotransplants, encodes PiZ which is a
mutant allele of α-1 antitrypsin (AAT) in which a glutamate to lysine substitution has
occurred (Glu342Lys) (Brantly et al., 1988). Accumulation of misfolded PiZ mutant AAT
protein triggers hepatocyte injury by aggregating in the endoplasmic reticulum, ultimately
leading to inﬂammation and cirrhosis (Lomas et al., 1992). We were able to determine that
these ZNF695 depleted cells produced higher levels of human albumin in the PiZ mice
after 12 weeks than the hiHeps without ZNF695 depletion, but lower levels than seen with
primary human hepatocytes. Albumin is not an srHC gene in fibroblasts, so there is not
necessarily a large barrier to overcome with its expression. However we did also notice
increased expression at the RNA level of albumin pre-transplant. Therefore, it does seem
that increased albumin is a direct effect of ZNF695 depletion. From the NSG-PiZ
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transplant experiments, it is not entirely clear if the increased secretion is due to more
albumin secreted per implanted cell, an increased likelihood of engraftment, or other
consequence of ZNF695 depletion. As a follow up study, it would be interesting to isolate
the transplanted liver, fix and paraffin embed them, and stain whole sections for a pan
human cell marker, which would allow for a better understanding of how the ZNF695
hiHeps engrafted in the livers.
Another experiment of interest would be to understand what effect the mouse liver
environment has on the hiHep chromatin state after transplant. Cells could be profiled for
H3K9me3 using CUT&RUN (Cleavage Under Targets & Release Using Nuclease) before
and after transplant, with and without depletion of ZNF695. One version of this experiment
could occur shortly after transplant, another time point could be 12 weeks post-transplant.
This would allow us to determine if there are changes to the H3K9me3 patterns that persist
during transplantation, or if the chromatin landscape is completely rearranged following
transplant. Persistence of these changes in human cells would indicate that an epigenetic
change has occurred. We could couple this with RNA-seq to understand if the same genes
remain upregulated following transplantation, or if the environment within the mouse liver
completely changes the transcriptome of these cells. Another option might be to explore
transplant free models that can better recapitulate the liver environment than monolayer
cultures, such as the generation of liver organoids (Takebe et al., 2013), 3D printed livers
(Faulkner-Jones et al., 2015), or decellularized scaffolds (Park et al., 2016). These could
be coupled with in vitro hiHep functional tests such as cytochrome P450 activity or albumin
secretion tests.
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4.4 New mechanisms of heterochromatin maintenance
H3K9me3 orchestrates repression of genes during development (Becker et al., 2016;
Nicetto et al., 2019; Pace et al., 2018; Wang et al., 2018) and plays a role in hindering the
binding of transcription factors (Becker et al., 2017; Soufi et al., 2012). The organization
of these changes, maintaining repression at certain genes, while others may lose
repression, as well as repressing repetitive elements, suggests that H3K9me3
heterochromatin is controlled by diverse mechanisms. Some of the heterochromatinassociated factors that I studied in Chapter 2 have known roles in chromatin regulation,
such as GATAD2A and GATAD2B that are components of the NuRD complex, which
mediates deacetylation of histones and facilitates recruitment of PRC2 for H3K27me3
methylation (Reynolds et al., 2012), and the methyltransferase SETDB1 clustered with
PPHLN1 a component of the HUSH complex that recruits SETDB1 (Tchasovnikarova et
al., 2015). However, the vast majority of the factors that we profiled in Chapter 2 have no
previously known role in heterochromatin formation or regulation.
We did uncover ERH, which we showed to be a key player in global heterochromatin
maintenance in human cells, and saw that ERH depletion has marked effects on global
H3K9me3 levels. We also found that ERH is required to maintain SUV39H1 on
heterochromatin. In Chapter 2, we clustered the heterochromatin-associated proteins by
common ability to repress srHC genes, and used these findings to create four distinct
clusters of proteins that selectively target genes marked by H3K9me3, H3K27me3, both
modifications, or neither. These clusters might represent as of yet undiscovered regulatory
pathways or even protein complexes. One possible way to verify these interactions could
be to begin with a pulldown mass spectrometry-based discovery experiment stemming
from hub proteins identified for each of the clusters, with the intent to uncover their
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associated proteins. Ideally, some of these experiments would uncover factors that we
clustered in Chapter 2. Then, through co-immunoprecipitation experiments interactions
could be verified. This approach could reveal complexes for future study.
Interestingly, we also noted that while H3K9me3 loss corresponded to srHC gene
de-repression, we also saw that some of these same genes actually gained H3K27me3,
indicating the complexity of histone mark dynamics. Consistent with previous observations
that H3K27me3 may compensate for H3K9me3 loss (Nicetto et al., 2019; Peters et al.,
2003), we saw that following ERH depletion, we also observed an increase in H3K27me3
levels at several classes of satellite repeats observed to lose H3K9me3. We also saw
considerable variability in changes to H3K27me3, H3K9me3, and gene expression that
varied by knockdown in different clusters. That is, Cluster 1 knockdowns caused
widespread decreases in H3K9me3 global levels, but limited decreases of H3K27me3.
Knockdowns of Cluster 2 hub proteins resulted in the greatest observed decreases in both
H3K9me3 and H3K27me3, despite not activating srHC genes with high H3K9me3 and
H3K27me3 profiles. Cluster 3 knockdowns caused small decreases in global H3K9me3
and H3K27me3. Cluster 4 knockdowns exhibited no appreciable effect on H3K9me3
levels. Despite causing the greatest activation of H3K27me3-marked srHC genes,
depletion of cluster 4 node proteins GATAD2A and ZNF438 caused the smallest decrease
in H3K27me3 levels globally by immunofluorescence, indicating that the de-repression
observed in these knockdowns apparently does not function through global loss of
H3K27m3.
This collection of findings indicates that in some cases, proteins are likely
regulating both H3K9me3 and H3K27me3, but for other heterochromatin-associated
proteins only one of the marks is being regulated. Additionally, H3K27me3 can be lost
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without causing widespread gene de-repression. While we saw H3K27me3 compensating
for H3K9me3 in the ERH knockdown, it would be interesting to see if this finding is
replicated with other hub protein knockdowns. It would also be interesting to try srHC-seq
with other knockdowns and investigate how true srHC changes with the observed changes
in H3K9me3 and H3K27me3. We did not investigate if ZNF695 or the other KRAB-ZFPs
have an effect on H3K27me3, so this would be another avenue of investigation to continue
that study as well.
It is also known that lysine methyltransferases can play a role in DNA methylation
at CpG dinucleotides (Epsztejn-Litman et al., 2008; Lehnertz et al., 2003). Therefore, it
would be interesting to perform bisulfite sequencing following any of these knockdowns
and see if there is redistribution of DNA methylation. This could be especially appropriate
for further studies of ZNF695, as KRAB-ZFPs have been implicated in maintaining
heterochromatin and DNA methylation at germline-derived imprinting control regions
(Coluccio et al., 2018; Li et al., 2008; Shi et al., 2019). It has also been shown that KRABZFP mediated recruitment of KAP1 in ESCs induces cytosine methylation that is
maintained during development, but does not lead to DNA methylation in differentiated
cells (Quenneville et al., 2012) so it is also possible that there would be no changes in
DNA methylation in these studies conducted in differentiated cells.
During the initial characterization of the heterochromatin proteins, we found that a
large number of them were classified as RNA-binding proteins (Becker et al., 2017). The
heterochromatin-associated proteins are enriched for RNA-binding RGG motifs, which are
capable of mediating liquid-liquid phase separation (Thandapani et al., 2013), a process
shown potentially play a role in heterochromatin formation (Larson et al., 2017; Strom et
al., 2017). While studying ERH as presented in Chapter 3, we found that ERH co175

fractionates with histones in an RNA-dependent manner. With this finding, a future study
could focus on determining if the RNA-binding capabilities of some of our other srHC
proteins are required for interactions with chromatin.

4.5 Enhanced understanding of KRAB-ZFP regulatory capabilities
Our studies of ZNF695 coupled with previous findings indicate that there may be other
roles for ZNF695 that could be a subject of future investigation. It has been shown that
ZNF695 is dynamically regulated throughout development with high expression in human
ESCs (Oleksiewicz et al., 2017) possibly indicating an important role for ZNF695 in
development. ZNF695 was also shown to be growth restricting in human iPSCs by
CRISPR-Cas9 screening in haploid cells (Yilmaz et al., 2018). A follow up study could
interrogate ZNF695 binding in ESCs to determine if ZNF695 may have an important role
in early development. To determine if ZNF695 is truly antagonistic to the liver lineage,
ZNF695 could be expressed in HepG2 or other hepatic lineage cells and see if there is a
loss of hepatic characteristic, such as repression of hepatic gene expression programs or
gross morphological changes.
Another possible avenue of study is the exploration of ZNF695 in cancer. It was
found that ZNF695 in the most highly upregulated KRAB-ZFP across many cancer types
(Machnik et al., 2019). Interestingly, ZNF695 has been associated with several types of
cancer. ZNF695 upregulation has previously been associated with HER2-enriched and
basal-like human breast cancer (Li et al., 2015) hepatocellular carcinoma (Sun et al.,
2018) and as an acute lymphoblastic leukemia prognostic risk factor (Li et al., 2017).
ZNF695 methylation predicts a response of esophageal squamous cell carcinoma to
definitive chemoradiotherapy (Takahashi et al., 2015). Recent studies have profiled
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members of the KRAB-ZFP family that may be acting as tumor suppressors or oncogenes,
and are frequently dramatically up or down regulated in different cancer types (Cylwa et
al., 2019; Machnik et al., 2019; Sobocińska et al., 2021) so this appears to be an active
and growing area of research. Given that ZNF695 is shown to be upregulated in many
cancer types, it could be interesting to try depleting ZNF695 in some cancer cell lines and
see if there is an effect on cellular proliferation or growth. If there is, a next step could be
to try tumor growth assays in mice.
KRAB-ZFP binding in the genome continues to be difficult to analyze. KRAB-ZFPs
have a basic conserved structure in which the C-terminal C2H2 zinc finger arrays are
tandem repeats of the CX2-4CX12HX2–6H motif (where X is any amino acid) interspaced
by seven residue-long linkers (Iuchi, 2001). Each zinc finger theoretically interacts with the
3 nucleotides on the primary DNA strand at amino acid position -1, 3, 6, of each C2H2
helix, and amino acid 2 can sometimes interact with the secondary DNA strand (Ecco et
al., 2017b). Considering each KRAB-ZFP can have from 2 to more than 40 tandem C2H2
zinc fingers, the theoretical binding motifs of some of these proteins are incredibly long
(Urrutia, 2003). In fact, existing motif prediction tools often find much shorter domains than
predicted, which may suggest that KRAB-ZFP DNA binding is occurring through just a few
fingers, through RNA or other protein intermediates, or it may demonstrate limitations to
existing motif finding tools (Imbeault et al., 2017; Najafabadi et al., 2015; Schmitges et al.,
2016). Considering ZNF695 has 13 C2H2 zinc fingers, it might be interesting to try
mutating them systematically to attempt to identify if different zinc fingers are required for
DNA binding at different target sites or in different cell types.
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4.6 Final Remarks
My findings for heterochromatin-associated proteins and KRAB-ZFPs indicate that there
is still much to be explored to better understand maintenance of mammalian
heterochromatin, and that there is much more complexity to this system than previously
thought. Our studies of heterochromatin-associated proteins provide many avenues for
future investigation, some of which have been suggested here. The KRAB-ZFP study
uncovered ZNF695 as a factor of interest that may be a candidate for future mechanistic
studies of H3K9me3 establishment and maintenance, as well as a target to enhance
hepatic differentiation in reprogramming experiments. These studies have provided a
better understanding of how heterochromatin is maintained at specific loci, and delivered
a framework to modulate specific regions of compacted chromatin to allow to for increased
gene expression and enhanced cellular reprogramming.

178

APPENDIX A: MICROSATELLITE ENHANCERS CAN BE TARGETED
TO IMPAIR TUMORIGENESIS
This appendix contains an Outlook that I wrote for the journal Genes & Development about
the article “Epigenome editing of microsatellite repeats defines tumor-specific enhancer
functions and dependencies” (Boulay et al., 2018). I was able to participate in the peer
review process for this article with my advisor Dr. Kenneth Zaret, and we were asked to
write this Outlook. I wrote this article with assistance from Dr. Zaret.
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APPENDIX B: GENOMIC AND PROTEOMIC RESOLUTION OF
HETEROCHROMATIN AND ITS RESTRICITON OF ALTERNATE FATE
GENES
This appendix contains a manuscript which was published in Molecular Cell
(Volume 68, pages 1023-1037) in December 2017, of which I am an author. The majority
of the work was conducted by Justin S. Becker, a former graduate student in the Kenneth
Zaret Lab. I was able to contribute to this study by performing the RNA-seq experiments
with knockdown of RBMX/L1 and SUV39H1 along with relevant controls, as well as the
RT-qPCR experiments presented in Figures 6 and 7.
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